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Chapter 1 : General introduction
General introduction
Autism Spectrum Disorders (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD) 
are severely impairing, highly heritable, and highly heterogeneous neurodevelop-
mental disorders that manifest early in development (Lichtenstein et al., 2010). ASD 
and ADHD are two common psychiatric disorders observed in children that frequently 
co-occur (APA, 2000, 2013), yet the exact causes and mechanisms underlying the single 
and comorbid occurrence of these disorders are poorly understood. The difficulties 
encountered in identifying causal factors that increase the risk of ASD or ADHD can be 
explained, at least in part, by the large within-disorder heterogeneity in symptom pre-
sentation, developmental course and underlying etiological mechanisms. The main aim 
of this thesis is to examine shared and unique mechanisms underlying ASD and ADHD 
by comparing pre-/perinatal antecedents and associated cognitive deficits in both 
disorders. An attempt is made to parse etiological heterogeneity by forming subgroups 
based on familial re-occurrence of the disorders. By contrasting and combining findings 
of ASD and ADHD, new insights can be gained into the pathophysiology of these two 
disorders. This might facilitate research on etiology and effective, individualized treat-
ment for ASD and ADHD.
In the following sections, a more elaborate description is given of the clinical manifes-
tations and associated cognitive deficits, and the genetic and early life environmental 
risk factors of both disorders. Then the difficulties with identifying (shared) risk factors 
for ASD and ADHD are discussed, followed by a description of the theoretical framework 
and limitations of the endophenotype model and how subgrouping based on family re-
occurrence could refine this model. Finally, the specific aims as well as the outline of the 
thesis are presented. In the subsequent chapters (chapters 2-7), six empirical studies 
are described, addressing the specific aims of the thesis. These chapters are followed by 
the summary (chapter 8), the general discussion, the key findings, the limitations, and 
the directions for future research (chapter 9).
clinical manifestations of asd and adHd
ASD are characterized by impairments in social interaction, deficits in verbal and non-
verbal communication and by restricted or repetitive patterns of behavior and interest 
(APA, 2000, 2013). ASD symptoms typically manifest early in life (i.e. before age 3 years), 
however social deficits and behavioral patterns may not become fully manifest until 
social demands exceed limited capacities, and may be masked by learned strategies in 
later life (APA, 2000, 2013). ADHD is characterized by symptoms of hyperactivity (e.g. 
fidgeting, restlessness [‘always on the go’], and excessive talking), impulsivity (e.g. 
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blurting out answers before questions have been completed, difficulty awaiting turn, 
and often interrupting or intruding on others), and/or inattention (e.g. forgetfulness, 
easily distracted, struggling to follow through on instructions, and difficulty sustaining 
attention) (APA, 2000, 2013). Recent prevalence rates for ASD and ADHD lie around 
0.9%-1.1% and 1.4%-8%, respectively (Akinbami et al., 2011, Baron-Cohen et al., 2009, 
Blumberg et al., 2013, Boyle et al., 2011, Elsabbagh et al., 2012, Erskine et al., 2013, Kim et 
al., 2011, Kogan et al., 2009, Russell et al., 2014). Both disorders affect males more than 
females. Large-scale populations-based studies have shown that 2-3 times more males 
than females are affected by ASD (Kim et al., 2011). In clinical ASD samples, male-female 
ratio estimates range up to 4-5 times more males than females with ASD (Fombonne 
et al., 2011). Like ASD, ADHD is more frequent in males than females. Meta-analyses in 
population-based samples from Europe and the United States have suggested males are 
2–4 times more likely to meet full DSM-IV criteria for ADHD than females (Collin et al., 
2013, Verte et al., 2006). In clinically referred ADHD samples, the gender ratio was about 
5:1 (Boulay and Paus, 2005).
Based on diagnostic criteria, ASD and ADHD have little in common, yet ASD and ADHD 
appear to frequently occur together in the same child (Rommelse et al., 2011, Ronald et 
al., 2008) and in the same family (Freitag, 2007). About 30%-80% of children with ASD 
have symptoms that satisfy DSM-IV diagnostic criteria for ADHD (Lee and Ousley, 2006, 
Matson et al., 2013, Nydén et al., 2011, Ronald et al., 2008, Simonoff et al., 2008, Sinzig 
et al., 2009), and vice versa, about 20%-50% of children diagnosed with ADHD show 
deficits in social interaction and communication, although in a lesser extent than can 
be seen in ASD (Goldstein and Schwebach, 2004, Kotte et al., 2013, Mayes et al., 1996, 
Plomin et al., 2004, Ronald et al., 2008). ADHD has been shown to be the second most 
common comorbid disorder in individuals diagnosed with ASD (Simonoff et al., 2008). 
In clinical practice, it is sometimes difficult to differentiate between ASD and ADHD, in 
part due to the entanglement of symptom descriptions of both disorders. For example, 
inattention (a core symptom of ADHD) can easily be mistaken for social inattention 
(a core feature of ASD) (Rommelse et al., 2010b). This might explain why a substantial 
proportion of children have been alternatively given a diagnosis of one or the other 
disorder throughout development (Fein et al., 2005).
Genetic and environmental risk factors for asd and adHd
ADHD and ASD are both highly heritable (Chang et al., 2013, Lichtenstein et al., 2010). 
In ASD, heritability has been estimated at > 90% for classical autism (Freitag, 2007). In 
ADHD, approximately 73% of the phenotypic variance is explained by heritable factors 
(Burt, 2009, Faraone et al., 2005, Rommelse et al., 2011). The genetics of ASD and ADHD are 
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complex. Briefly ASD literature reports that approximately 10% of individuals with ASD 
have an identifiable genetic etiology corresponding to known chromosomal rearrange-
ments or single gene disorders (such as Fragile X), another 7%-10% carry monogenic 
forms due to de novo pathogenic mutations or copy number variances (CNVs), yet the 
majority of ASD cases likely stem from multifactorial underpinnings involving several 
to many loci and gene-gene and gene-environment interactions (Berg and Geschwind, 
2012, Devlin and Scherer, 2012, Persico and Napolioni, 2013, Ruggeri et al., 2014). ADHD 
is currently viewed as a polygenic, multifactorial disorder with (interacting) contribu-
tions from both genes and environmental factors of small effect (Williams et al., 2012). 
To date, ADHD research has mainly focused on common genetic variants in candidate 
gene studies and several genes have been implicated in the etiology of ADHD, including 
dopaminergic (e.g. DRD4, DAT1, DRD5, COMT), noradrenergic (e.g. DBH, ADRA2A), sero-
tonergic (e.g. 5-HTT, HTR1B, HTR2A), cholinergic (CHRNA4), and central nervous system 
development pathway genes (e.g. SNAP25, BDNF) (Caylak, 2012). More recently, studies 
report that rare genetic variants with a large effect (such as large rare copy number 
variations [CNVs]) may relate to ADHD etiology as well (Ben Amor et al., 2005, Williams et 
al., 2012, Williams et al., 2010).
Some studies state that the high co-morbidity between ASD and ADHD might be 
explained by shared genetic factors (Rommelse et al., 2010a). Support for this view has 
been found in recent twin-, family-, and linkage studies that indicate that ASD and ADHD 
share a portion of their heritable etiology (Lichtenstein et al., 2010, Mulligan et al., 2009, 
Nijmeijer et al., 2010). That is, about 50-72% of the contributing genetic factors overlap 
between ASDH and ADHD (Lichtenstein et al., 2010, Rommelse et al., 2010b). Thus, the 
same variant might contribute to the risk of both disorders. This is confirmed by findings 
from genome-wide association studies (GWAS) that rare CNVs identified in ADHD were 
significantly enriched for loci implicated in ASD (Lionel et al., 2011, Williams et al., 2012, 
Williams et al., 2010). Using a quantitative trait locus (QTL) approach, some overlap-
ping susceptibility loci for ASD and ADHD were found on 7q, 12q, 15q, 16q, and 18q 
(Nijmeijer et al., 2010). Recently, the Cross-Disorder Group of the Psychiatric Genomics 
Consortium reported that common single-nucleotide polymorphisms (SNPs) in regions 
on chromosomes 3p21 and 10q24, and within a L-type voltage-gated calcium channel 
subunit (CACNB2) were associated with a range of psychiatric disorders of childhood 
onset or adult onset, including ASD and ADHD (Cross-Disorder Group of the Psychiatric 
Genomics et al., 2013). The overlap of genetic factors in major psychiatric disorders (in-
cluding ASD and ADHD) confirms previously reported evidence of pleiotropy (i.e. when 
one gene has an effect on multiple phenotypes) in human complex disorders (pleiot-
ropy might involve roughly 17% of genes that are associated with diseases or disease 
traits) (Grosbras et al., 2005). Nevertheless, family studies also suggest some specificity 
in risk factors given that shared genetic variants (50-72%) do not entirely explain the 
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manifestation of ASD and ADHD. Thus, in addition to pleiotropic (transdiagnostic) risk 
factors, many genes and polymorphisms are expected to confer a liability to individual 
psychiatric diseases (Ozonoff et al., 2011). Elucidating both shared and unique causal 
variants might help answer the question why one child develops ASD whereas the other 
child develops ADHD given shared genetic risks. All in all, these findings suggest the ex-
istence of hundreds of (pleiotropic or specific) risk genes for ASD and ADHD. It is beyond 
the scope of this thesis to provide a detailed overview of the genetic variants associated 
with either ASD or ADHD or both. For extensive reviews of the literature, we refer the 
interested reader to Berg and Geschwind, 2012, Caylak, 2012, Devlin and Scherer, 2012, 
Persico and Napolioni, 2013, Ruggeri et al., 2014.
In addition to their strong genetic background, early and later life environmental fac-
tors also play an important role in susceptibility to the disorders. For example, a range 
of factors that adversely affect brain development during pre-/perinatal life are associ-
ated with an increase in the risk of ASD and ADHD. In meta-analyses of ASD, advanced 
parental age at birth, maternal prenatal medication use, gestational bleeding, diabetes, 
being firstborn, fetal distress, birth injury or trauma, low 5-minute APGAR score and low 
birth weight (< 5.5 pounds or 2,500 gram) were more frequently observed in ASD than in 
controls (Gardener et al., 2009, 2011). Additionally, maternal infections, maternal stress, 
suboptimal condition of the child at birth, prematurity, smoking during pregnancy, and 
high birth weight more than two standard deviations above average for gestational age 
were also found related to ASD (Abel et al., 2013, Visser et al., 2013). Research on ADHD 
indicates that prenatal exposure to nicotine, alcohol, drugs or toxins, and maternal 
stress, low birth weight, low maternal age and poor maternal diet are associated with 
an increased likelihood of developing ADHD (Langley et al., 2005, Mick et al., 2002, Mill 
and Petronis, 2008, Thapar et al., 2013, Throckmorton-Belzer et al., 2009). A recent study 
report that advanced paternal age was associated with offspring psychiatric morbidity, 
possibly due to increased genetic mutations during spermatogenesis. Compared with 
offspring born to fathers 20 to 24 years old, offspring of fathers 45 years and older were 
at heightened risk of ASD and ADHD (D’Onofrio et al., 2014). These findings suggest 
that certain pre-/perinatal insults might be associated with both disorders (such as 
advanced parental age, low birth weight, maternal smoking, and stress during preg-
nancy), however studies directly comparing the role of these pre-/perinatal risk factors 
in ASD and ADHD are currently lacking. It is well recognized that not all of those who 
are exposed to environmental adversity develop ASD or ADHD. Some early and later life 
environmental factors may be particularly harmful in combination with susceptibility 
genes through gene x environment interactions (Neuman et al., 2007). This thesis will 
not further address gene x environment interactions in ASD and ADHD. However, it is 
worth mentioning it, because it highlights the enormous complexity of the etiologies 
with possibly hundreds of (shared or unique) risk genes, environmental risk factors and 
15
Chapter 1 : General introduction
the interaction between those in the developmental pathways leading up to ASD and/
or ADHD, which poses a huge challenge to research that tries to figure out what makes 
an ADHD case and what makes an ASD case.
coGnitive deficits in asd and adHd
Both ASD and ADHD have been associated with impairments in various cognitive func-
tions. Studies of cognition in ASD have found deficits in intelligence, social cognition, 
executive functions (EF), and central coherence, three core cognitive domains that have 
each been proposed to explain the autistic phenotype (the cognitive theories of ASD 
are described in more detail in chapter 3) (Erskine et al., 2013, Reiersen and Todd, 2008, 
Whiteford et al., 2013). Typically, strengths in performal IQ over verbal IQ are reported in 
ASD cases compared to controls (Lee et al., 2011). Children with ASD have difficulty with 
false-belief tasks, have a poorly developed Theory of Mind, and are less able to identify 
or respond to the emotional states of others (Uljarevic and Hamilton, 2013). Studies 
have also reported deficits in planning and set-shifting, theory of mind, and fluid and 
crystallized intelligence (Happe and Ronald, 2008, Joshi et al., 2013, Pisula, 2010). Lastly, 
children with ASD often show a bias for parts versus wholes, resulting in an enhanced 
local processing style, which might explain why autistic individuals often have difficul-
ties to extract global form/meaning, but may perform superior on tasks where a local 
processing is beneficial (Frith and Happe, 1994, Pellicano et al., 2006).
ADHD is associated with deficits in executive functions, state regulation, reward 
processing, time reproduction, motor timing and motor control, and attentional control 
(Geurts et al., 2006, Luman et al., 2005, Nigg, 2005, Rommelse et al., 2008a, Rommelse 
et al., 2007a, Rommelse et al., 2008b, Rommelse et al., 2007b). Meta-analyses show that 
children with ADHD demonstrate substantial impairments in response inhibition, verbal 
and visuo-spatial working memory, planning and organization, set shifting, and process-
ing speed (Willcutt et al., 2005). Recent theories of ADHD emphasize the central role of 
attentional and executive dysfunctions, as well as impairments in affective components 
such as motivational processes and sensitivity to reward and reinforcement (Nigg et al., 
2005, Sonuga-Barke, 2005, Willcutt et al., 2005). Lately, social problems in ADHD have 
received more research interest, and studies have reported difficulties in recognizing 
facial expressions (Corbett and Glidden, 2000, Da Fonseca et al., 2009, Uekermann et al., 
2010) and affective prosody (Corbett and Glidden, 2000, Shapiro et al., 1993) in children 
with ADHD. These findings suggest ASD and ADHD share similar functional brain abnor-
malities; both are associated with deficits in executive function and with difficulties in 
social cognition (Matson et al., 2013). It is unlikely that a single theory can account for 
the range of neurocognitive deficits found in children with ASD and ADHD. Instead, it is 
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proposed that a combination of cognitive risk factors gives rise to the ASD and ADHD 
phenotypes (Nigg and Casey, 2005, Pellicano et al., 2006), but these multiple cognitive 
processes might be differentially affected in ASD and ADHD.
WitHin-disorder HeteroGeneity presents a substantial 
cHallenGe for identifyinG risk factors for asd and adHd
Given their etiological complexity, involving numerous genetic and environmental risk 
factors and the interaction between these, the identification of relevant risk factors for 
ASD and ADHD has been a great challenge. Multiple causal pathways underlie the same 
clinical profiles (a phenomenon that has been referred to in developmental psychopa-
thology as equifinality (Cicchetti and Rogosch, 1996)) and at the same time, the complex 
etiology may result in highly heterogeneous clinical profiles within ASD and within 
ADHD. This large within-disorder heterogeneity, both in symptom presentation, devel-
opmental course, and underlying etiological mechanisms, is common to both disorders 
(Jones and Klin, 2009) and strongly hinders research on etiology and effective treatment. 
For example, the identification of susceptibility genes for ASD and ADHD by linking 
genotype to phenotype has been troublesome, partly because of the heterogeneity at 
both levels (Buitelaar, 2005, Gottesman and Gould, 2003). In their hallmark paper, Got-
tesman and Gould describe that “models of complex genetic disorders predict a ballet 
choreographed interactively over time among genotype, environment, and epigenetic 
factors, which gives rise to a particular phenotype. Therefore, more optimally reduced 
measures of neuropsychiatric functioning should be more useful than behavioral “mac-
ros” in studies pursuing the biological and genetic components of psychiatric disorders” 
(Gottesman and Gould, 2003). Thus, the heterogeneity characteristic of both disorders 
on multiple levels (behavioral manifestations, associated cognitive deficits, genetic risk 
factors, and environmental precursors of the disorder) has spurred increasing interest in 
the identification of subgroups of patients possibly sharing pathophysiological under-
pinnings.
parsinG etioloGical HeteroGeneity based on underlyinG 
vulnerability traits (endopHenotypes)
One approach to create homogeneous subgroups of ASD or ADHD is to group patients 
based on their underlying endophenotypes (Gottesman and Gould, 2003, Wang et al., 
2012). Endophenotypes are defined as heritable vulnerability traits that increase the risk 
of developing a disorder (Gottesman and Gould, 2003). A variety of criteria have been 
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proposed to define viable and useful endophenotypes (Bearden and Freimer, 2006, 
Cannon and Keller, 2006, Gottesman and Gould, 2003). First, endophenotypes should 
be measured reliably and reproducibly. Second, an endophenotype must be associated 
(a) with the disease in the general population and (b) within the family. Third, the endo-
phenotype should be heritable and familial, indicating that it must have a genetic basis 
and is observable in unaffected first-degree relatives of an affected individual (given 
that first-degree relatives are likely to carry some of the susceptibility genes for the dis-
order). Last, the trait should be state-independent, meaning it should become manifest 
in an individual whether or not the illness is active. Endophenotypes do not need to 
be disease-specific; endophenotypes that affect multiple disorders should be found for 
genetically related disorders (Cannon and Keller, 2006), such as ASD and ADHD. It has 
been hypothesized that endophenotypes offer a simplified approach to dissect complex 
traits by reducing heterogeneity (Wang et al., 2012) and as such may boost the power for 
genetic analyses, as well as shed light on the functional outcomes of genes (Almasy and 
Blangero, 2001, Gottesman and Gould, 2003, Viding and Blakemore, 2007). Endopheno-
types can potentially be very helpful in ASD and ADHD research, as simple, quantitative 
and heritable traits can be typically linked to smaller sets of underlying genes compared 
to complex behavioural dimensions (Kendler and Neale, 2010, Ruggeri et al., 2014).
To test whether a trait meets the criteria for an endophenotype, an affected-unaffected 
sibling design is often applied (Almasy and Blangero, 2001, Waldman, 2005). Behavioral, 
cognitive, neuroanatomical, and biochemical abnormalities that are present in unaf-
fected parents or siblings and thus shared between affected and unaffected first-degree 
relatives are assumed to provide an index of the multifactorial liability to the disorder 
(Waldman, 2005). Conversely, abnormalities that are not shared between affected and 
unaffected siblings may have a unique effect on the development of the disorder. This 
affected-unaffected siblings design has been frequently applied in ADHD research and 
has led to many studies documenting an increased incidence of behavioral symptoms, 
comorbid symptomatology, and ADHD-related cognitive deficits in unaffected family 
members of ADHD probands [for extensive reviews, see (Rommelse, 2008, Rommelse et 
al., 2011)].
A similar strategy has rarely been applied in ASD research (Gizzonio et al., 2014, Rom-
melse et al., 2011, Tierney et al., 2012), but given the high heritability of ASD and thus 
the high likelihood that unaffected relatives share some of the heritable risk factors for 
the disorder, it is worthwhile to pursue this approach in ASD. The few studies that have 
investigated potential endophenotypes for ASD report that, amongst others, hypersero-
toninemia, macrocephaly, immune abnormalities, brain hypo-connectivity, weak central 
coherence, abnormal face processing, and impaired EF are likely candidates (Ruggeri et 
al., 2014), though more research is clearly needed before firm conclusions can be drawn. 
In addition to identifying potential endophenotypes, this affected versus unaffected 
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sibling design is also helpful in examining the role early and later life environmental risk 
factors play in a disorder. When certain environmental factors are present in both affect-
ed and unaffected siblings, these factors are probably related to an overall increased risk 
of developing the disorder (trait factors), without a unique, determining contribution to 
the disorder. Vice versa, environmental risk factors (predominantly) found in affected 
offspring but not in unaffected offspring may have a more penetrant, possibly uniquely 
determining effect on the development of the disorder (state factors).
open questions and caveats of tHe endopHenotype desiGn
Despite the advantages of the concept of endophenotypes, some open questions and 
potential caveats in relation to ASD and ADHD remain. First, a topic that is relatively 
underexplored is whether or not endophenotypes are specific for ASD and ADHD or 
shared between the disorders. Related to that, it is currently unclear whether or not 
the presence of comorbid symptoms of ADHD impacts on the manifestation of ASD 
endophenotypes and vice versa. A main cause of heterogeneity in psychiatric disease 
is the co-occurrence with other psychiatric disorders (such as ADHD symptoms in ASD 
patients and vice versa). ASD and ADHD share common etiological factors in which it is 
even possible that a comorbid diagnosis of ASD and ADHD represents a different no-
sologic entity compared to the pure forms and that the deficits of the comorbid group 
differ from the simple additive combination of the deficits associated with ASD and 
ADHD only (Rommelse et al., 2011). This suggests that studies should take these comor-
bid symptoms into account and assess the impact of these symptoms when studying 
candidate endophenotypes for a given disorder. In 2011, a comprehensive review was 
published specifying the most promising endophenotypic measures for future genetic 
research targeting pleiotropic risk genes for ASD and ADHD (Rommelse et al., 2011). Sev-
eral cognitive domains were implicated as promising pleiotropic endophenotype candi-
dates for ASD and ADHD (based on robust associations with at least one of the disorders, 
in combination with findings of comparable impairments in the other disorder, known 
neurobiological underpinnings, demonstrated heritability and familiality), including IQ 
profiles, executive functions, social cognition, motor coordination, and response vari-
ability, but only a handful of studies have pursued this issue further, including one study 
presented in this thesis (chapter 3) (Oerlemans et al., 2014). Most studies did not include 
standardized assessment for both disorders and thus psychiatric comorbidity may have 
passed unnoticed and ‘blurred’ current findings. That is, groups described as ASD might 
partially be a combined ASD+ADHD group and groups described as ADHD might also 
include children with subthreshold or full-blown ASD (Rommelse et al., 2011). With the 
possibility to co-diagnose ASD and ADHD in DSM-5, this will hopefully change, with 
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routine use of standardized measures to chart possible ADHD symptoms in individuals 
who are referred for possible ASD and vice versa being available for future research.
A second open question is whether these cognitive endophenotypes segregate 
dependently or independently within families. That is, if and to what extent multiple 
cognitive processes are influenced by similar familial factors. Most studies examining 
the viability of candidate endophenotypes have targeted one cognitive domain at a 
time. However, it is known from the literature that deficits in different cognitive domains 
are often linked (Pellicano et al., 2006, Rommelse et al., 2008b). It is of great relevance to 
gain more insight into this issue, because it could provide clues how to use these traits in 
genetic analyses and further knowledge on the etiological pathways of ASD and ADHD.
An important caveat of the endophenotype design is that it does not differentiate 
between various heritable forms of ASD and ADHD. That is, the endophenotype design 
is particularly useful under the assumption that psychiatric disorders are caused by mul-
tiple inherited risk factors, each increasing the susceptibility of the disorder by a small 
amount, that are (partly) shared between affected and unaffected relatives (Gottesman 
and Gould, 2003). However, it is known from literature that non-shared genetic and non-
genetic causes (such as de novo mutations or birth complications due to high parental 
age) underlie a substantial amount of ASD cases (Berg and Geschwind, 2012, D’Onofrio 
et al., 2014, Freitag, 2007) and recent studies point towards a role for rare genetic vari-
ants such as de novo mutations in ADHD as well (Ben Amor et al., 2005, D’Onofrio et al., 
2013, Williams et al., 2012, Williams et al., 2010). This would suggest that the usefulness 
of the endophenotype model might be limited to cases of ASD and ADHD with a posi-
tive family history (familial cases). Without adjusting for these different forms of genetic 
influences, unaffected relatives with or without familial loading for the disorder will be 
examined as a mixed group, possibly diluting findings. A recent study in schizophrenia 
confirmed the idea that unaffected relatives of psychiatric patients are a heterogeneous 
group in itself (Quee et al., 2014). The authors reported different cognitive subtypes 
(normal, mixed, impaired) within the unaffected sibling group and recommended 
that future studies should investigate underlying factors that can explain why siblings 
fit into certain cognitive subtypes (Quee et al., 2014). We would like to argue that dif-
ferent modes of genetic transmission might explain why different cognitive subtypes 
exist within unaffected relatives, with cognitively unimpaired siblings stemming from 
families with non-shared (de novo) risk factors underlying the disorder in the proband 
and the cognitively impaired siblings stemming from families with shared (inherited) 
risk factors underlying the disorder in the proband.
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parsinG etioloGic HeteroGeneity based on family occurrence 
of tHe disorder
Distinguishing multi-incidence families (here referred to as multiplex [MPX]) from 
single-incidence families (here referred to as simplex [SPX]) has been shown helpful 
in genetic ASD research. The hypothesis is that the constellation of etiological fac-
tors differs between SPX versus MPX families; it is expected that individuals from SPX 
families are more likely than individuals from MPX families to develop ASD as a result 
of sporadic genetic and/or non-genetic causes strictly personal to the patient. This has 
been confirmed by studies demonstrating that a more than threefold rate of de novo 
mutations was identified in ASD SPX families (~7-10%), compared to ASD MPX families 
(~2-3%) or control families (~1%) (Sebat et al., 2007). In contrast, members of MPX fami-
lies more often exhibit ASD traits compared to members of SPX families, indicative of a 
more pronounced role of shared genetic predispositions (Gerdts et al., 2013). See Table 
1 for a brief overview of definitions, underlying assumptions and evidence for SPX-MPX 
stratification. Thus, subgrouping based on family re-occurence might help differentiate 
between families with non-shared (de novo) risk factors underlying the disorder in the 
proband (SPX) and families with shared (inherited) risk factors underlying the disorder 
in the proband (MPX). To our knowledge, no attempts have been made so far to test 
whether the usefulness of SPX-MPX stratification translates to ADHD, but with recent 
studies confirming the involvement of highly penetrant, rare (non-)genetic risk factors 
in addition to small disease-increasing effects of multiple genes, it is highly worthwhile 
to pursue this issue further. Of great interest is further whether SPX-MPX stratification 
may also be successful in the identification of shared versus unique risk factors for ASD 
and ADHD, thus combining findings from SPX and MPX ASD and ADHD families. This 
novel application of the SPX-MPX stratification method allows us to test whether the 
overlap between ASD and ADHD in affected children and their first-degree family mem-
bers depends on the shared or non-shared causal mechanisms underlying the primary 
disorder in the family. In other words, whether the type of diagnosis (ASD or ADHD) of 
the proband is informative for behavioral comorbidity outcomes in these children and 
their unaffected relatives.
Thus, stratification into SPX and MPX families attempts to reduce etiological hetero-
geneity by differentiating between different forms of heritability in ASD and ADHD. 
Comparing SPX and MPX cases and their unaffected siblings with each other on 
behavioral manifestations and disorder-related cognitive deficits may unravel distinct 
etiological pathways for these different forms of transmission/occurrence. This may 
facilitate research into genetic risk factors and may help to (more) effective, individual-
ized treatment. Additionally, SPX-MPX stratification may further our insight into the role 
of pre-/perinatal insults in the phenotypic manifestation and developmental course of 
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ASD and ADHD by differentiating between common (potentially genetic) risk factors 
present in multiple family members (which will be more frequent in MPX families) versus 
non-shared unique (or incidental) risk factors, only present in affected persons (more 
frequent in SPX families).
table 1. Definition, assumptions and evidence for parsing heterogeneity based on family classification
SIMPleX (SPX) MultIPleX (MPX)
Definition Nuclear families with one affected 
individual
Nuclear families with two or more affected 
individuals
Graphical 
representation
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  Assumptions   
 Causes The disorder may likely be caused by rare, 
sporadic (non-) genetic (such as de novo 
mutations or early life experiences such as 
pre-/perinatal insults) risk factors unique to 
the affected individual. 
The disorder is caused by (multiple) inherited risk 
factors (i.e. risk genes or shared environmental 
factors), each increasing the susceptibility of the 
disorder by a small amount. 
 Are these 
causes likely 
shared with 
unaffected 
relatives? 
No Yes  
Evidence   
 ASD A more than threefold rate of de novo 
mutations was identified in ASD SPX 
families (~7-10%), compared to ASD MPX 
families (~2-3%) or control families (~1%) 
(Sebat et al., 2007) 
Members of MPX families more often exhibit ASD 
traits compared to members of SPX families, 
indicative of a more pronounced role of shared 
genetic predispositions (Gerdts et al., 2013) 
Aggregation of autistic traits is different for 
simplex and multiplex ASD families (Virkud et al., 
2009) 
 ADHD Rare genetic mutations or non-shared 
environmental factors with a large effect are 
related to ADHD (Ben Amor et al., 2005, 
Most ADHD studies have focused on multi-
incidence families. These studies suggest that 
ADHD is polygenic and multifactorial with 
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Graphical 
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Members of MPX fa ilie more often exhibit ASD 
traits compared to members of SPX famili s,
indicative of a more pronounced r le of shared 
gen tic predispositions (Ger t  et al., 2013) 
Aggregation of autistic traits is different for 
simplex and multiplex ASD fa i ies (Virkud et al., 
2009) 
 ADHD Rare genetic mutations or non-shared 
environmental factors with a l rge effect are
related to ADHD (Ben Amor et al., 2005, 
Most ADHD studies have focu ed on multi-
incidence f milies. Th se studies suggest that 
ADHD is polygenic and multifactorial with 
Assumptions
Causes The disorder may likely be caused by rare, 
sporadic (non-) genetic (such as de novo 
mutations or early life experiences such as 
pre-/perinatal insults) risk factors unique 
to the affected individual.
The disorder is caused by (multiple) 
inherited risk factors (i.e. risk genes or 
shared environmental factors), each 
increasing the susceptibility of the 
disorder by a small amount.
Are these causes 
lik ly shared with 
unaffected relatives?
No Yes
Evidence
ASD A more than threefold rate of de novo 
mutations was identified in ASD SPX 
families (~7-10%), compared to ASD MPX 
families (~2-3%) or control families (~1%) 
(Sebat et al., 2007)
Members of MPX families more often 
exhibit ASD traits compared to members 
of SPX families, indicative of a more 
pronounced role of shared genetic 
predispositions (Gerdts et al., 2013)
Aggregation of autistic traits is different 
for simplex and multiplex ASD families 
(Virkud et al., 2009)
ADHD Rare genetic mutations or non-shared 
environmental factors with a large effect 
are related to ADHD (Ben Amor et al., 2005, 
Elia et al., 2012, Lionel et al., 2011, Williams 
et al., 2012, Williams et al., 2010)
Advanced paternal age (associated with 
increased genetic mutations during 
spermatogenesis) is associated with 
increased risk of ADHD (D’Onofrio et al., 
2014)
Most ADHD studies have focused 
on multi-incidence families. These 
studies suggest that ADHD is polygenic 
and multifactorial with (interacting) 
contributions from both genes and 
environmental factors that increase risk 
for the disorder (Williams et al., 2012) 
and is highly heritable, confirmed by 
findings of (sub) threshold symptoms 
and cognitive difficulties in unaffected 
relatives (Banaschewski et al., 2010)
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tHe aims of tHis tHesis
Both ASD and ADHD are clinically and etiologically heterogeneous and complex dis-
orders. The difficulties encountered in identifying risk factors for either ASD or ADHD 
or both disorders could be, at least in part, explained by this large within-disorder het-
erogeneity. The main focus of this thesis is to examine shared and unique mechanisms 
underlying ASD and ADHD by comparing pre-/perinatal antecedents and associated 
cognitive deficits in both disorders. An attempt is made to parse etiological heterogene-
ity by forming subgroups based on familial re-occurrence of the disorders.
The specific aims were:
a) To identify viable cognitive endophenotypes for ASD -following ADHD research 
in which this method has been frequently and successfully applied-, and to test a) 
whether these endophenotypic candidates co-segregate within families and b) the 
impact of comorbid ADHD symptoms in this context (chapters 2 and 3).
b) To explore shared and unique underpinnings for ASD and ADHD by comparing 
behavioral traits, cognitive functioning and pre/perinatal antecedents between 
disorders and between single-, and multi-incidence families (chapters 4-7).
c) To examine the validity of SPX-MPX stratification as a means for identifying shared 
and unique underpinnings for ASD and ADHD and parsing etiological heterogeneity 
within disorders (chapters 4-7).
To this end data from two different samples of well-phenotyped groups of children 
and adolescents with ASD or ADHD, their unaffected siblings and their parents were 
analyzed.
samples
Families were recruited as part of two large family-genetic studies: the Biological Origins 
of Autism (BOA) study and the Dutch part of the International Multicenter ADHD Genet-
ics (IMAGE) study; both studies have been described in detail in previous publications 
which can be consulted for greater detail (e.g. van Steijn et al., 2012). The BOA and 
IMAGE projects aim to examine the genetic, biochemical and cognitive origins of ASD 
and ADHD and in addition study the overlap between both disorders on these levels. 
Families were included if (a) they had at least one child (aged 2-20 years) with a clinical 
diagnosis of ASD (BOA) or if they had at least one child (aged 5-19 years) with a clinical 
ADHD (combined subtype) diagnosis (IMAGE), (b) at least one biological sibling (regard-
less of age or diagnostic status) was available and (c) at least one biological parent was 
willing to participate. Exclusion criteria for all families were an IQ < 60 and a diagnosis 
of epilepsy, brain disorders or known genetic disorders, such as Down-syndrome or 
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Fragile-X-syndrome. Comorbid DSM-IV disorders were not excluded except for autistic 
disorder in the IMAGE study (other ASD subtypes were allowed). Control families were 
recruited via information leaflets that were sent to families living in the same geographi-
cal regions as the participating ASD families (BOA) or from primary and high schools 
from the same geographical regions as the participating ADHD-families (IMAGE). Se-
lected controls were required to have no formal or suspected ASD or ADHD diagnosis.
All children and parents from both cohorts were carefully phenotyped for ASD and 
ADHD using validated and standardized questionnaires and diagnostic interviews, and 
DNA was collected for all family members. All children were also subjected to a range of 
neurocognitive tasks, including intelligence (estimated total, verbal and performal IQ), 
executive functions (set shifting, visuo-spatial and verbal working memory, and inhibi-
tion), and motor functions (speed, variability, control and timing of motor output). In the 
ASD cohort, social cognition (face recognition, recognition of emotional expressions, 
and affective prosody) was assessed as well. See Table 2 for an overview of the tasks and 
measures used.
In the studies described in chapters 4-7, case families from both cohorts were strati-
fied into SPX and MPX families based on the number of affected individuals per family. 
The procedures for phenotyping and family classification are described in more detail 
in the chapters. Briefly, stratification was based on the primary diagnosis of recruitment, 
which is ASD in ASD families and ADHD in ADHD families. The presence of comorbid 
disorders was not taken into account. To classify as SPX, families were required to 
have a single affected proband, a minimum of one male sibling, and all siblings and 
parents of the proband unaffected by ASD or ADHD on the basis of non-clinical scores 
on the screening-questionnaires and/or administered diagnostic interviews. Families 
with siblings and parents who displayed (sub) threshold ASD and/or ADHD symptoms, 
in addition to the affected child, were categorized as multiplex (MPX). Families were 
excluded if a) only one unaffected parent from a presumed SPX family based on the 
number of affected children participated in this study to minimize the risk of erroneous 
categorization because of missing parental data, or b) if the affected proband had only 
female unaffected siblings to account for higher sibling recurrence risk in male siblings 
than female siblings.
tHe structure of tHis tHesis
In the first two chapters we sought to identify viable cognitive endophenotypes for ASD, 
following ADHD research in which this method has been frequently and successfully 
applied. Chapter 2 focuses on the three core cognitive domains that are proposed to 
underlie ASD (i.e. social cognition, executive function and central coherence), examining 
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table 2. Description of the neurocognitive tasks used in this thesis
Paradigma Name task Task components Dependent 
variables
Intelligence
Estimated IQ Vocabulary, 
Similarities, Block 
Design, Picture 
Completion (WISC-
III/WAIS-III)
Administered according to manual guidelines Performal, Verbal 
and Total IQ
Executive function
Inhibition Go-NoGo [GNG] 
in ASD cohort and 
STOP task in ADHD 
cohort
Stimuli consisted of go-trails and no-go-trails. 
Children were asked to press a mouse key as 
quickly and accurately as possible when the 
go-stimulus was presented, but withhold their 
response to the stop-trial.
Inhibition (% false 
alarms - % misses) 
in ASD cohort and 
Stop signal reaction 
time (SSRT) in 
ADHD cohort
Verbal 
working 
memory
Digit Span (WISC-
III/WAIS-III)
Stimuli consisted of sequences of numbers. 
Children were instructed to repeat a sequence in 
the opposite order as accurately as possible.
Maximum span 
backwards
Visuo-spatial 
working 
memory
Spatial Temporal 
Span [STS] in 
ASD cohort and 
Visuospatial 
Sequencing [VSS] 
in ADHD cohort
Stimuli consisted of nine figures presented 
symmetrically in a 3 by 3 square. On each 
trail, a sequence of figures was pointed at by 
a computer-driven hand. Children were then 
instructed to reproduce the sequence in backward 
order.
Percentage correct 
identified targets in 
correct order (part 
forward  [STS and 
VSS] and backward 
[STS])
Set shifting
Response 
Organisation 
Objects [ROO] in 
ASD cohort and 
Shifting Attention 
Set Visual [SSV] in 
ADHD cohort.
The stimulus was a colored circle that was 
presented to the left or right of a fixation cross 
[ROO] or a colored square colored square 
that moved across a bar of ten grey squares 
in a random direction [SSV]. Three parts were 
administrated: in part 1, the stimulus was colored 
green and compatible responses were required 
(i.e. children were instructed to click the mouse 
key that corresponded to the direction in which 
the stimulus moved). In part 2, the stimulus was 
colored red and incompatible responses were 
required (i.e. children were instructed to click the 
response mouse button opposite to the direction 
of the moving stimulus). In part 3, the color of the 
stimulus shifted randomly between green and red 
and both compatible and incompatible responses 
were required. (Oerlemans et al., 2013a)
Differences in 
percentage of 
errors (accuracy) 
between part 1 
and the compatible 
trials of part 3
Motor function
Variability 
of motor 
control
Baseline Speed [BS] The stimulus was a fixation cross in the center of a 
computer that changed into a square at randomly 
varied time points. Children were asked to press a 
mouse key as quickly as possible after emergence 
of the square.
Standard deviation 
of reaction time 
in ms
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whether these domains hold potential as candidate endophenotypes and co-segregate 
within families based on sibling (cross-)correlations. Chapter 3 zooms in on the social 
cognition domain and investigates whether recognition of facial emotion and affective 
prosody are viable endophenotype candidates for ASD. Subsequently, the impact of 
comorbid ADHD symptoms on emotion recognition in ASD is assessed.
table 2. Description of the neurocognitive tasks used in this thesis (continued)
Paradigma Name task Task components Dependent 
variables
Stability 
of motor 
control
Tracking [TR] Children were instructed to trace an invisible 
midline (radius 8 cm) between an outer (radius 8.5 
cm) and inner (radius 7.5cm) circle with a mouse 
cursor, clockwise with the right hand and counter 
clockwise with the left hand.
Stability of motor 
output (standard 
deviation of the 
distances in mm 
with non-preferred 
hand)
Timing 
of motor 
control
Motor Timing [MT] Children were asked to press a mouse button 
when they thought a 1-second time interval had 
elapsed. The start of the interval was announced 
by a tone. After the response, visual feedback 
concerning the accuracy of the response was 
presented on the screen. A response was 
corrected if it fell between the lower and upper 
boundary set by a dynamic tracking algorithm.
Variability in 
reaction time
Social cognition (only in the ASD cohort)
Recognition 
of human 
faces
Face recognition 
[FR]
Stimuli consisted of color photographs of a 
human face with a neutral expression, were 
presented on a computer screen. Children were 
then asked to identify a target face in a display set 
that consisted of four faces, by clicking a mouse 
button
Percentage errors 
(accuracy)
Mean reaction time 
(in ms)
Recognition 
of facial 
expressions
Identification of 
facial emotions 
[IFE]
Stimuli consisted of photographs of a human 
face, presented on a computer screen, with each 
photograph presenting a face with either a neutral 
or emotional (happy, sad, angry, fear, disgust, 
surprise, shame, contempt) expression. Children 
were asked to judge whether the presented 
photograph showed the target emotion or not by 
clicking a mouse button
Percentage errors 
(accuracy)
Mean reaction time 
(in ms)
Recognition 
of emotion 
‘in voices’
Prosody [PR] Stimuli consisted of spoken sentences with a 
neutral content, presented through a headphone. 
Sentences were spoken in a happy, sad, angry 
or frightened manner, with each emotion 
represented by twelve sentences, in random order. 
The children were asked to verbally identify the 
emotion in the voice. Response time was recorded 
using a headphone that acted like a voice-key 
response.
Percentage errors 
(accuracy)
Mean reaction time 
(in ms)
WISC-III = Wechsler Intelligence scale for Children; WAIS-III =  Wechsler Adult Intelligence scale
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The subsequent four chapters report on comparisons between patients and their 
unaffected siblings from SPX and MPX families. Chapter 4 examines whether stratifica-
tion based on family recurrence (i.e. stratification into single-incidence [simplex, SPX] 
and multi-incidence [multiplex, MPX] families) is a promising approach (a) for creating 
etiologically more homogeneous subgroups of patients, and (b) to detect overlapping 
and unique underpinnings for both ASD and ADHD, based on symptom presentation of 
ASD and ADHD traits in probands and their unaffected relatives. Chapter 5 and 6 aim at 
answering whether the cognitive architecture underlying SPX and MPX ASD and ADHD 
families is different and useful for parsing the etiological heterogeneity of the disorders. 
The cognitive performance of probands with ADHD (chapter 5) and ASD (chapter 
6) and their unaffected siblings from SPX and MPX families is compared with normal 
controls on neurocognitive tasks tapping into various cognitive domains. Chapter 7 sets 
out to (a) identify the pre- and perinatal risk factors that  may be associated with ASD, 
ADHD, or both disorders and (b) examine whether these are incidental (only found in 
affected offspring) or common (also present in non-affected offspring siblings), using 
the MPX-SPX stratification approach.
Finally, a summary of the findings is provided in chapter 8 and in the general discus-
sion provided in chapter 9 we discuss key findings and limitations, and provide recom-
mendations and directions for future research.
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abstract
Cognitive research proposes that social cognition (SC), executive functions (EF) and lo-
cal processing style (weak CC) may be fruitful areas for research into the familial-genetic 
underpinnings of Autism Spectrum Disorders (ASD). The performance of 140 children 
with ASD, 172 siblings and 127 controls on tasks measuring SC (face recognition, affec-
tive prosody, and facial emotion recognition), EF (inhibition, cognitive flexibility, and 
verbal working memory) and local processing style was assessed. Compelling evidence 
was found for the interrelatedness of SC and EF, but not local processing style, within 
individuals and within families, suggesting that these domains tend to co-segregate in 
ASD. Using the underlying shared variance of these constructs in genetic research may 
increase the power for detecting susceptibility genes for ASD.
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introduction
Autism spectrum disorders (ASD) are pervasive developmental disorders, characterized 
by impairments in social interaction and communication, and by restricted repetitive 
and stereotyped patterns of behavior, interests and activities (APA, 2000). Evidence from 
twin and family studies suggest a large genetic contribution, with heritability estimates 
up to 90% (see for reviews Freitag, 2007, Holt and Monaco, 2011). Twin and family stud-
ies have also shown that genetic liability for ASD is expressed in unaffected relatives 
of individuals with ASD through features that are milder but qualitatively similar to 
the defining characteristics of ASD (Losh et al., 2009). This is referred to as the “broader 
autistic phenotype” (BAP). Exploration of the BAP might be a useful method of identify-
ing possible etiological mechanisms that underlie ASD and of increasing the power to 
identify genes linked with ASD (Wong et al., 2006). Research into the broader autistic 
phenotype has been primarily focused on the behavioral or ‘phenotypic’ similarities 
between individuals with ASD and their first-degree relatives (Bernier et al., 2012, Bishop 
et al., 2006, Losh et al., 2008, Piven et al., 1997, Ronald et al., 2006), but lately an increas-
ing number of studies are available on the cognitive similarities of autistic individuals 
and their first degree relatives in an attempt to identify heritable cognitive traits that 
increase the risk for developing the disorder (see for review Happe and Ronald, 2008). 
Examining cognitive traits in autistic individuals and relatives offers several important 
advantages over clinical phenotypes, because they provide insight in the causal chains 
of action, they aid in forming etiologically more homogeneous subgroups of patients 
and are hypothetically more powerful in genetic analyses (Gottesman and Gould, 2003, 
Rommelse et al., 2011).
Most studies have focused on three core cognitive domains that have each been 
proposed to explain the autistic phenotype, namely impaired social cognition, execu-
tive dysfunction and ‘weak central coherence’ (Happe, 2003). Social cognition (SC) is a 
broad term that refers to the encoding, storage, retrieval and processing of information 
relating to other persons, and includes, among others, face and emotion recognition 
and Theory of Mind (ToM). Impaired recognition and understanding of emotions and 
impaired ToM (Baron-Cohen et al., 1985) were among the first cognitive mechanisms that 
were claimed to explain the autistic phenotype and were remarkably successful in mak-
ing predictions about the impairments in socialization, imagination and communication 
shown by autistic individuals (Frith and Happe, 1994). However, the failure to explain the 
non-social deficits as well as the ‘islets of ability’ (including good visuo-spatial ability, 
enhanced route memory and uneven IQ profile (Frith, 1989, Pellicano et al., 2006)) that 
are often found in ASD, led to postulate two additional theories: the theory of executive 
dysfunction and the theory of weak central coherence. Executive functions (EF) refer to 
a rather broad range of component processes necessary for the control and execution 
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of complex behaviors and include different meta-cognitive domains such as planning, 
fluency, inhibition, working memory and cognitive flexibility. The executive dysfunction 
hypothesis is said to explain the repetitive behaviors and inflexibility in novel situations, 
in terms of impairments in planning, set-shifting, inhibition and working memory (see for 
reviews Happe and Ronald, 2008, Pisula, 2010, Rommelse et al., 2011). Some discussion 
remains however, as to which executive functions are impaired in ASD. Previous studies 
have suggested that only a subset of executive processes might be impaired, with some 
mentioning impairments in cognitive flexibility, working memory and planning with a 
relative sparing of inhibitory control (Ozonoff, 1997), while others report impairments in 
inhibitory control with a relative intact working memory (Geurts et al., 2004). The theory 
of weak central coherence (CC) refers to the detail-focused processing style proposed to 
characterize ASD (Frith, 1989, Happe and Frith, 2006). Autistic individuals often show a 
bias for parts versus wholes, resulting in an enhanced local processing style, which might 
explain why autistic individuals have often difficulty to extract global form/meaning, 
but may perform superior on tasks where a local processing style is beneficial (Frith and 
Happe, 1994).  It is proposed that a combination of cognitive risk factors (e.g. poor social 
cognition and EF and weak CC) gives rise to the core aspects of the autistic phenotype 
and there is strong evidence that autistic individuals show atypicalities across multiple 
cognitive domains (Happe et al., 2006, Pellicano et al., 2006). Furthermore, previous stud-
ies highlighted functional relationships between these cognitive domains, particularly 
social cognition (ToM) and EF (Jarrold et al., 2000, Ozonoff et al., 1991, Pellicano, 2010, 
Pellicano et al., 2006). Recently, literature has begun to document similar impairments 
in SC, EF and CC in unaffected first-degree relatives of individuals with ASD (Goussé et 
al., 2009, Happe et al., 2001, Happe and Frith, 2006, Losh et al., 2009, Nydén et al., 2011, 
Wallace et al., 2010, Wilson et al., 2010). This suggests that these cognitive domains may 
be fruitful areas for further research into the familial-genetic underpinnings of ASD as a 
continuum.
However, only a few studies have jointly evaluated all three domains in autistic indi-
viduals (Pellicano, 2010, Pellicano et al., 2006) and their relatives (Goussé et al., 2009, Losh 
et al., 2009, Nydén et al., 2011) and results have been inconclusive. A local processing 
style was found to be more common in individuals with ASD than were deficits in social 
cognition or EF (Pellicano et al., 2006). Further and importantly, central coherence was 
associated with aspects of executive function, but unrelated to social cognition. Later, 
central coherence and executive functions skills turned out to be longitudinally pre-
dictive of theory of mind performance (an aspect of social cognition)(Pellicano, 2010), 
suggesting a common underlying factor to all of these impaired cognitive functions. 
However, it is unclear whether these findings would also apply to unaffected relatives 
of autistic individuals, which might not necessarily be so given that patients are at the 
extreme end of the ASD continuum and therefore by chance more likely to be impaired 
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in all three domains. Two other studies did examine the three domains in both autistic 
individuals and their unaffected relatives and reported that selective deficits in both 
affected and unaffected relatives appeared present regarding social cognition (Losh et 
al., 2009) and executive function (Nydén et al., 2011). However, Nydén and colleagues 
(2011) only examined family correlations within, but not between, cognitive domains. 
Losh and colleagues (2009) briefly addressed the issue of interrelatedness between 
autistic individuals and their first-degree relatives, but the small subsample of intact 
families (biologically related parents and ASD children) prevented them from conduct-
ing reliable correlation analyses. Therefore, it remains unclear if and to what extent social 
cognition, executive function and local (detail-focused) processing are influenced by 
similar familial factors. In other words, do these cognitive functions tend to co-segregate 
within families? Preliminary results suggest they don’t. Findings suggest that cognitive 
impairments may decouple and segregate independently in autistic individuals and 
unaffected relatives (Happe and Ronald, 2008). In their review, Happé and Ronald (2008) 
argue that there are multiple cognitive weaknesses and strengths that account for the 
range of autistic behaviors and that are independent at the genetic and cognitive level 
(e.g. task success in one cognitive domain and task failure in another). Nevertheless, 
the authors stress that impairments in social cognition, executive dysfunction and weak 
central coherence co-occur above chance in autistic individuals. It is of great relevance 
to gain more insight into this issue, because it could provide clues how to use these 
traits in genetic analyses and further knowledge on the etiological pathways of ASD.
Therefore, the current study set out to examine whether these three domains indeed 
segregate independently in ASD. We administered a relatively large battery of cognitive 
tasks selected to assess processing within a given domain in a relatively large group 
of high-functioning children with ASD (N = 140 probands), their siblings (N = 172) and 
healthy controls (N=127). We chose three social cognition tasks, namely face recogni-
tion, facial emotion recognition and affective prosody. Most studies examine emotion 
recognition using facial expression cues (see Harms et al., 2010), but we added a task 
that examined the recognition of emotions ‘in voices’ (affective prosody) as well, because 
previous studies showed ASD is strongly related to impairments in affective prosody 
(Golan et al., 2007, Korpilahti et al., 2007, Lindner and Rosen, 2006, Philip et al., 2010). 
Furthermore, we included three executive function measures: response inhibition, cog-
nitive flexibility and verbal working memory. Response inhibition was measured with 
the commonly used Go-NoGo paradigm, where children were instructed to withhold a 
response when the NoGo target (25% of trials) was pictured. Cognitive flexibility was as-
sessed by administering a task that required a mixture of compatible and incompatible 
responses, hypothesized to require a higher level of cognitive flexibility. Verbal work-
ing memory was assessed using the Wechsler Intelligence Scale for Children, subtest 
Digit Span (backward condition) (Wechsler, 2002, Wechsler, 2000). Last, we included a 
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measure with a strong local-global component. Children who show a weak CC should be 
better at finding the target among similar distracter targets than children with strong CC. 
All selected tasks have been shown to be associated with ASD previously (Geurts et al., 
2004, Oerlemans et al., 2014, Serra et al., 2003, van der Meer et al., 2012). Correlations and 
sibling (cross-) correlations were calculated to examine the interrelatedness of the three 
cognitive domains within children, as well as within families. If social cognition, execu-
tive functioning and local processing style would indeed segregate independently in 
ASD, we expected that there would be no significant correlations between tasks tapping 
the three cognitive domains within children. Furthermore, we expected that the three 
cognitive domains would show signs of familiality (e.g.  significant correlations between 
scores on, for example, social cognition tasks in probands and such scores in siblings), 
but not of dependent segregation (e.g. no significant correlations between scores on 
social cognition, executive function and local processing style within the probands/
siblings or between probands and siblings).
metHod
participants
Families with at least one child with a clinical diagnosis of ASD (Autism, Asperger’s 
Syndrome (AS) or PDD-NOS; APA 2000; diagnosis mostly based on Autism Diagnostic 
Interview - Revised (ADI-R) and Autism Diagnostic Observation Scale (ADOS) assess-
ment) and at least one unaffected sibling were recruited as part of the Biological Origins 
of Autism (BOA) study at Karakter Child and Adolescent Psychiatry, University Medical 
Center Nijmegen, the Netherlands, which aims to examine the genetic, biochemical 
and cognitive origins of ASD. Control families (at least two participating biological 
siblings) were recruited via information leaflets that were send to families living in the 
same geographical regions as the participating ASD families as part of the BOA project. 
Controls were required to have no formal or suspected ASD diagnosis. A total of 140 
ASD families consisting of 140 ASD probands and 172 siblings (145 without and 27 
with ASD) and 62 control families (127 children) were included in the current study. The 
proband group had proportionally more males. All children were between the ages of 
6 and 21 and were of European Caucasian descent. Participants were excluded if they 
had an IQ < 60, a diagnosis of epilepsy, brain disorders or known genetic disorders, such 
as Down-syndrome or Fragile – X – syndrome. The study protocol was approved by the 
local medical-ethics committee. Written informed consent was obtained from parents 
and children over the age of 12 before testing.
Both the children already clinically diagnosed with ASD, their siblings and the control 
children were similarly screened for autism spectrum disorders using the parent and 
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teacher Social Communication Questionnaire ([SCQ] Berument et al., 1999). A cut-off 
score of > 10 for the parent version (Corsello et al., 2007) or ≥15 for the teacher version 
was considered as clinical. A lower cutoff was chosen for the parent reported SCQ to 
avoid false negatives in their undiagnosed offspring (van Steijn et al., 2012). For all chil-
dren scoring on either the parent or teacher rated SCQ in the clinical range (this included 
all children previously diagnosed with ADHD and a subsample of siblings (N=27)), a 
formal diagnosis of ASD was made by a certified clinician using the ADI-R (Le Couteur 
et al., 2003). Clinically diagnosed children who did not fulfill ADI-R criteria (N=6) were 
excluded from the analyses along with their siblings (N=7). Siblings were regarded as 
unaffected if they obtained scores below cut-off on both the parent and teacher SCQ. No 
ADI-R was administered concerning unaffected siblings. Control children were required 
to obtain non-clinical scores on the parent and teacher SCQ (i.e. a raw score of < 10 and 
< 15 respectively) in order to be accepted in the current study.
Full-scale IQ was estimated using four subtests of the Dutch version Wechsler Intel-
ligence Scale for children (WISC-III): Similarities, Vocabulary, Block Design and Picture 
Completion (Wechsler, 2002). These selected WISC-III subtests are known to correlate 
between .90-.95 with the Full-scale IQ (Groth-Marnat, 1997). For children older than 16 
years, the Wechsler Adult Intelligence Scale (WAIS-III) was administered (Wechsler, 2000) 
See Table 1 for sample characteristics.
table 1. Sample characteristics
1. Probands
N = 140
2. Siblings
N = 172
3. Controls
N = 127
F Contrasts based on p 
values of <.05
M sd M sd M sd
Age in years 12.4 3.0 12.2 3.9 11.0 3.6 6.6 1=2>3
Males (%) 82.1 47.7 42.5 30.0 1>2=3
Estimated Full Scale IQ 102.0 13.8 105.5 12.9 107.4 12.4 5.8 1<2=3
Estimated VIQ 99.9 15.5 104.8 14.7 108.4 14.1 ns 1<2=3
Estimated PIQ 104.5 17.0 106.7 16.7 106.7 15.8 11.2 1=2=3
SCQ parents Total score 19.2 6.7 5.8 6.6 3.1 2.6 313.3 1>2>3
Diagnostics (%)
ASD 100 15.7 0
1 = probands;  2= siblings; SCQ = Social Communication Questionnaire (total score); ASD = Autism Spec-
trum Disorders; VIQ = Verbal IQ ; PIQ= Performal IQ
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materials
In total, six tasks from the Amsterdam Neuropsychological Tasks (ANT) program (De 
Sonneville, 1999) and one subtest (Digit Span) of the Wechsler Intelligence Scale 
(Wechsler 2000, 2002) were selected in this study. The ANT is a computer-aided assess-
ment battery that allows for the systematic evaluation of information processing capaci-
ties and has been proven to be a sensitive and valid tool in research into autism-related 
disorders. Test–retest reliability and validity of the ANT-tasks are satisfactory and have 
been described and illustrated elsewhere (De Sonneville, 2005, Serra et al., 2003). A short 
description of each task is presented below. Each computer task contained an instruc-
tion trial where the examiner provided a typical item of the task, and a separate practice 
session. If necessary the instruction was repeated (De Sonneville, 2011). All subjects were 
able to perform the training items before testing. Digit Span was administered following 
manual guidelines (Wechsler, 2002, Wechsler, 2000). For all ANT tasks the main outcome 
variables were speed (mean reaction time) and accuracy (number of errors) of responses.
Social Cognition (SC)
Face Recognition
The Face Recognition (FR) task was used to measure the capacity to process social (facial) 
stimuli (De Sonneville, 1999). Stimuli consisted of color photographs of a human face 
with a neutral expression, were presented on a computer screen. Children were asked 
to identify a target face in a display set that consisted of four faces (see Figure 1a). The 
 
B. 
target 
similar 
nontarget 
similar 
target 
dissimilar 
nontarget 
dissimilar 
target 
C. 
E. 
2 
3 
1 
  
A. 
target 
D. 
Go 
stimulus 
NoGo 
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B. display set 
figure 1 Examples of the stimuli used in the computerized tasks implemented in this study.
a. Example of a target face and display set in the face recognition task
b. Example of facial expressions in the facial emotion recognition task
c. Target stimulus and examples of similar and dissimilar trials in the global-local processing task
d. ‘Go’ and ‘NoGo’ stimulus in the inhibition task
e. Stimulus in the cognitive flexibility task, 1 = similar condition, 2 = dissimilar condition, 3 = mixed condi-
tion
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target face was presented for 2,500 ms and then it disappeared from the screen. After 
500 ms, it was followed by a display set, which remained on the screen until the child 
pressed a key: if the target face was present in the display set the subject was asked to 
click the ‘yes-button’ (right computer mouse button for right-handed subjects, and left 
computer mouse button for left-handed subjects), if the display set did not contain the 
target face the subject was asked to press the ‘no-button’ (left computer mouse button 
for right-handed subjects, right computer mouse button for left-handed subjects). The 
task consisted of 40 trials in half of which the target set contained the target face (target 
trials) and half of which the target face was absent. Dependent measures were speed 
(mean reaction time) and accuracy (number of errors).
Facial Emotion Recognition
The Identification of Facial Emotions (IFE) task was used to measure the capacity to 
understand facial emotional expressions (De Sonneville, 1999). Stimuli consisted of 
photographs of a human face, presented on a computer screen, see Figure 1b. Each 
photograph presented a face with either a neutral expression or one of eight different 
types of emotion (happiness, sadness, anger, fear, disgust, surprise, shame, contempt) 
and children were asked to judge whether the presented photograph showed the target 
emotion or not by clicking a mouse button. For the current study four target emotions 
were selected: happiness, sadness, anger and fear. If the presented photograph showed 
the target emotion the subject was asked to click the ‘yes-button’ , if the presented 
photograph did not show the target emotion, the subject had to click the ‘no-button’ 
(responses were to be given as described above). Each emotion condition consisted 
of 40 trials; half of which were the target emotion (requiring a ‘yes’ response) and half 
of which were a random selection of other emotions (requiring a ‘no’ response). Mean 
speed and accuracy (error) scores were calculated by averaging the scores of the four 
targeted emotions.
Affective Prosody
The Prosody (PR) task was administered to test the ability to recognize ‘emotions in voices’ 
(De Sonneville, 1999). Stimuli designed by Vingerhoets (Vingerhoets et al., 2003) were used. 
They consisted of spoken sentences with a neutral content, presented through a head-
phone. Sentences were spoken in a happy, sad, angry or frightened manner, with each 
emotion represented by twelve sentences, in random order. Sentences were of approxi-
mately equal length and were articulated by two professional actors, one male and one fe-
male. The children were asked to verbally identify the emotion in the voice. Response time 
was recorded using a headphone that acted like a voice-key response. During listening, the 
emotions to be discriminated were presented on the computer screen. The task consisted 
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of 48 trials, 12 per emotion. A missed trial was replaced. Mean speed and accuracy (error) 
scores were calculated by averaging the scores of the four targeted emotions.
Executive Functions (EF)
Inhibition
The Go-NoGo (GNG) task was used to measure the capacity to inhibit a prepotent 
response (De Sonneville, 1999). Stimuli consisted of the “Go”-stimulus and the “NoGo”-
Stimulus, as presented in Figure 1d. Children were instructed to click a mouse button 
as quickly and accurately as possible if the “Go”-stimulus was presented. If the “NoGo”-
stimulus was presented, the subjects were instructed to withhold clicking the button. 
The stimulus was presented for 300 ms. The valid response window was 200-1,500 ms 
post onset of the stimulus. Stimuli were pseudo-randomly presented (biased condition: 
56 “Go”-stimuli and 18 “NoGo” stimuli) to measure inhibition of an ongoing response. 
Dependent variables were measures of speed (mean reaction time “Go”-signals) and 
accuracy (% false alarms - % misses).
Cognitive Flexibility
The Response Organisation Objects (ROO) was used to measure cognitive flexibility 
(De Sonneville, 1999). The stimulus was a figure of a colored ball that was presented 
to the left or right of a fixation cross, as presented in Figure 1e. The color of the ball 
determined the required response. Three parts were administrated. In Block 1, the ball 
was colored green and compatible responses were required. Children were instructed to 
click the mouse button that corresponded with the orientation of the stimulus. In Block 
2, the stimulus was colored red and incompatible responses were required. Children 
were instructed to click the response mouse button opposite to the orientation of the 
stimulus. In Block 3, the color of the stimulus shifted randomly between green and red 
and both compatible and incompatible responses were required. Cognitive flexibility was 
operationalized as the differences in mean reaction time (speed) and number of errors 
(accuracy) between part 1 and the compatible trials of part 3. The difference between 
both blocks lay in the fact that in Block 3, the participant did not know on forehand that 
a compatible response was required, whereas the participant did in Block 1.
Verbal working Memory: Digit Span Backward
The backward part of the Digit Span task (Wechsler, 2002, Wechsler, 2000) was used to 
measure verbal working memory. Stimuli consisted of sequences of numbers. Children 
were instructed to repeat a sequence in the opposite order as accurately as possible. 
One digit was added to the sequence if a child reproduced the sequence successfully. 
A maximum of 8 experimental sequences were administered, dependent on the child’s 
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performance. The maximum span backward was used to obtain an indication of verbal 
working memory.
Local Processing Style
The Feature Identification (FI) task was administered to test detail-focused (local) pro-
cessing (De Sonneville 1999). The stimulus was a predefined target pattern of 3 red and 
6 white squares in a 3x3 matrix. After memorization of this target pattern children were 
asked to detect the target stimulus in a signal consisted of four patterns, as presented 
in Figure 1c. There were two conditions. In the first condition, the distracter patterns 
looked very similar to the target pattern, making the recognition of the target rather 
difficult. The first condition consisted of 40 trials, half of which contained the target 
(requiring a ‘yes’ response e.g. target trials) (responses were to be given as described 
above) and half of which required a ‘no’ responses (nontarget trials). In the second condi-
tion, the distracter patterns looked very dissimilar to the target pattern, which makes 
target detection easy. Again, this condition consisted of 40 trials, 20 of which were target 
trials and 20 of which were nontarget trials. The various types of trials (similar, dissimilar, 
target, nontarget) were presented in a random order. The target pattern was presented 
only at the beginning of the task and was the same for all trials. Dependent variables 
were the differences in speed (mean reaction time) and accuracy (number of errors) 
between the similar minus the dissimilar trials. It is expected that the similar condition 
represents a more local processing style and the dissimilar condition represents a global 
processing style. Therefore, a higher score on both dependent measures represented a 
more global processing style.
procedure
Testing the children with ASD, their siblings and controls took place at Karakter Child 
and Adolescent Psychiatry University Centre Nijmegen and was conducted for all the 
children of the same family simultaneously. Stimulants were discontinued for at least 
24 hours before testing and non-stimulants according to their plasma half life to allow 
for sufficient wash-out. Children were motivated with small breaks. The tasks described 
in this study were part of a broader neuropsychological assessment battery used in the 
BOA study. The order of administration of the tasks was counterbalanced across partici-
pants (but identical for family members). 
statistical analyses
All analyses were carried out in SPSS version 20. All measures were subjected to a Van 
der Waerden transformation to normalize the measures (SPSS version 20) (Norusis, 1992) 
and to depict all measures on the same scale (z-scores). Some scores were mirrored, 
so that the scores of all variables would imply the same: higher z-scores indicated bet-
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ter performances (i.e. less errors and faster response). Subsequently, a mean z-score 
was calculated per cognitive task by averaging the accuracy and speed z-scores. The 
following three terms were used: correlation (referring to a correlation between two 
variables in the same subject), sibling correlation (referring to a correlation between 
siblings for the same variable) and sibling cross-correlation (referring to a correlation 
between siblings for two different variables). Correction for multiple testing was applied 
using the False Discovery Rate (FDR) correction with a q-value of 0.05. Following Cohen’s 
guidelines (Cohen, 1988), effect sizes for correlations were defined in terms of small (r = 
.10), medium (r = .30) and large effects (r = .50).
First, group differences between children with ASD and controls, corrected for age, sex 
and total estimated IQ, were calculated for all cognitive measures, to examine whether 
the selected tasks were significantly associated with ASD. Further, to test the interre-
latedness of the domains within individuals, correlations were calculated between all 
dependent variables. These analyses were run separately for ASD probands, siblings and 
controls and the size of the corresponding correlations was compared between groups 
using the independent correlation coefficients calculation test (Preacher, 2002). Then for 
each ASD proband/control child, one sibling closest in gender and age was selected, and 
sibling correlations and sibling cross-correlations were calculated to examine the degree 
of familiality of all dependent measures. Results were reported with and without correc-
tion for differences in age and intellectual ability (estimated Total IQ) between siblings.
Second, a component score was calculated for social cognition and executive function 
by averaging the mean z-scores of the corresponding tasks. Regression analyses were 
conducted to examine whether the performance of the ASD probands on, for example 
the SC component score, could predict the performance of their siblings on the SC 
component score as well as on the EF component score and on local processing style. 
Three separate regression analyses were conducted with the SC, EF component score or 
the local processing style score of the probands as predictor and the three component 
scores of the siblings as dependent variables. Age difference and Total IQ difference 
between siblings were implemented in the model as well. Similar analyses were run for 
control sibling pairs.
results
The affective prosody recognition task was not administered to children younger than 
9 years of age. Affective prosody recognition data was based on 119 ASD probands, 131 
siblings and 81 controls. The percentage of missing data was random and < 1% for ac-
curacy and speed measures of the face recognition and facial emotion recognition task, 
< 3% for local processing style measures, digit span, cognitive flexibility and affective 
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prosody recognition (for children aged ≥ 9 years) and 10% for response inhibition. Miss-
ing data were replaced by means of Expectation Maximization (Tabachnick and Fidell, 
2001). Analyses were carried out with and without expectation maximization, which 
revealed similar results. Results were therefore reported with missing data replaced. 
All analyses were carried out with (N=172) and without ASD affected siblings (N=145) 
and revealed similar results. Reported results include affected siblings. Raw means and 
standard deviations are presented in Table 2.
Crude comparisons between children with ASD (probands and affected siblings) and 
controls, corrected for age, sex and total estimated IQ, revealed a significant multivariate 
group effect (F (7, 203) = 3.14, p = .004), indicating that children with ASD performed 
generally worse on the tasks used in this study compared to healthy controls. Post hoc 
analyses revealed significant group differences on 5/7 cognitive measures (face recogni-
tion (F (1, 292) = 22.15, p <.001), facial emotion recognition (F (1, 292) = 6.11, p = .014), 
affective prosody recognition (F (1, 217) = 10.50, p = .001), response inhibition (F (1, 292) 
= 9.87, p = .002) and verbal working memory (F (1, 297) = 8.42, p = < .004)). A marginally 
significant effect was found for cognitive flexibility (F (1, 292) = 3.78, p = .076).
interrelatedness of cognitive domains
Significant positive correlations with medium to large effect sizes were found within the 
SC domain, as well as between all tasks of the SC and EF domain, as is shown in Table 3. 
This suggests that a worse performance on SC was related to poorer EF skills. Within the 
EF domain, all three tasks were positively correlated with medium to large effect sizes. 
Furthermore, a small negative correlation was found between the local processing mea-
sure and facial emotion recognition in probands, indicating that poorer facial emotion 
recognition skills related to a more detailed focused (local) processing style in children 
with ASD. This correlation was not found for unaffected siblings or controls.
About half of the correlations remained significant after correction for age and esti-
mated Total IQ, but effect sizes for these correlations became small to medium. Verbal 
working memory was mostly unrelated to other EF and SC tasks after correction for age 
and IQ. Four of the measures revealed significantly higher correlations in controls than 
in ASD probands. In one of the measures, the correlation was highest for ASD probands 
(facial emotion recognition-local processing). However, these differences became non-
significant after controlling for age and IQ, see Table 3.
familiality of the domains
Sibling correlations were calculated for all tasks with and without correction for the age 
and total IQ difference between probands and siblings (Table 4). Siblings resembled 
each other significantly on all SC and EF tasks (with sibling correlations ranging from 
.21- .71, Table 4) suggesting familiality for these tasks. One of the measures revealed 
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higher correlations in control sibling pairs, than in proband-sibling pairs (inhibition). No 
sibling correlations were found for the local processing task.
co-segregation of sc, ef and local processing style (weak cc)
In order to examine whether the domains co-segregate in ASD families, sibling cross-
correlation (corrected for the age and IQ difference between probands and sibling) were 
calculated. All social cognition tasks were significantly cross-related between siblings 
within the SC domain, and a few significant positive sibling cross-correlations were also 
found between SC tasks (mostly face recognition and facial emotion recognition) and 
some EF tasks, indicating that poorer SC skills in probands were related to poorer EF 
skills in their siblings, and vice versa. These correlations became more pronounced (with 
medium to large effect sizes) after correction for age and IQ difference between siblings. 
A few significant sibling cross-correlations of small to medium effect size were found be-
tween EF tasks within the EF domain. No sibling cross-correlations were found between 
local processing on the one hand and SC and EF tasks on the other hand, indicating that 
poorer SC and/or EF skills in probands were unrelated to processing style in his or her 
sibling. In five of the measures, higher correlations in control sibling pairs compared to 
proband-sibling pairs were revealed (Table 4).
To further examine whether SC, EF and local processing style co-segregated within 
families, we examined whether we could predict the cognitive performance of the 
siblings, based on the SC and EF component score and the local processing score of 
their ASD proband/control sibling. Results showed that the performance of probands 
on SC tasks could significantly predict the performance of their siblings on SC as well as 
figure 2 Illustration of the correlations between the cognitive performances of ASD probands/controls and 
their siblings (z-scores).  Siblings’ SC, EF and local processing composite scores as a function of the same 
composite scores in probands/controls.
Note. Higher z-score indicates better performance and a more local (i.e. detailed focused) processing style. 
The performance of probands grouped on either SC and EF performance could significantly predict the 
performance of their siblings on both SC and EF composite scores.
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EF (all p-values < .001). That is, if the proband performed poorly on SC, his or her sibling 
would perform poorly on SC, and also on EF tasks. Vice versa, probands’ EF significantly 
predicted siblings’ EF and SC performances (both p-values < .001), see Figure 2. Similar 
results were found for control sibling pairs. In ASD families only, the local processing 
score of probands could significantly predict their siblings’ EF performance (p = .029).
discussion
The current study set out to examine whether SC (face recognition, facial emotion 
recognition and emotional prosody), EF (inhibition, cognitive flexibility and verbal 
working memory) and local processing style (weak CC) segregate independently within 
ASD. Based on Happé and Frith’s (2008) theory, we would have expected independent 
segregation as reflected by the absence of significant correlations between social cogni-
tion, executive function and local processing tasks and no significant cross-correlations 
between probands and their siblings. This was not what we found. We found that SC 
and EF tend to co-segregate together. These findings contrast the majority of studies 
that argue that cognitive deficits tend to decouple and segregate independently in 
ASD (Happe and Ronald, 2008, Pellicano et al., 2006). Particularly SC and EF (mostly 
inhibition and cognitive flexibility) appeared strongly interrelated, both within children 
and within families. This was true for both ASD probands and their siblings and for the 
control children. All sibling cross-correlations between SC tasks reached significance 
with correlations of medium size, suggesting that performances in these functions (face 
and facial emotion recognition and affective prosody) partly originate from the shared 
familial sources. The same holds true for inhibition, cognitive flexibility and verbal work-
ing memory suggesting that these functions have similar familial underpinnings, as has 
been reported before in ADHD (Rommelse et al., 2008). Furthermore, the majority of 
sibling cross-correlations between SC and EF were significantly correlated. That is, SC 
in probands was related to EF in their siblings and vice versa. The sibling (cross) correla-
tions became even more pronounced when variance attributed to differences in age 
and intellectual ability was controlled for. The interdependence of both domains was 
further underlined by the finding that poorer performance in siblings on both domains 
could be predicted by the performance of the proband to which they were familially 
related. This suggests that especially SC and EF may be fruitful targets in future fam-
ily studies of the genetic contribution to ASD. Although correlations between SC and 
EF have been reported before in autistic individuals (Goussé et al., 2009, Ozonoff et al., 
1991, Pellicano, 2007, 2010, Pellicano et al., 2006) and typically developing children 
(Carlson et al., 2004, Carlson and Moses, 2001, Carlson et al., 2002), our study is the first to 
address the interrelatedness of these two domains in autistic children and their (mostly 
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unaffected) siblings by examining cross-correlations. We build on the studies of Losh 
and colleagues (2009) and Nydén and colleagues (2011) by including a larger sample of 
intact biological ASD (and control) sibling pairs and examining family correlations both 
within and between cognitive domains. Our findings demonstrate that the cognitive 
performance of children with ASD and their first degree relatives (siblings) was not only 
related within (Nydén et al., 2011), but also between cognitive domains. These findings 
contrasts Losh and colleagues (2009), who did not report significant associations be-
tween children with ASD and their first degree relatives. However, the authors raised the 
possibility that the lack of power due to the small number of intact families in their study 
could explain the absence of significant correlations. Another factor that may play a role 
is that we tested siblings, whereas Losh and colleagues (2009) tested parents of children 
with ASD. All in all, our results add to knowledge that the two domains are not only 
interrelated within children, but are also likely influenced by shared familial factors as 
reflected by significant sibling cross-correlations. Furthermore, most studies examining 
the relationship between SC and EF have reported findings on the interrelatedness of 
ToM abilities with various EF functions. Our results expand this relationship between SC 
and EF to measures of face and (facial and prosodic) emotion recognition as well.
In contrast to the above reported results, local processing style (weak CC) appeared 
relatively independent from both other domains. With the exception of a small correla-
tion between local processing style and SC (facial emotion recognition) in ASD probands 
only, no evidence for co-segregation of local processing with the other domains was 
found. Moreover, local processing performance itself appeared not to be familial, as 
indicated by a non-significant sibling correlation. These findings suggest that a local 
processing style might be a relatively independent atypicality in ASD with generally 
different underlying factors (genetic and environmental) than the other two domains 
and may be related to etiological factors unique to the affected child not shared by unaf-
fected family members. These findings corroborate with previous findings that favor the 
current notion that weak CC is dissociable from SC and EF (Happe and Ronald, 2008, 
Morgan et al., 2003), but contrast the findings of Jarrold and colleagues (2000). Given 
that we only administered one task to reflect local processing style which was not con-
vincingly associated with ASD in this sample, and the validity of the weak CC construct 
has been proven to be a complex one (Pellicano et al., 2005, Pellicano et al., 2006); our 
results need replication before firm conclusions can be drawn on the co-segregation of 
weak CC, SC and EF.
The finding that the pattern of co-segregation between SC and EF was highly similar 
within ASD and control families indicates that the reported co-segregation of cognitive 
functions associated with ASD is not specific to ASD. In other words, it was previously 
hypothesized that the co-occurrence of cognitive deficits in ASD may be explained by 
patients being at the extreme end of the ASD continuum and therefore by chance more 
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likely to be impaired in all three domains, but our data suggests otherwise. Furthermore, 
the tendency for siblings to display a similar cognitive profile as their affected brother 
or sister, regardless of their own affected status, puts them at risk for developing impair-
ments in one of multiple domains, even in the absence of (milder) ASD features. This 
highlights the importance of following siblings over time.
A number of limitations need to be considered. First, although effort was made to 
include several tasks tapping the domains of SC and EF, we were not able to assess all 
aspects of these domains. For example, theory of mind has not been accessed here. 
It may be possible that our findings do not generalize across the entire SC spectrum, 
but only relate to face and emotion recognition. However, given that theory of mind 
relies greatly on the ability to perceive emotions, it is likely that poor performances 
on emotion recognition tasks relate to poorer performances on theory of mind tasks 
(Buitelaar and van der Wees, 1997). Furthermore, several important aspects of EF were 
not assessed here, such as planning and fluency. These functions, in addition to inhibi-
tion, cognitive flexibility and working memory, have been proposed to be key domains 
within EF and impairments in these domains have been reported in individuals with ASD 
(Geurts et al., 2004, Hill, 2004a, Hill, 2004b). It would be interesting to examine whether 
deficits in planning or fluency also co-segregate with other EF functions or SC skills in 
ASD. This might not necessarily be so given that EF refers to a broad range of related, 
but distinct high-level cognitive capacities. Therefore, we must be cautious when in-
terpreting the co-segregation between SC and EF as reflective of the entire EF domain. 
Second, only one task was administered reflecting local processing style. Therefore, 
caution is warranted when interpreting the results of this task as reflective of weak CC. 
The validity of the CC construct has been proven to be a complex one (see Pellicano 
et al., 2006), and future studies would do well by including several tasks designed to 
favor a detail-focused, local processing style in order to obtain a more comprehensive 
measure of weak CC. Third, our sample consisted of high-functioning children with 
ASD which might limit the generalizability of our findings to the broad range of ASD. 
It might be worthwhile to extend these results to lower-functioning individuals, where 
the impairments on the various cognitive domains might be more pronounced, perhaps 
resulting in a different pattern of co-segregation. Previous studies have indeed shown 
that low- and high functioning individuals with autism demonstrate distinct patterns of 
EF impairment (Turner, 1997), which could result in a distinct pattern of between-tasks 
or between-domain correlations. Fourth, error percentage analyses revealed a ceiling 
effect in the cognitive flexibility task (<10% errors) and the task was only marginally 
significantly related to ASD in this sample. This suggests that the task was probably too 
easy due to the predictable nature of the task (the problem solving rule in the flexibility 
task was known to the subject and constant during the test). However, this effect was 
not mediated by the presence of ASD (e.g. error percentage was similar for ASD pro-
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bands, their (mostly unaffected) siblings and controls and it could not account for the 
observed overlap between SC and other EF tasks). Last, this study did not include the 
cognitive performances of parents of autistic individuals, which would have made an 
interesting contribution to the study. By including parental information, more insight in 
the parent-offspring (cross) relationships of SC, CC and EF could be gained.
Taken together, compelling evidence was found for co-segregation of SC and EF, but 
not local processing style, within ASD, indicating that particularly SC and EF may be 
fruitful domains in future family studies of the genetic contribution to ASD. Given that 
SC and EF are both strongly related to ASD, using the underlying shared variance of 
both constructs in genetic research may increase the power for detecting susceptibil-
ity genes for ASD (Sham et al., 2000). This approach was recently successfully applied 
in ADHD research (Frazier-Wood et al., 2012) and is expected to offer great potential 
for future studies in ASD. Furthermore, our results have shown that performances on 
SC and EF tasks are highly correlated within probands, suggesting that probands who 
perform worse on one domain are likely to display deficits in the other domain. More-
over, siblings of autistic individuals (regardless of their affected status) tend to display 
a similar cognitive profile as their affected brother or sister and are therefore at risk for 
impairments on SC and EF as well. This finding highlights the importance of following 
sibling risk groups over time.
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abstract
Autism is a highly heritable and clinically heterogeneous neuropsychiatric disorder 
that frequently co-occurs with other psychopathologies, such as attention-deficit/
hyperactivity disorder (ADHD). An approach to parse heterogeneity is by forming more 
homogeneous subgroups of autism spectrum disorder (ASD) patients based on their 
underlying, heritable cognitive vulnerabilities (endophenotypes). Emotion recogni-
tion is a likely endophenotypic candidate for ASD and possibly for ADHD. Therefore, 
this study aimed to examine whether emotion recognition is a viable endophenotypic 
candidate for ASD and to assess the impact of comorbid ADHD in this context. A total 
of 90 children with ASD (43 with and 47 without ADHD), 79 ASD unaffected siblings and 
139 controls aged 6-13 years, were included to test recognition of facial emotion and 
affective prosody. Our results revealed that the recognition of both facial emotion and 
affective prosody was impaired in children with ASD and aggravated by the presence 
of ADHD. The latter could only be partly explained by typical ADHD cognitive deficits, 
such as inhibitory and attentional problems. The performance of unaffected siblings 
could overall be considered at an intermediate level, performing somewhat worse than 
the controls and better than the ASD probands. Our findings suggest that emotion 
recognition might be a viable endophenotype in ASD and a fruitful target in future 
family studies of the genetic contribution to ASD and comorbid ADHD. Furthermore, 
our results suggest that children with comorbid ASD and ADHD are at highest risk for 
emotion recognition problems.
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introduction
Autism Spectrum Disorders (ASD) are a group of neurodevelopmental disorders, charac-
terized by impairments in interaction, communication and restricted, stereotyped and 
repetitive behaviour (APA, 2000). Twin studies have demonstrated a high heritability for 
ASD (> 90%) (Freitag, 2007) and the search for potentially ASD risk genes has become 
a fast moving area of research. Despite this high heritability, the identification of genes 
linked to ASD has been a difficult endeavour (Neves et al., 2011). This might be due, 
among others, to the clinical and etiological heterogeneity of ASD. ASD presents with 
a wide range of symptoms and symptom severities, associated cognitive deficits and 
underlying etiological factors (Pelphrey et al., 2011). An approach to parse heteroge-
neity is to create homogeneous subgroups of ASD patients based on their underlying 
endophenotypes (Gottesman and Gould, 2003, Wang et al., 2012). Endophenotypes are 
defined as heritable vulnerability traits that heighten the risk for developing a disorder 
(Gottesman and Gould, 2003). Endophenotypes offer a simplified approach to dissect 
complex traits by reducing heterogeneity (Wang et al., 2012) and as such may boost 
the power for genetic analyses, as well as shed light on the functional outcomes of 
genes (Almasy and Blangero, 2001, Gottesman and Gould, 2003, Viding and Blakemore, 
2007). Homogeneous subgroups of patients based on their endophenotypes may 
facilitate our understanding of the involved biological processes (Wang et al., 2012). A 
common approach in endophenotype research is the affected-unaffected sibling design 
(Almasy and Blangero, 2001, Waldman, 2005). This design is particularly useful under 
the assumption that psychiatric disorders are caused by a complex interplay between 
multiple susceptibility genes and environmental factors (i.e. polygenetic or multifacto-
rial heritability model) (Gottesman and Gould, 2003). If a targeted marker is indeed a 
useful endophenotype, abnormalities should also be present in unaffected siblings, 
because they are likely to carry susceptibility genes for the disorder (given that they 
share on average 50% of their genes with their affected brother or sister) and share 
common environmental influences. This affected-unaffected sibling design has led to 
many fruitful results in for instance attention-deficit/hyperactivity disorder (ADHD) and 
schizophrenia cognitive studies, firmly demonstrating subthreshold impairments in un-
affected relatives on cognitive functions and brain morphology (Allen et al., 2009, Hoff 
et al., 2005, Rommelse et al., 2011) and their utility in molecular genetics research (Chen 
et al., 2012, Doyle et al., 2008, Rommelse et al., 2008). Despite these promising results, a 
similar strategy has less often been applied in autism research (Rommelse et al., 2011, 
Tierney et al., 2012).
One of the most promising risk markers that may be present in unaffected relatives 
of individuals with ASD is impaired social cognition (Soorya and Halpern, 2009). Social 
cognition refers to the interdependence of cognition and social behavior and is substan-
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tially heritable (Anokhin et al., 2010). It relies upon a specific network of brain regions, 
including the medial frontal cortex, temporoparietal junction, superior temporal sulcus 
and temporal poles (Anokhin et al., 2010). An important aspect of social cognition is 
emotion recognition, which refers to the capacity to perceive and understand affective 
expressions. Problems in emotion understanding are a core diagnostic feature in ASD 
(Harms et al., 2010). Research on emotion recognition has traditionally focused on the 
visual aspect of emotion recognition (the identification of facial expressions) and most 
studies have shown that children and adolescents with ASD display deficits in their 
ability to accurately recognize and understand facial expressions of emotions (Charbon-
neau et al., 2013, Downs and Smith, 2004, Harms et al., 2010, Sinzig et al., 2008, Uljarevic 
and Hamilton, 2012). Similar impairments have been reported in unaffected first-degree 
relatives as well (Losh et al., 2009, Neves et al., 2011). Parents and siblings of autistic chil-
dren showed a remarkable reduction in processing the eye region in faces, a pattern that 
was previously reported to occur in autism (Adolphs et al., 2008). However, other studies 
have reported normal abilities in emotion recognition in autistic children (Buitelaar et 
al., 1999, Castelli, 2005), leaving the status of emotion recognition in ASD uncertain. In 
a recent meta-analysis, it was reported that there is an emotion recognition difficulty 
in ASD and that these difficulties might be specifically related to particular emotions 
or stimuli, rather than being a global emotion recognition deficit that is primary and 
universal in ASD (Uljarevic and Hamilton, 2012). Much less is known about the auditory 
aspects of emotion recognition, named affective prosody recognition. Affective prosody 
plays an important role in the understanding and verbal expression of affect (McCann 
and Peppe, 2003). Difficulties with using and understanding affective prosody could 
have implications for recognizing emotions in other persons. Even though impaired 
prosody is considered a prime characteristic of ASD, relatively little research has been 
done in this area. Whereas some studies reported impaired affective prosody recognition 
in ASD (e.g. autistic participants had more difficulty identifying emotional expressions 
from prosody and were less able to discriminate between vocal emotional expressions) 
(Charbonneau et al., 2013, Golan et al., 2007, Korpilahti et al., 2007, Lindner and Rosen, 
2006, Philip et al., 2010), others did not (Baker et al., 2010, Grossman et al., 2010, Heik-
kinen et al., 2009, Jones et al., 2011), making it difficult to draw firm conclusions. One 
study reported on fathers of autistic children demonstrating atypical neural responses 
to affective prosody (Korpilahti et al., 2007), but more research is needed to examine if 
affective prosody recognition is impaired in relatives of ASD patients.
Another main cause of heterogeneity in ASD is the co-occurrence with other disorders 
as psychopathologies, such as ADHD (Baird et al., 2008, de Bruin et al., 2007). Particularly 
the ADHD characteristic symptoms of increased inattention, hyperactivity and impulsiv-
ity appear frequently present in patients with ASD with comorbidity estimates rang-
ing from 30-80% (de Bruin et al., 2007, Leyfer et al., 2006, Rommelse et al., 2010) and 
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an increased incidence of ADHD was reported in (unaffected) family members of ASD 
patients and vice versa (Nijmeijer et al., 2009). Although research into social cognition 
impairments in ADHD is relatively sparse, difficulties in recognizing facial expressions 
(Corbett and Glidden, 2000, Da Fonseca et al., 2009, Uekermann et al., 2010) and affective 
prosody (Corbett and Glidden, 2000, Shapiro et al., 1993) have also been described in 
children with ADHD. Children with ADHD showed mild-to-moderate deficits in the per-
ception of affect (through facial expressions and speech intonation) and were less able 
to identify emotions using contextual information. Moreover, some studies reported 
more severe social cognition deficits in the ASD+ADHD group (e.g. slower and less ac-
curate) compared to the ASD only group (Sinzig et al., 2008, Van der Meer et al., 2012). 
This suggests that we should take comorbid ADHD symptoms into account and assess 
the impact of these symptoms when studying emotion recognition in ASD.
 The present study therefore aimed to examine whether recognition of facial 
emotion and affective prosody are viable endophenotypic candidates for ASD and to 
assess the impact of comorbid ADHD symptoms in this context. First, we hypothesized 
that if emotion recognition would indeed be an endophenotype in ASD, probands 
would perform worse than controls on both emotion recognition tasks and unaffected 
siblings would form an intermediate group based on their performance. Second, we 
hypothesized that probands with both ASD and comorbid ADHD would be more im-
paired in emotion recognition than children with only ASD. If children with ASD and 
comorbid ADHD would indeed be more impaired on emotion recognition, it would raise 
the question of whether children with ASD and comorbid ADHD have more difficulties 
in emotion recognition per se or perhaps secondary as a consequence of typical ADHD 
cognitive problems, such as impaired reaction time speed, inhibition and attention. 
Therefore, we included some general neuropsychological measures as covariates in the 
analyses, to better understand the mechanisms of comorbid ADHD on emotion recogni-
tion.
metHod
participants
Families with at least one child with a clinical diagnosis of Autism Spectrum Disorder 
(Autism, Asperger’s Syndrome (AS) or PDD-NOS; diagnosis mostly based on Autism 
Diagnostic Interview - Revised (ADI-R) and Autism Diagnostic Observation Scale (ADOS) 
assessment) (APA, 2000) (aged 2 - 20 years)  and at least one biological sibling (regardless 
of age and possible ASD status) were recruited in order to participate in the Biological 
Origins of Autism (BOA) study at Karakter Child and Adolescent Psychiatry University 
Center Nijmegen, the Netherlands. The BOA project aims to examine the genetic, bio-
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chemical and cognitive origins of ASD and study the overlap between ASD and ADHD 
on these levels. Control children were recruited from a random population cohort study 
(School kids Project of Interrelating DNA and Endophenotype Research; SPIDER, 32.4%) 
and via information leaflets that were send to families living in the same geographical 
regions as the participating ASD families as part of the BOA project (67.6%). Selected 
controls were required to have no formal or suspected ASD or ADHD diagnosis.
A subsample of 90 children with ASD (probands), 79 ASD unaffected siblings and 139 
controls were included in the current study. Data from these children was collected 
between December 2008 and July 2012. All selected children were between the ages 
of 6 and 13 and were of European Caucasian descent. Participants were excluded if they 
had an IQ ≤ 60, a diagnosis of epilepsy, brain disorders or known genetic disorders, such 
as Down-syndrome or Fragile-X-syndrome. The study has been approved by the local 
medical ethics board and written informed consent was obtained from parents and 
children over the age of 12 before testing.
Both the children already clinically diagnosed with ASD, their siblings and the control 
children were screened for the presence of ASD and ADHD symptoms using the par-
ent Social Communication Questionnaire (SCQ) (Berument et al., 1999) and the parent 
and teacher Conners Rating Scales Revised (CPRS; CTRS) (Conners, 1996) respectively. 
A raw score of ≥ 10 on the SCQ and T-scores ≥ 63 on the Conners’ DSM-IV Inattention, 
Hyperactivity-Impulsivity or Combined scales were considered as clinical. A lower cutoff 
was chosen for the parent reported SCQ to avoid false negatives in their undiagnosed 
offspring (Corsello et al., 2007, Eaves et al., 2006, van Steijn et al., 2012). For all children 
scoring above cut-off on the SCQ, a formal diagnosis of ASD was made by a certified 
clinician using the Autism Diagnostic Interview-Revised (ADI-R) (Lord et al., 1994). For all 
children scoring clinically on at least one of the DSM-IV ADHD scales, a semi-structured, 
standardized, investigator-based interview that covers the DSM-IV symptoms of ADHD 
(Parental Account of Childhood Symptoms; PACS) (Taylor et al., 1991) was administered. 
Thereafter, a standardized algorithm was applied using the scores of the PACS and the 
teacher version of the CRS-R to construct a formal diagnosis of ADHD (Rommelse et al., 
2007). The protocol for screening and measuring ADHD was similar to the protocol used 
in the International Multicenter ADHD Genetics (IMAGE) study, fully described elsewhere 
(Brookes et al., 2006). Control children were required to obtain non-clinical (i.e. a raw 
score on the SCQ of < 10 and T-score < 63 on the Conners’ DSM-IV scales) scores in order 
to be accepted in the current study.
Depending on the child’s age, full-scale IQ was estimated by four subtests of the 
Dutch version of the Wechsler Intelligence Scale for Children (WISC-III):  Similarities, 
Vocabulary, Block design and Picture completion (Wechsler, 2002). For 14.6% (N=45) of 
control children (SPIDER cohort), the subtest Arithmetic was administered instead of 
the subtest Vocabulary. These selected WISC-III subtests are known to correlate between 
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.90-.95 with the Full-scale IQ (Groth-Marnat, 1997). Two tasks were administered to 
test emotion recognition; 1) a visual task assessing the ability to recognize emotional 
facial expressions and 2) an auditory task to assess the ability to recognize emotions ‘in 
voices’ (affective prosody). The affective prosody recognition task was not administered 
to children younger than 9 years of age. Therefore, affective prosody recognition data 
was based on 66 ASD affected probands (30 with ADHD and 36 without ADHD), 49 ASD 
unaffected siblings and 72 controls. See Table 1 for sample characteristics.
materials
Emotion recognition tasks
Facial emotion recognition
Stimuli consisted of digitized, high quality color photographs of a human face with 
a distinct affective expression presented on a computer screen (see Figure 1). Each 
photograph presented a face with either a neutral expression or one of eight different 
types of emotion (happiness, sadness, anger, fear, disgust, surprise, shame, contempt) 
and children were asked to judge whether the presented photograph showed the 
target emotion or not by clicking a mouse button (De Sonneville et al., 2002). For the 
current study four target emotions were selected: happiness, sadness, anger and fear. 
If the presented photograph showed the target emotion the child was asked to click 
the ‘yes-button’ (right button for right-handed children, and left button for left-handed 
children). ‘No-responses’ were given by clicking the ‘no-button’ (left button for right-
handed children and right button for left-handed children). The photograph remained 
on the screen until the subject pressed the button. Each emotion condition consisted 
of 40 trails; half of which were the target emotion (requiring a ‘yes’ response) and half of 
which were a random selection of other emotions (requiring a ‘no’ response). Children 
were required to respond within 200-3,000 ms. After responding the next photograph 
appeared after a 1,000 ms interval. The sequence of target and nontarget stimuli was 
 
happy sad angry fear 
figure 1 Examples of stimuli in the facial emotion recognition task
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randomly assigned. Dependent variables were measures of speed (mean reaction time) 
and accuracy (percentage of errors) for the four emotions separately.
Affective prosody recognition
Stimulus material, designed by Vingerhoets et al. (2003), was adopted in the Amsterdam 
Neuropsychological Tests program (De Sonneville, 2005, Vingerhoets et al., 2003) and 
consisted of spoken sentences with a neutral content, presented through a headphone. 
Sentences were spoken in a happy, sad, angry or frightened intonation. Children were 
asked to verbally identify the emotion with which the sentence was spoken. A typical 
sentence was for example: ‘Put the plug in the wall socket’ (presented in Dutch). Reac-
tion times were recorded using a voice-key response (i.e. as soon as the child identified 
the expressed emotion in the tone of voice, the child was required to pronounce that 
particular emotion in a microphone that was connected to the computer). Subjects were 
required to respond within 300-6,000ms. Thereafter, the examiner registered the con-
tent of the response (type of emotion) the child identified by clicking the corresponding 
answer button. The next trial was presented 1,200ms after the examiner had registered 
the response. The complete task consisted of 48 trials (12 per emotion - 6 spoken by a 
man, 6 spoken by a woman), which were presented in randomized order. Missed trials 
were replaced automatically. Dependent variables were speed (mean reaction time) and 
accuracy (percentage of errors) for the four emotions separately.
General neuropsychological measures
Baseline Response Speed
This task was used to measure the speed and variability of motor output, comparable 
to a simple reaction time task (De Sonneville, 1999). When a fixation cross in the centre 
of a computer screen changed into a white square, children pressed a key as quickly as 
possible. To prevent anticipation strategies, the time interval between a response and 
the emergence of the next square varied randomly between 500 and 2500 ms. Response 
speed (mean reaction time) was used as covariate in the analyses.
Response inhibition
The Response Organisation Objects (ROO) was used to measure response inhibition (De 
Sonneville, 1999, Van der Meer et al., 2012). The stimulus was a figure of a colored ball 
that was presented to the left or right of a fixation cross. Two parts were administrated. 
In Part 1, baseline speed and accuracy were measured. Children were instructed to click 
the mouse button that corresponded with the orientation of the stimulus, as soon as 
they noticed a green ball on the left or the right of a fixation cross. In part 2, the ball was 
colored red, and children had to click the mouse button on the opposite side. Motor 
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inhibition was calculated as the difference in mean reaction time and percentage of 
errors between blocks one and two. Both measures were included as covariates in the 
analyses.
Verbal Attention
The forward condition of the Digit Span task of the WISC-III (Wechsler, 2002) was used 
to obtain an indication of verbal attention (Van der Meer et al., 2012). Children were 
instructed to repeat a sequence of verbally presented numbers. The difficulty level 
increased after each succeeded trial. The total number of correct sequences in identical 
order was included as covariate in the analyses.
procedure
The tasks described were part of the broader neuropsychological assessment batteries 
used in the BOA and SPIDER projects. Children completed the battery in approximately 
two hours and the order of task administration was counterbalanced. Testing of the 
BOA cohort took place at Karakter Child and Adolescent Psychiatry University Center 
in Nijmegen, The Netherlands, and was conducted for all the children of the same fam-
ily simultaneously. If possible, stimulants were discontinued for at least 24 hours and 
non-stimulants according to guidelines to allow for sufficient wash-out. Children were 
motivated with small breaks and received a reward after test administration. Control 
children were tested in a similar way at Karakter (BOA) or in a quiet room at their school 
(SPIDER).
statistical analyses
A Van der Waerden transformation was used to normalize the dependent measures 
(Norusis, 1992). The normal scores were mirrored, so that the z-scores of all tasks would 
have the same meaning: lower z-scores indicated a worse performance (i.e. more errors 
and slower performance).  In first instance, we examined the main effects of possible 
confounders (sex, total IQ, modality (two modalities: visual/auditory) and age (linear and 
curvilinear)) on performance on the two tasks. This was done within the control group to 
avoid dependency with the factor group. Furthermore, interactions between group and 
the confounders were examined to investigate whether effects of possible confounders 
were comparable across groups. Analyzing the possible confounding effect of modality 
was done in children ≥ 9 years of age, so that sample size and composition was compa-
rable for the two tasks.
Group differences on facial emotion recognition and affective prosody were examined 
using linear mixed models with group (probands, unaffected siblings, and controls) as 
factor, age and total IQ as covariates, and family as random effect to account for within 
family correlation. Also, the interactions between group and age and group and total IQ 
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were implemented in the initial model. When the interactions were non-significant, they 
were dropped from the model. If the main effects of age and IQ were non-significant, 
they were dropped from the model as well. Group contrasts were calculated within the 
mixed model using pairwise comparisons with age, IQ and sex as covariates. The analy-
ses were run separately for facial emotion and affective prosody recognition measures, 
a) with the four emotions as repeated measure, to examine whether an overall deficit 
in emotion recognition was present and b) separately for the four emotions (happi-
ness, sadness, anger and fear), to examine post-hoc which emotions specifically were 
impaired.  Subsequently, analyses were rerun, but with factor group defined as: ASD 
probands with ADHD versus ASD probands without ADHD versus controls, and includ-
ing response inhibition speed and accuracy measures, verbal attention and baseline 
response speed as covariates, to investigate the effect of comorbid ADHD and typical 
ADHD cognitive deficits on emotion recognition. A False Discovery Rate (FDR) correction 
with a q-value setting of 0.05 was applied to control for multiple testing. All analyses 
were carried out in SPSS version 20.
results
testing of the possible confounding effects of sex, iq, modality and age
The percentage of missing data was random and less than 3% for accuracy and speed 
measures on the facial emotion recognition task, <4% for accuracy and speed measures 
for affective prosody recognition (for children aged 9-13 years) and <4% on response 
inhibition, verbal attention and baseline response speed. Missing data were replaced by 
means of Expectation Maximization (Tabachnick and Fidell, 2001). Analyses were carried 
out with and without expectation maximization, which revealed similar results. Results 
were therefore reported with missing data replaced. For 24 (26.7%) affected children 
and 2 (2.4%) ASD unaffected siblings, discontinuation of medication was neither pos-
sible nor desirable and 12 (15.2 %) ASD unaffected siblings fulfilled criteria for ADHD. 
Analyses were performed with and without including the data of these children, which 
revealed overall similar results. Results were therefore reported including these children.
main effects of sex, iq, modality and age
We tested for the effects of sex, IQ, modality and age on emotion recognition within the 
control group to avoid dependency with the factor group. Overall, no significant effects 
of sex were found for the speed and accuracy measures of facial emotion and affective 
prosody recognition, except for  a significant sex effect on the visual recognition of fear 
(accuracy: F (1, 132.2) = 4.27, p = .041) and the auditory recognition of anger (speed: F (1, 
64.2) = 4.92, p = .030) and fear (speed: F (1, 67.0) = 8.47, p = .005), with boys performing 
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less accurate or slower than girls. However, these effects became non-significant after 
FDR correction. For 8/16 analyses, significant effects of IQ were found that survived FDR 
correction. Significant IQ effects were found for accuracy on the visual recognition of 
sadness and fear (F (1, 128.9) = 6.31, p = .013 and F (1, 125.0) = 14.16, p <.001), and for 
speed on happiness and anger (F (1, 123.5) = 7.84, p = .006 and F (1, 131.8) = 9.22, p = 
.003) and for the auditory recognition of sadness (speed; F (1, 66.2) = 8.29, p = .005), an-
ger (accuracy; F (1, 64.7) = 9.42, p = .013 and speed; F (1, 64.4) = 6.56,  p = .003) and fear (F 
(1, 67.0) = 6.26, p = .015). Significant effects of modality were found for both accuracy (F 
(1, 69.5) = 229.4, p <.001) and speed measures (F (1, 70.3) = 310.5, p <.001). Age (in linear 
terms) had a strong main effect on all speed measures of facial emotion and  affective 
prosody recognition (all p-values < .010) indicating that older children performed better 
than younger children. Furthermore, significant age effects were found for accuracy on 
the visual recognition of happiness (F (1, 138.9) = 4.94, p = .028), anger and fear (both 
p-values <.001) and on accuracy on the auditory recognition of anger (F (49.9) = 6.78, 
p = .012). Overall, no main effects of curvilinear age were present, except for a small 
significant effect for accuracy on the auditory recognition of anger (F (1, 129.0) = 4.40, p 
= .004), which did not survive FDR correction.
interactions between group and possible confounders
Only 1/16 group*sex interactions had a p-value below .05 (speed of auditory recognition 
of happiness: F (2, 167.9) = 3.23, p = .042), which did not survive FDR correction. Only 
2/16 group*IQ interactions had a p-value below .05 [accuracy of auditory recognition of 
happiness (F (2, 166.0) = 3.59, p = .030) and sadness (F (2, 167.9) = 4.73, p = .010)], which 
did not survive FDR correction. No significant group*modality analyses were found for 
accuracy (F (2, 182.1) = 2.24, p = .109) and speed (F (2, 183.8) = .81, p = .446). Only 2/32 
group*age (linear or curvilinear) interactions had a p-value below .05 (facial recognition 
of happiness (linear: F (2, 303.9) = 4.25, p = .015; curvilinear: F (2, 289.5) = 3.87, p = .022)), 
which did not survive FDR correction.
Based on the results of these analyses, we decided to omit sex from further analyses, 
since no sex differences in the control group were found and sex had a similar effect on 
emotion recognition in the groups. Age and IQ and the interactions between age, IQ and 
group were included as covariates in the initial analyses, because of the strong age and 
IQ effects that were found for the majority of dependent measures. Facial emotion rec-
ognition and prosody were separately analyzed, because of the main effect of modality. 
Means and standard deviations of the unstandardized scores are presented in Table 2.
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Group differences between asd probands, unaffected siblings and controls
Facial emotion recognition
A significant group effect was found for accuracy (F (2, 181.5) = 3.21, p = .043). Pairwise 
comparisons revealed a significantly worse performance of probands compared to 
controls (p = .015). Analyses per emotion revealed a significantly worse performance 
of probands and unaffected siblings compared to controls on the recognition of happi-
ness (p = .034 and p = .007, respectively). No group differences were found for accuracy 
on the other emotions. Furthermore, significant group effects were found for speed (F 
(2,182.8) = 4.27, p = .015). Analyses per emotion revealed significant differences between 
probands and controls on happiness (p = .01), sadness (p = .017), anger (p = .024) and 
fear (p = .006), with probands performing worse than controls. Unaffected siblings did 
not differ significantly from probands and controls, see Figure 2a.
Affective prosody recognition
A significant group effect was found for accuracy (F (2, 164.2) = 3.20, p = .043). Analyses 
per emotion revealed a significant group difference between probands and controls 
on the auditory recognition of sadness (p = .023) and between probands and unaf-
fected siblings on the auditory recognition of anger (p = .022). Furthermore, a significant 
group*IQ interaction effect was found (F (2, 165.8) = 3.32, p = .038). Analyses revealed 
that IQ had no significant effect on accuracy in controls (F (1, 67.1) = .01, p = .91), but 
had large effects in ASD probands (F (1, 62.0) = 13.09, p = .001) and siblings (F (1, 68.0) 
= 273.4, p <.001), with children with higher IQ’s performing better than children with 
lower IQ’s. A significant group effect was found for speed (F (2, 179.1) = 9.56, p <.001). 
Analyses per emotion revealed significant differences between probands and controls 
on the recognition of happiness, sadness, anger and fear (all p-values <.004) and be-
tween unaffected siblings and controls on the recognition of fear (p = .01), see Figure 2b.
Group differences between asd probands with adHd, asd probands without 
adHd and controls
Facial emotion recognition
Overall, a significant group effect was found for accuracy (F (2, 194.8) = 4.35, p = .014). 
This group effect remained significant after correction for general cognitive measures 
and medication use. Pairwise comparisons revealed a significant difference between 
ASD probands with ADHD and controls (p = .004), but no significant difference between 
ASD probands with and without ADHD. Analyses per emotion revealed that ASD 
probands with ADHD performed worse on the recognition of happiness compared to 
controls (p = .012), but this effect became non-significant after controlling for medica-
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tion use. Furthermore, a signifi cant group eff ect was found for speed (F (2, 192.8) = 4.91, 
p = .008) with ASD probands with (p = .005) and without ADHD (p = .027) performing 
signifi cantly worse than controls. Analyses per emotion revealed signifi cant diff erences 
between ASD probands with ADHD and controls on happiness (p = .003) and fear (p = 
 
figure 2a  and  2b. Group diff erences between ASD probands, ASD unaff ected siblings and controls on 
accuracy (% errors) and speed measures of facial emotion and aff ective prosody recognition, separate for 
the four emotions
Note.   ASD = Autism Spectrum Disorders. The means are adjusted for the covariates age and IQ and error 
bars represent 1 standard error. A higher z-score indicates a faster or more accurate response. Results were 
based on 308 children (age 6-13 years; facial emotion recognition) and 187 children (age 9-13 years; aff ec-
tive prosody recognition). The dotted lines indicate marginally signifi cant group diff erences
a Eff ect became non-signifi cant when unaff ected siblings with ADHD were excluded from the analyses
b Eff ect became non-signifi cant after correction for medication use
c Signifi cant group diff erence appeared after correction for medication use
76
.004) and between ASD probands without ADHD and controls on anger (p = .021) and 
fear (p = .042; did not survive FDR correction). These effects became non-significant after 
controlling for inhibition speed and baseline response speed, see Figure 3a. For means 
and standard deviations of the unstandardized scores of ASD probands with ADHD and 
ASD probands without ADHD, see Supplementary Table 1.
Affective prosody recognition
A significant effect of group (F (2, 134.0) = 3.12, p = .048) and a group*IQ interaction (F 
(2, 130.2) = 3.13, p = .047) were found for accuracy, which remained significant after cor-
rection for ADHD cognitive measures and medication use. Group differences were found 
between ASD probands with ADHD and controls on sadness (p =. 012) and between ASD 
probands with and without ADHD on happiness (p =.039). Further, analyses revealed 
that IQ had no significant effect on accuracy in controls (F (1, 67.1) = .01, p = .91), but had 
large effects in ASD probands with ADHD (F (1, 90.1) = 107.0, p <.001) and without ADHD 
(F (1, 27.0) = 11.89, p = .002), with probands with higher IQ’s performing better than 
probands with lower IQ’s. A significant group effect was found for speed (F (2, 121.0) = 
9.01, p <.001). Analyses per emotion revealed group differences between ASD probands 
with ADHD and controls on all four emotions (all p-values <.016) and between ASD pro-
bands without ADHD and controls (all p-values <.042). However, the difference between 
ASD probands without ADHD and controls on anger did not survive FDR correction. The 
difference between ASD probands with ADHD and controls on happiness and anger 
became non-significant after controlling for medication use, see Figure 3b.
discussion
The present study aimed to examine whether recognition of facial emotion and affec-
tive prosody are viable endophenotypic candidates for ASD and to assess the impact of 
comorbid ADHD in this context. Studying these issues is of vital importance to enhance 
our understanding of the genetic underpinnings of ASD and comorbid ADHD, and 
the problems children with autism face in every day social life. The results for the ASD 
probands are consistent with previous research findings that the recognition of facial 
expressions and affective prosody are affected in children with ASD (Charbonneau et 
al., 2013, Golan et al., 2007, Harms et al., 2010, Korpilahti et al., 2007, Lindner and Rosen, 
2006, Philip et al., 2010, Sinzig et al., 2008, Uljarevic and Hamilton, 2012). Children with 
ASD were overall slower and less accurate in identifying the emotional state of others 
compared to controls. The impairments were present in all four emotions, and were 
most pronounced for speed measures. This indicates that children with ASD are slower 
in identifying emotions, which might make it difficult for them to quickly adapt their 
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behavior adequately in social settings, for example responding appropriately to highly 
emotional charged conversations.
 
figure 3a  and  3b. Group diff erences between ASD probands with and without ADHD and controls on 
accuracy (% errors) and speed measures of facial emotion and aff ective prosody recognition, separate for 
the four emotions
Note.   ASD = Autism Spectrum Disorders. The means are adjusted for the covariates age and IQ and error 
bars represent 1 standard error. A higher z-score indicates a faster or more accurate response. Results were 
based on 229 children (age 6-13 years; facial emotion recognition) and 138 children (age 9-13 years; aff ec-
tive prosody recognition). The dotted lines indicate group diff erence that did not survive FDR correction.
a Eff ect became non-signifi cant after correction for ADHD cognitive measures.
b Eff ect became non-signifi cant after correction for medication use
c Signifi cant group diff erence appeared after correction for ADHD cognitive measures
d Signifi cant group diff erence appeared after correction for medication use
78
Furthermore, some support was found for emotion recognition being a cognitive en-
dophenotype of ASD. That is, the performance of unaffected siblings could be considered 
at an intermediate level, performing somewhat worse than the controls and better than 
the ASD probands regarding the speed measures. This was best visible in the domain of 
auditory recognition of sadness, anger and fear. This finding confirms previous findings 
on emotion recognition deficits in relatives of autistic individuals (Neves et al., 2011) 
and is in line with previous studies employing this affected-unaffected sibling design 
in for instance ADHD or schizophrenia cognitive studies (Hoff et al., 2005, Rommelse et 
al., 2011). The findings were less convincing with respect to facial emotion recognition 
and error measures. Despite a linear trend in group contrast, the performance of unaf-
fected siblings was more like controls than that of affected siblings. An explanation for 
this finding might be that facial emotion recognition deficits, more so than problems 
in affective prosody recognition, are part of the defining features of ASD, rather than 
being an endophenotypic trait that can be seen in unaffected relatives. An alternative 
explanation however, might be that the task demands differed between the visual and 
auditory emotion recognition tasks. A difference in difficulty level between visual and 
auditory tasks has been reported previously (Aylward et al., 2002) and was supported 
by our findings that overall, the participants performed more poorly on the auditory 
measures compared to the visual measures. In addition, Spencer et al. demonstrated 
that unaffected siblings of autistic adolescents demonstrated an atypical implicit re-
sponse to facial emotional expressions and Kaiser et al. found neural atypicalities in 
unaffected siblings of children with ASD during a social biological motion task (Kaiser et 
al., 2010, Spencer et al., 2011). Given that neuroimaging measures may be more sensitive 
than neuropsychological tests in detecting subtle functional deficits or compensatory 
activity, it is premature to conclude that visual emotion recognition is normal in unaf-
fected relatives of ASD probands. Overall, our results suggest subtle emotion recogni-
tion impairments to be present in unaffected relatives. This may suggest that deficits 
in emotion recognition are not only associated with the disorder, but may be related 
to shared familial sources, which may make it a useful tool in future studies aimed at 
unraveling the genetic underpinnings of ASD. Even though unaffected siblings do not 
portray obvious ASD symptoms, they appear to share at least some of the underlying 
neuropsychological difficulties characteristic of ASD, which may be easily overlooked. 
This highlights the importance of following siblings over time, since they are at risk for 
impairments in social functioning.
Overall, some support was found for the hypothesis that ASD+ADHD probands would 
be more impaired than ASD only probands on emotion recognition. The findings sug-
gested that the presence of ADHD might add up to a more severe deficit in emotion 
recognition than ASD alone. This raised the question of whether children with ASD 
and comorbid ADHD have more difficulties in emotion recognition per se or perhaps 
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secondary as a consequence of typical ADHD cognitive problems, such as impaired 
reaction time speed, inhibition and attention. After controlling for these cognitive 
measures, group differences remained significant for affective prosody recognition, but 
became non-significant for facial emotion recognition. This might imply that poorer 
facial emotion recognition skills in ASD children with ADHD (compared to ASD children 
without ADHD) might be a result of additive effects of ADHD neurocognitive symptoms 
on emotion recognition problems. In contrast, poorer performance on the auditory 
recognition of emotions is more likely reflective of poorer affective prosody recognition 
skills amongst this comorbid group compared to children with ASD only. Somewhat 
similar results that poorer performance in facial affect recognition in children with ASD 
and comorbid ADHD was mostly caused by ADHD inattentive symptoms were reported 
previously (Sinzig et al., 2008). However, an alternative explanation for the findings may 
be the different nature and complexity of the tasks: for facial emotion recognition, reac-
tion times were all calculated by clicking a mouse button, whereas a voice-key response 
(verbally identifying the target emotion, no motor action required) was used in the 
affective prosody task. This might explain why baseline response speed and inhibition 
(both manual reaction time tasks) were related to the recognition of facial emotion, but 
not affective prosody. Another possibility is that the different nature of the tasks (voice-
key vs. clicking a button) in itself might lead to different performances in ASD children 
with and without ADHD, not just the difference in stimuli (facial vs. auditory). Neverthe-
less, even though some emotion recognition problems may be secondary to core ADHD 
cognitive problems, our results do suggest that children with comorbid ASD and ADHD 
are at highest risk for emotion recognition problems and clinicians should therefore pay 
special attention to these children suffering from symptoms of both spectra.
A number of limitations need to be considered. First, no children with ADHD only 
and their unaffected siblings were present in this study, limiting our ability to draw 
conclusions about the endophenotypic properties of emotion recognition in ADHD. 
We can therefore not conclude that emotion recognition deficits are common deficits 
across ASD and ADHD. Second, sample sizes were relatively small with regard to the 
ASD probands with and without ADHD, which might have resulted in undetected effects 
due to a lack of power. However, even though sample sizes were relatively small, group 
effects were significant, underlining the presence of group differences between ASD 
probands with and without ADHD. Third, when comparing performances on the facial 
emotion recognition and the affective prosody recognition tasks, it should be noted 
that a) the number of children who have participated in both tasks is not identical, b) 
the children involved in the affective prosody recognition task are older to the ones who 
did the facial emotion recognition task, and c) the level of complexity of the two tasks 
is different (i.e. one task requires a verbal answer while the other requires pressing a 
button and one involves target detection among distracters, while the other is a labeling 
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task). Whilst we corrected for the difference in sample composition by analyzing the 
effect of modality in children > 9 years only (i.e. in the affective prosody sample), we 
were unable to correct for the difference in task complexity and therefore we cannot 
firmly conclude that recognition of affective prosody is more impaired than recogni-
tion of facial emotional expressions based on the current data. Future research should 
consider this issue by using facial emotion and affective prosody recognition tasks with 
comparable experimental designs and difficulty levels. Fourth, we did not report on the 
treatments and cares that have been offered to the ASD probands. The recognition of 
emotions is currently at the heart of training and this could have impacted the current 
data. Several studies have been published that report improvements in social skills (e.g. 
recognition of emotional expressions) in children with ASD after social skills training 
(Hopkins et al., 2011, Reichow et al., 2012). This would suggest that emotion recognition 
deficits might be state-dependent (and can be improved or even resolved after social 
skills training), and this would imply that emotion recognition deficits might be a weak 
endophenotypic candidate. However, we feel that our findings reflect shared areas of 
dysfunction in children with ASD and their unaffected siblings, suggesting that emotion 
recognition deficits might be, at least to some extent, trait-related. Although we have 
not specifically asked and therefore cannot report on whether or not the ASD probands 
received social skills training in their past, it is highly unlikely that their unaffected, 
undiagnosed siblings have received social skills training. Finding similar deficits in both 
ASD affected and ASD unaffected siblings supports the hypothesis that emotion rec-
ognition might be a viable endophenotypic candidate for ASD. Fifth, we did not assess 
the presence of Oppositional Defiant Disorder (ODD) or Conduct Disorder (CD) in this 
sample, even though oppositional behavior is often observed in children with ASD and/
or ADHD (Gadow et al., 2008, Guttmann-Steinmetz et al., 2009) and all of these disorders 
are associated with impairments in social cognition (Cadesky et al., 2000, Downs and 
Smith, 2004). Future studies should examine ASD, ADHD and ODD/CD in tandem to gain 
a better understanding of social cognition deficits in children with psychopathology. 
Last, 15.2% (facial emotion recognition sample)/10.2% (affective prosody recognition 
sample) of the ASD unaffected siblings presented clinical ADHD symptoms, which could 
have obscured our findings with regard to the intermediate performance of siblings. 
However, analyses were run with and without these siblings and revealed similar results.
In conclusion, this study has shown that the recognition of both facial emotion and 
affective prosody was impaired in children with ASD and aggravated by the presence of 
ADHD. The latter could only be partly explained by typical ADHD cognitive deficits, such 
as inhibitory and attentional problems. Some evidence was found for the viability of 
emotion recognition as endophenotype in ASD. Particularly speed measures of emotion 
recognition may be of interest in future family studies of the genetic contribution to ASD 
and comorbid ADHD.
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Simplex and multiplex stratification in ASD 
and ADHD families: a promising approach 
for identifying overlapping and unique 
underpinnings of ASD and ADHD?
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abstract
Autism spectrum disorders (ASD) and attention-deficit/hyperactivity disorder (ADHD) 
are highly heterogeneous neuropsychiatric disorders that frequently co-occur. This 
study examined whether stratification into single-incidence (SPX) and multi-incidence 
(MPX) is helpful in a) parsing heterogeneity and b) detecting overlapping and unique 
underpinnings of the disorders. ASD and ADHD traits were measured in 56 ASD/31 
ADHD SPX, 59 ASD/171 ADHD MPX, and 203 control families. In ASD but not in ADHD, 
behavioral traits were less elevated in SPX compared to MPX unaffected relatives, 
suggesting that SPX-MPX stratification may thus help parse ASD, but not ADHD hetero-
geneity. Particularly unaffected relatives from MPX ASD and ADHD families displayed 
elevated trait levels of both disorders, indicating shared (multifactorial) underpinnings 
underlying ASD and ADHD in these families. Cross-disorder traits were highest in MPX 
ASD unaffected siblings.
89
Chapter 4 : ASD and ADHD traits in simplex versus multiplex families
introduction
Autism spectrum disorders (ASD) and attention-deficit/hyperactivity disorder (ADHD) 
are both severely impairing neurodevelopmental disorders. ASD is characterized by 
impairments in interaction, communication and restricted, stereotyped and repeti-
tive behaviour. ADHD is characterized by symptoms of hyperactivity, impulsivity and/
or inattention (APA, 2013). Both ADHD and ASD are disorders with a strong heritable 
component that frequently co-occur within patients and families due to overlapping 
etiological factors (Rommelse et al., 2010, Rommelse et al., 2011, Ronald et al., 2008). 
Common to both disorders is the large within-disorder heterogeneity, both in symptom 
presentation, developmental course and underlying etiological mechanisms (Jones and 
Klin, 2009, Wahlstedt et al., 2009). This strongly hinders optimal diagnosis and treatment. 
Finding methods that may aid in detecting more homogeneous subgroups of patients 
are therefore needed.
One such method currently applied in the field of ASD research is the stratification ac-
cording to family history for ASD (Sullivan et al., 2012). In this so-called SPX-MPX design, 
single-incidence or simplex families (SPX) are defined as nuclear families with only one 
affected individual and at least one unaffected male sibling, and multi-incidence or mul-
tiplex families (MPX) as families with two or more affected individuals in the family. The 
hypothesis is that the constellation of etiological factors differs between SPX versus MPX 
families. Research on genetic factors in ASD shows that symptoms of affected individuals 
from SPX families more often have a sporadic cause, such as de novo mutations, that is 
unshared with other family members (Sebat et al., 2007). In contrast, polygenic or multi-
factorial modes of inheritance (i.e. multiple (genetic) risk factors shared between family 
members) appear to play a more important role in MPX families (Freitag, 2007), with 
studies showing that members of MPX families more often exhibit ASD traits compared 
to members of SPX families (Bernier et al., 2012, Losh et al., 2008, Schwichtenberg et al., 
2010, Virkud et al., 2009). Thus, stratification according to family history seems sensitive 
in discriminating between (genetic) risk factors uniquely present in the proband (mostly 
present in SPX families) versus risk factors shared by multiple family members (in MPX 
families) (Sullivan et al., 2012).
In ADHD research, this approach has rarely been used, probably since the majority 
of studies suggest that ADHD is caused by small disease-increasing effects of multiple 
genes in interaction with environmental factors (Banaschewski et al., 2010). The evi-
dence for this model is strong and also supported by numerous studies documenting an 
increased incidence of ADHD symptoms and ADHD-related cognitive vulnerabilities in 
family members of ADHD probands (Rommelse, 2008, Rommelse et al., 2011). However, 
several recent reports do indicate that rare genetic mutations or non-shared environ-
mental factors (such as low birth weight and medical conditions) with a large effect may 
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relate to ADHD as well (Ben Amor et al., 2005, Elia et al., 2012, Lionel et al., 2011, Williams 
et al., 2012, Williams et al., 2010). These findings suggest that applying the SPX-MPX 
stratification in ADHD families may also be worthwhile.
Applying the SPX-MPX stratification in ASD and ADHD families might be a promising 
approach to form more homogenous groups of patients, thereby enhancing chances to 
uncover the etiologies of both disorders. This is highly relevant for research of genetic 
and neurobiological causes of ASD and ADHD, which may be otherwise confounded 
by the mixing of causally-distinct subgroups within study samples (Virkud et al., 2009). 
SPX-MPX stratification adds to current genetic designs in that it differentiates between 
monocausal (such as rare genetic variants or de novo mutations with large penetrance 
unique to the affected individual; expected in SPX families) and multifactorial genetic 
factors (shared between siblings; expected in MPX families). Traditional twin and adop-
tion designs do not differentiate between these different causal (genetic) factors which 
might result in overestimation of heritability (Trzaskowski et al., 2013). Attempting to 
differentiate between risk factors that are unique to the affected individuals and risk 
factors shared between affected and unaffected relatives may increase our knowledge 
of the mechanisms that play a key role in ASD and ADHD. A related approach to ours that 
also focuses on differentiating between shared and non-shared risk factors is examining 
monozygotic (MZ) twins discordant for the disorder (Wong et al., 2014, Zwijnenburg et 
al., 2010). Although MZ twins are generally considered ‘genetically identical, evidence 
for genetic and epigenetic differences within MZ twin pairs has accumulated (Zwijnen-
burg et al., 2010). Examining the differences between discordant monozygotic twins can 
contribute to our understanding of the pathogenesis of the disorder, aid in finding new 
shared and unique risk factors, and guide us to why one twin may manifest symptoms 
differently than the other (Wong et al., 2014, Zwijnenburg et al., 2010).
Of great interest is further whether SPX-MPX stratification may also be successful 
in the identification of common versus unique risk factors for ASD and ADHD. To our 
knowledge, no such attempt has been made thus far. Several reports have been pub-
lished on the overlap between ASD and ADHD (Rommelse et al., 2011), and studies have 
indicated that a large portion of this covariance might be explained by shared additive 
genetic factors (Ronald et al., 2008). If these factors are polygenic in nature, then we 
would expect to find a heightened prevalence of comorbid ASD symptoms in ADHD 
MPX, but not SPX families (and vice versa higher prevalence of ADHD in ASD MPX but 
not SPX families). Such knowledge could inform the search for shared and unique ge-
netic risk factors for both disorders. Consideration of (comorbid) ASD and ADHD traits in 
family members also has important clinical implications in terms of treatment planning. 
For example, awareness of the impact of family history on the presence of ASD and/or 
ADHD risk factors in unaffected relatives is crucial for the development of a treatment 
plan and for genetic counseling.
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The aim of this study was twofold. First, we examined whether the SPX-MPX stratifi-
cation method may be a useful approach to create (etiologically) more homogeneous 
subgroups of patients based on symptom presentation of unaffected relatives. We 
hypothesized that (a) unaffected relatives from MPX but not SPX ASD families will 
have elevated levels of ASD traits compared to controls and (b) unaffected relatives in 
MPX but not SPX ADHD families will have elevated levels of ADHD traits compared to 
controls. Second, we examined whether SPX-MPX stratification is a useful tool to detect 
shared etiological underpinnings of ASD and ADHD. We expected unaffected relatives in 
MPX more than SPX ADHD families will have elevated levels of ASD traits, and vice versa 
higher levels of ADHD traits in MPX than SPX ASD unaffected relatives.
metHod
participants
ASD and ADHD families were recruited as part of two family-genetic studies: the Biologi-
cal Origins of Autism (BOA) study and the Dutch part of the International Multicenter 
ADHD Genetics (IMAGE) study (as described previously in van Steijn et al., 2012). Inclu-
sion criteria for all participants were at least two biological siblings (in case families: at 
least one child with a clinical diagnosis of ASD or ADHD) and one biological parent will-
ing to participate, offspring age between 4 and 20 years, European Caucasian descent, 
an IQ ≥ 70, and no diagnosis of epilepsy, brain disorders or known genetic disorders, 
such as Down-syndrome or Fragile-X-syndrome.
procedure
Parents were invited to fill out several questionnaires concerning their own and their 
children’s behavior. Additional data collected included blood samples of all family mem-
bers for DNA-isolation and neuropsychological assessment of the children. The study 
was approved by the local medical ethics board and parents and children (12 years and 
older) signed for informed consent.
screening and measures
Children
The exact screening procedures and measures for ASD and ADHD phenotyping in chil-
dren have been described in previous publications which can be consulted for greater 
detail (van Steijn et al., 2012). The parent and teacher Social Communication Question-
naire (SCQ) (Rutter et al., 2003), the Child Social Behavior Questionnaire (CSBQ)(Hartman 
et al., 2006), and Conners Rating Scales Revised (CPRS; CTRS) (Conners, 1996) were used 
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to identify children with ASD and/or ADHD symptoms. These questionnaires are vali-
dated instruments to measure ASD and ADHD traits (Charman et al., 2007, Conners et al., 
1998b, Rutter et al., 2003). All children scoring above cut-off on any of the questionnaires 
underwent full diagnostic ASD and ADHD assessment, including the Autism Diagnostic 
Interview-Revised (ADI-R) (Le Couteur et al., 2003) and Parental Account of Childhood 
Symptoms ADHD subversion (PACS) (Taylor et al., 1991).
Parents
In the ASD cohort, case and control parents were screened for ASD using the Autism 
Spectrum Quotient (AQ) (Baron-Cohen et al., 2001) and the Adult Social Behavior Ques-
tionnaire (ASBQ) (Horwitz et al., 2005). The ASBQ is the adult version of the CSBQ and, 
although still under development, shows promising first results in terms of reliability 
and validity for the ASBQ (Horwitz et al. submitted for publication). In the ADHD cohort, 
case and control parents were screened for ADHD using the self-report questionnaire 
for ADHD (Kooij et al., 2005), the self and spouse Conners Adult Rating Scales Self Re-
port (CAARS:S-L) (Conners et al., 1998a, 1999), and the Schedule for Affective Disorders 
and Schizophrenia for School-Age Children - Present and Lifetime Version (K-SADS-PL; 
administered in follow-up study [NeuroIMAGE]) (Kaufman et al., 1997). Parents scoring 
above cut-off (Hoekstra et al., 2008, Kooij et al., 2005) on any of the ASD/ADHD question-
naires, or on the semi-structured ADHD interview, were considered a suspected case.
Control children and their parents were required to obtain non-clinical scores in order 
to be accepted in the study.
Family classification
Families were then stratified into SPX and MPX families, see Figure 1 for details. SPX 
families were required to have a single-affected proband, a minimum of one male sib-
ling and all siblings and parents of the proband unaffected by ASD or ADHD on the basis 
of non-clinical scores on the screenings questionnaires and/or administered diagnostic 
interviews. Families with siblings and/or parents who displayed (sub) threshold ASD 
and/or ADHD symptoms, in addition to the proband, were categorized as multiplex 
(MPX). Families were excluded if a) only one unaffected parent from a presumed SPX 
family based on number of affected children participated in this study (to minimize the 
risk of erroneous categorization because of missing parental data) and b) if the affected 
proband had only female unaffected siblings (to account for higher sibling recurrence 
risk in male siblings than female siblings). SPX-MPX stratification was made on the basis 
of the primary clinical diagnosis of the probands. That is, SPX and MPX ASD families 
originate from an ASD cohort in which the primary clinical diagnosis of the proband is 
ASD, SPX and MPX ADHD families originate from an ADHD cohort in which the primary 
clinical diagnosis of the proband is ADHD.  ASD+ADHD probands were not considered 
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figure 1 Flowcharts of SPX-MPX stratification in the ASD and ADHD cohorts
Note. A conservative approach was adopted to the inclusion of simplex (SPX) families in this study. All SPX 
families were required to have a single-affected proband, a minimum of one male sibling and all siblings 
and parents of the proband unaffected by ASD or ADHD on the basis of non-clinical scores on the screen-
ings questionnaires and/or administered diagnostic interviews. Families with siblings and parents who dis-
played (sub) threshold ASD and/or ADHD symptoms, in addition to the affected child, were categorized as 
multiplex (MPX). Families were excluded (ASD: N = 62, 35.0% of ASD cohort; ADHD: N=33, 13.9% of ADHD 
cohort) if a) only one unaffected parent from a presumed SPX family based on number of affected children 
participated in this study (to minimize the risk of erroneous categorization because of missing parental 
data) (ASD: N=3, 1.7%; ADHD: N=3, 1.3%) and b) if the affected proband had only female unaffected sib-
lings (to account for higher sibling recurrence risk in male siblings than female siblings) (ASD: N=54, 30.5%; 
ADHD: N=25, 10.5%) or both a and b (ASD: N = 5, 2.8%; ADHD: N=5, 2.1%). In grey, the final number of se-
lected SPX and MPX families that fulfilled inclusion criteria.
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a separate category within the SPX-MPX stratification, because of the main reason 
that this would interfere with our aim to examine quantitatively the cross-disorder 
relationships between both symptom dimensions. By treating ASD+ADHD families as 
a separate category –families with a likely high cross-disorder loading- the quantitative 
cross-disorder loading would be artificially reduced. A total of 56 ASD and 31 ADHD SPX 
nuclear families, 59 ASD and 171 ADHD MPX nuclear families, and 203 control nuclear 
families were included in the current sample, see Table 1 for sample characteristics.
Dependent measures
Dependent measures were the CSBQ (or ASBQ) ‘ASD Composite score’ (i.e. aggregate 
score of the four subscales: reduced contact and social interests, difficulties in under-
standing social information, stereotyped behaviour and fear of and resistance to chang-
es), the SCQ Total score (children), and the parent and teacher (children) and self-report 
(parents) Conners’ DSM-IV Combined Subscale scores of the ADHD questionnaires. We 
choose to use the ASD composite score (based on four CSBQ subscales) instead of the 
summed score of all six CSBQ subscales, because the subscales ‘orientation’ and ‘tuned’ 
are not specific for ASD (i.e. similar behaviors are scored in ADHD) and it was our aim to 
specifically focus on the most differentiating ASD core symptoms (Hartman et al., 2012).
data analyses
Most of the dependent variables were not normally distributed, therefore, a van der 
Waerden transformation was used to normalize the dependent measures (Norusis, 1992). 
This facilitated the comparison between variables since variables were all depicted on 
the same scale (i.e. higher z-scores indicated more ASD or ADHD symptoms). For child 
data, the percentage of missing data was < 5% for each dependent measure. The SCQ 
was not administered in control children (N = 275) of the IMAGE cohort. The CSBQ was 
not administered to 23.0% (N = 99) children from the BOA cohort since it was added 
at a later stage to the protocol. For parental data, the percentage of missing data was 
5.2% for self-reported ADHD symptoms. ADHD symptoms were not assessed in control 
parents of the IMAGE cohort (N=282). For self-reported ASD symptoms (ASBQ), the per-
centage of missing data was 37.0% for ASD families, 28.5% for ADHD families, 26.2% for 
control families. Variables with less than 5% missing data were subjected to expectation 
maximization (EM) algorithm to replace the missing data (Tabachnick and Fidell, 2001). 
All analyses were carried out with and without expectation maximization and Van der 
Waerden transformation, and revealed similar results. Results were therefore reported 
for transformed measures with missing data replaced. Missing data was not imputed for 
variables with > 5% missing values.
The analyses were run separately for child and parental data. For children, we con-
ducted linear mixed models with diagnosis (probands versus unaffected siblings), type 
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of disorder (ASD [BOA cohort] versus ADHD [IMAGE cohort]) and type of family (SPX 
versus MPX) as fixed factors, age and sex as covariates and family number as random 
effect to account for within family correlation. The two-way interactions and three-way 
interaction between diagnosis, type of disorder and type of family were implemented in 
the initial model and dropped from the model when non-significant. The control group 
was used as reference value. Dependent variables were the four parent- and teacher-
reported ASD and ADHD scales. Separate analyses for subscales were run.
For parents, we conducted linear mixed models with type of disorder of the child (ASD 
versus ADHD) and type of family (SPX versus MPX) as fixed factors and family as random 
effect. Affected (MPX) parents were only used as reference but further omitted from the 
analyses, because by definition no affected SPX parents were available for comparison. 
Dependent measures were the two parental spouse-, and self-report ASD and ADHD 
scales. Pairwise comparisons between unaffected relatives from SPX ASD, SPX ADHD, 
MPX ASD and MPX ADHD families (separately for siblings and parents) were calculated 
to test whether the unaffected relatives differed with regard to symptom presentation 
severity. Correction for multiple comparisons was applied using the False Discovery Rate 
(FDR) controlling procedure with a q-value setting of 0.05 (Benjamini, 2010). Only the 
effects that remained significant after FDR correction were reported in the tables and 
figures. FDR-adjusted p-values (q-values) were reported for effects that became non-
significant after FDR correction. All analyses were carried out in SPSS version 20.
results
Regarding child data, none of the three-way interactions between diagnosis * type of 
disorder * type of family were significant (p-values >.65) and were therefore dropped 
from the models. Further, 9/12 two-way interactions between diagnosis*type of disor-
der, diagnose*type of family and type of disorder*type of family for the four dependent 
measures had a corrected p-value below .05 and therefore were retained in the model. 
The multitude of significant interactions in child data involving the factor type of family 
indicated that the stratification into SPX and MPX moderated the effects of diagnosis 
in both cohorts. Therefore, post-hoc analyses were performed testing the effect of 
diagnosis separately for ASD/ADHD SPX and ASD/ADHD MPX families. In parental data, 
a marginally significant two-way interaction between type of disorder*type of family 
was found for the ADHD (F (1, 236.5) = 3.66, p = .057). No type of disorder*type of family 
interaction was found for the ASD dependent measure (F (1, 171.3) = 0.66, p = .42). Here, 
analyses were performed to examine the effect of type of family separately for ASD and 
ADHD families.
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multiplex families
For ASD families, a significant main effect of diagnosis was found for both parent-
reported ASD measures (SCQ: F (2, 160.4) = 213.5,  p < .001 and CSBQ: F (2, 297.7) = 
199.42, p < .001) and for parent- and teacher-reported ADHD measures (CPRS: F (2, 
351.3) = 117.81, p < .001 and CTRS: F (2, 452.4) = 24.45, p < .001). ASD probands demon-
strated significantly more ASD and ADHD symptoms than controls (p-values <.001) and 
ASD unaffected siblings formed an intermediate group, demonstrating less ASD/ADHD 
symptoms than their affected brothers and sisters (p-values <.001), but significantly 
more symptoms than controls (p-values < .001), see Figure 2. For untransformed means 
and standard deviations, see Table 2.
figure 2 ASD and ADHD traits in SPX and MPX probands and unaffected siblings from ASD and ADHD 
families
Note. The interpolation lines represent the mean and 95% confidence interval (CI) of the standard errors of 
controls. The error bars represent the 95% CI of the standard errors of cases. Higher z-scores indicate more 
symptoms. Figures a and b display ASD traits; figures c and d display ADHD traits.
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figure 3 ASD and ADHD traits in SPX and MPX affected and unaffected parents from ASD and ADHD fami-
lies
Note. The interpolation lines represent the mean and 95% confidence interval (CI) of the standard errors of 
controls. The error bars represent the 95% CI of the standard errors of cases. Higher z-scores indicate more 
symptoms. Figure a displays ASD traits; figure b displays ADHD traits. No affected parents are present in SPX 
ASD and ADHD families.
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For ADHD families a similar pattern was found. A significant main effect of diagnosis 
was found for both ADHD measures (CPRS: F (2, 748.9) = 55.75, p < .001 and CTRS: F 
(2, 750.6) = 60.86, p < .001) and both ASD measures (SCQ: F (2, 304.4) = 46.44, p < .001 
and CSBQ: F (2, 515.9) = 259.70, p < .001). Again, ADHD probands showed significantly 
elevated levels of ADHD and ASD symptoms compared to controls (p-values < .001) and 
ADHD unaffected siblings formed an intermediate group differing from affected siblings 
(p-values < .001) and controls (p-values < .001). Subscale analyses for SCQ, CSBQ and 
CRS (parent- and teacher reported) revealed similar results, see Supplementary Table 1.
Unaffected parents from MPX ASD families and MPX ADHD families demonstrated 
significantly more ASD (both p-values < .001) and ADHD symptoms (p = .002 and p < 
.001, respectively) compared to control parents, see Figure 3.
simplex families
For ASD families, a significant main effect of diagnosis was found for both ASD measures 
(SCQ: F (2, 138.7) = 215.6, p < .001 and CSBQ: F (2, 344.9) = 121.39, p < .001) and both 
ADHD measures (CPRS: F (2, 325.6) = 68.97, p < .001 and CTRS: F (2, 525.4) = 13.25, p < 
.001). Pairwise comparisons revealed that ASD probands showed elevated levels of ASD 
and ADHD symptoms compared to controls (p-values < .001). ASD unaffected siblings 
showed no significantly elevated levels of ASD symptoms according to the SCQ (p = 
.91) and CSBQ (p = .18), but intermediate levels on CPRS and CTRS were found (p-values 
< .001). Compared to MPX ASD unaffected siblings, the SPX ASD unaffected siblings 
showed significantly less ASD and ADHD symptoms (SCQ; p = .001; CSBQ: p = .006; CPRS: 
p = .001, and CTRS: p = .066). SPX and MPX ASD probands did not differ from each other 
(p-values > .10); see Figure 2 and Table 2.
In ADHD families, largely comparable results were found. A significant main effect of 
diagnosis was found for all measures (SCQ: F (2, 199.4) = 9.99, p < .001; CSBQ: F (2, 257.9) 
= 77.97, p < .001; CPRS: F (2, 287.4) = 115.90, p < .001, and CTRS: F (2, 410.7) = 113.62, 
p <.001). ADHD probands demonstrated elevated levels of ADHD and ASD symptoms 
compared to controls (p-values < .001). ADHD unaffected siblings either a) did not dif-
fer from controls (SCQ; p = .52, CPRS: p = .37) or b) demonstrated significantly elevated 
levels of ADHD and ASD symptoms (CSBQ and CTRS: both p-values < .01) compared to 
controls. SPX and MPX ADHD unaffected siblings did not differ significantly from each 
other on all measures (all p-values > .10). Except for a trend-level effect on CSBQ (p = 
.062), SPX and MPX ADHD probands could not be dissociated from each other (other 
p-values > .19). Comparisons between ASD and ADHD unaffected siblings from the two 
types of families revealed that SPX ASD unaffected siblings showed significantly less 
ASD traits than MPX ADHD unaffected siblings (p = .012), and MPX ASD unaffected sib-
lings showed more ASD and ADHD traits than (SPX and MPX) ADHD unaffected siblings 
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(SCQ: p= . 033; CPRS and CTRS: p < .006), although the first effect did not survive FDR 
correction (q-value = .075).
Unaffected parents from SPX ASD families demonstrated significantly more ASD 
symptoms (p = .012), but not ADHD symptoms (p = .165) compared to control parents. 
Vice versa, unaffected parents from SPX ADHD families demonstrated more ADHD (p 
< .001), but not ASD (p = .082) symptoms, see Figure 3. Comparisons between cohorts 
revealed that unaffected parents from (SPX and MPX) ADHD families demonstrated 
significantly more ADHD symptoms than unaffected parents from SPX ASD families (p = 
.008 and p = .012, respectively).
discussion
This is the first study to examine whether the SPX-MPX stratification method is a 
promising approach for creating (etiologically) more homogeneous subgroups of ASD 
and ADHD patients based on the symptom presentation of unaffected relatives. This 
approach builds on the idea that polygenic and multifactorial causes of disease will 
increase symptom levels in most or all members of the family, whereas sporadic genetic 
and non-genetic causes will be strictly personal to the patient. In addition, we wished 
to test the SPX-MPX stratification method as a means to detect overlapping and unique 
underpinnings of both ASD and ADHD. Results indicate that the symptom presentation 
of SPX and MPX (ASD and ADHD) probands was highly similar, showing equally elevated 
levels of both ASD and ADHD symptoms compared to controls. Unaffected relatives 
(siblings and parents) from MPX ASD and ADHD families displayed a similar (yet milder) 
profile as the affected child, with elevated symptom levels of both ASD and ADHD, con-
sistent with what would be expected based on existing literature. Novel findings are that 
in ASD families, behavioral traits were indeed found less frequently in unaffected rela-
tives of SPX families compared to unaffected relatives of MPX families. In ADHD families, 
SPX and MPX unaffected relatives could not be clearly dissociated based on symptom 
presentation. Importantly, higher levels of ADHD symptoms in ASD unaffected family 
members were found compared to ASD symptoms in ADHD unaffected family members.
These behaviorally based findings suggest that causes of ASD might differ between 
SPX and MPX families. Undiagnosed first-degree relatives of MPX ASD families might 
be more prone to develop ASD symptoms, as previously reported (Gerdts et al., 2013, 
Virkud et al., 2009). However, the finding that unaffected parents from both SPX and 
MPX displayed equally heightened levels of ASD traits contradicted previous reports 
(Gerdts et al., 2013, Losh et al., 2008). Also, SPX unaffected siblings were not entirely 
‘normal’ either, displaying somewhat elevated levels of ASD traits compared to controls. 
This suggests that the SPX-MPX stratification detects some quantitative differences, 
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with SPX ASD families being less densely affected and possibly having a smaller genetic 
loading for ASD than MPX families, yet that there is no simple dichotomy, with only the 
proband showing behavioral symptoms in SPX families. Thus, whilst factors uniquely 
present in the affected child (such as de novo mutations) might underlie ASD in some of 
the SPX cases, multifactorial risk factors might still underlie the disorder in others. This 
is supported by genetic findings that de novo variations most likely play a role in the 
development of simplex ASD, but do not fully explain genetic etiology (Krumm et al., 
2013).
The validity of SPX-MPX stratification in ADHD families was not confirmed. SPX and 
MPX unaffected relatives (siblings and parents) both showed equally elevated levels of 
ADHD traits compared to controls. This suggests that in most ADHD cases, multifacto-
rial risk factors underlie the disorder and supports the prevailing model that ADHD is 
caused by small disease-increasing effects of multiple genetic and environmental risk 
factors (Banaschewski et al., 2010, Franke et al., 2009). It might nonetheless be premature 
to conclude that SPX-MPX stratification is not a valid approach for creating more homo-
geneous subgroups of ADHD patients based on behavioral findings alone, taking into 
consideration (subtle) neurocognitive/functional deficits might improve dissociation of 
these unaffected relatives (Rommelse et al., 2011). In any case, a small proportion of 
ADHD families exist in which only one individual has developed ADHD whilst the other 
family members are also at heightened risk (given elevated levels of ADHD traits in unaf-
fected relatives). These families might be particularly valuable for detecting protective 
mechanisms decreasing the risk of developing ADHD.
SPX-MPX stratification proved useful in identifying shared etiological underpinnings 
of ASD and ADHD. Particularly unaffected relatives from MPX ASD and ADHD probands 
displayed elevated levels of cross-disorder behavioral traits (i.e., elevated levels of ASD 
in the ADHD cohort and ADHD in the ASD cohort) compared to controls, suggesting 
that pleiotropic risk factors for ASD and ADHD are likely polygenic and multifactorial in 
nature. That is, pleiotropic risk factors are likely common genetic influences operating 
across ASD traits and ADHD behaviors throughout normal variation and at the extreme 
as was previously suggested by Ronald and colleagues (Ronald et al., 2008) and also 
discussed in a recent publication by Martin and colleagues (Martin et al., 2014). The pres-
ence of ASD traits in ADHD probands and vice versa has been extensively documented 
before (Lichtenstein et al., 2010, Rommelse et al., 2011, Ronald et al., 2008). Previous 
studies on cross-disorder traits in unaffected relatives of ASD or ADHD probands are 
relatively scarce, but report similar findings (e.g. ADHD unaffected siblings had higher 
levels of ASD compared to the population) (Mulligan et al., 2009, Nijmeijer et al., 2009). 
Importantly, it was found that the type of diagnosis (ASD or ADHD) of the proband 
was informative for unaffected relatives’ ADHD outcomes. That is, significantly higher 
levels of ADHD traits were found in unaffected siblings of ASD MPX families compared 
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to ADHD (SPX and MPX) families, which was not the case for ASD traits. This is in line 
with findings by Lichtenstein and colleagues (2010) who reported that among co-twins 
of children with ASD, the probability of having ADHD was 44.4% for monozygotic- and 
15.4% for dizygotic twins, yet the probability of co-twins of ADHD children of having 
ASD was 22.5% and 7.0%, respectively (Lichtenstein et al., 2010). In other words, the 
risk for ADHD in siblings of ASD probands is higher, than vice versa the risk for ASD in 
siblings of ADHD probands. This suggests that ADHD might be seen as a milder, less 
severe subtype within the ASD spectrum as has been stated in the gradient overarching 
disorder hypothesis (Van der Meer et al., 2012) or that risk factors underlying ASD may 
overlap to a larger degree with risk factors underlying ADHD than vice versa (Rommelse 
et al., 2010, van Steijn et al., 2012). However, since this pattern of results was not found in 
parents, further research is needed to confirm these hypotheses.
A number of strengths and limitations of this study should be considered when 
weighing the results. Strengths were the relatively large sample size, the use of well-
established measures and the differentiation between different heritable forms (i.e. 
monocausal [most likely present in SPX families] and multifactorial genetic risk factors 
[most likely present in MPX families]) of ASD and ADHD. Another strength was the inclu-
sion of parental affected status into the SPX-MPX classification. Most studies base the 
SPX-MPX classification solely on the number of affected children in the family (Gerdts 
and Bernier, 2011, Gerdts et al., 2013, Virkud et al., 2009), but given the high heritability 
of both disorders, it is highly relevant to include parental affected status as well. That 
said, it should be noted that no formal diagnosis was made in parents. Instead, we based 
the affected status of parents on self- and spouse report questionnaires (particularly for 
parents of ASD families), which may have overstepped the clinical boundaries of these 
instruments. Self reported symptoms may be less valid in high scoring individuals due 
to limited self awareness (Mazefsky et al., 2011), which may results in an underestimation 
of behavioral symptoms. However, we believe that by using multiple screening ques-
tionnaires and selecting low cut-off scores in order to avoid false negatives, all parents 
with threshold ASD or ADHD traits (i.e. suspected cases) were successfully identified and 
accounted for in the SPX-MPX classification. A second limitation is that SPX-MPX classifi-
cation is not a straightforward one. Correct classification requires confident knowledge 
of family history and fecundity is a major confounder (Sullivan et al., 2012). However, 
we are confident that by including parental data from both parents and accounting 
for higher sibling recurrence risk in male compared to female siblings, we acquired 
the most optimal SPX-MPX classification in our sample. Third, only a small proportion 
of ADHD families could be classified SPX (about 1/8 families), compared to the large 
number of ADHD families that were considered MPX (about 3/4 families), which might 
have resulted in undetected effects due to lack of power. It follows that our study need 
replication. Fourth, only ‘intact’ families were included in this study (i.e. families with 
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available data of both parents). Possibly, families where one or both biological parents 
are absent or unwilling to participate in research may have children more severely af-
fected. This could have implications for the representativeness of the findings for ASD 
and ADHD families in general.
All in all, our study suggests that the SPX-MPX stratification detects quantitative rather 
than qualitative differences between ASD families and in its current form does not ap-
pear to be helpful in stratifying ADHD families. Nevertheless, unaffected relatives from 
MPX families are at highest risk of displaying subthreshold ASD and/or ADHD symp-
toms, making these families of particular interest for genetic counseling and therapeutic 
interventions. Some evidence was found suggesting risk factors underlying ASD may 
overlap to a larger degree with risk factors underlying ADHD than vice versa, but further 
research herein is warranted.
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abstract
background: We may improve our understanding of the role of common versus unique 
risk factors in attention-deficit/hyperactivity disorder (ADHD) by examining ADHD-
related cognitive deficits in single- (SPX), and multi-incidence (MPX) families. Given that 
individuals from MPX families are likely to share genetic vulnerability for the disorder, 
whereas SPX ADHD may be the result of sporadic (non-)genetic causes unique to the 
patient, we hypothesized that cognitive impairments may be different in SPX and MPX 
ADHD as indicated by (a) the presence of cognitive deficits in MPX, but not SPX unaf-
fected siblings and (b) dissimilar cognitive profiles in SPX and MPX ADHD patients.
Methods: Tasks measuring total IQ, verbal attention, executive functioning, motor func-
tioning, and time estimation were administered to 31 SPX/264 MPX ADHD probands, 47 
SPX/123 MPX unaffected siblings, and 263 controls, aged 6-19 years.
results: SPX unaffected siblings were unimpaired compared to controls, except for ver-
bal working memory, whereas MPX unaffected siblings showed impairments on most 
cognitive domains. The cognitive profiles of SPX and MPX probands were highly similar, 
except that verbal attention, response inhibition and motor control deficits were more 
pronounced in MPX probands, and -compared to their unaffected siblings- impairments 
in IQ, visual working memory and timing abilities were more pronounced in SPX cases.
Conclusions: Our results support the hypothesis that a partly different cognitive ar-
chitecture may underlie SPX and MPX forms of ADHD, which becomes evident when 
contrasting cognitive performances within families. Cognitive factors underlying MPX 
forms of ADHD are familial, whereas non-familial in SPX ADHD. SPX-MPX stratification 
may be a step forward in unravelling diverse causal pathways.
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introduction
Attention-deficit/hyperactivity disorder (ADHD) is a severely impairing neurodevel-
opmental disorder, characterized by symptoms of hyperactivity, impulsivity and/or 
inattention (Diagnostic and Statistical Manual of Mental Disorders; DSM-5) (APA, 2013). 
ADHD is a highly heritable disorder, with heritability estimates ranging to 76% (Faraone 
et al., 2005, Thapar et al., 2013). Common to ADHD is the large within-disorder hetero-
geneity, in symptom presentation, developmental course and underlying etiological 
mechanisms (Wahlstedt et al., 2009). The prevailing etiological model suggests that 
ADHD is caused by small disease-increasing effects of multiple common genetic and en-
vironmental risk factors (Franke et al., 2009, Thapar et al., 2013). However several recent 
studies report that rare genetic mutations or non-shared environmental factors (such as 
low birth weight and medical conditions) with a large effect may relate to ADHD aetiol-
ogy as well (Ben Amor et al., 2005, Williams et al., 2010). This suggests that while in many 
cases multifactorial factors, possibly shared with (unaffected) relatives, might underlie 
ADHD, factors uniquely present in affected individuals, such as de novo mutations, might 
underlie the disorder in at least some cases.
More insight into the role of shared versus unique genetic factors for ADHD might 
be obtained by examining the presence of ADHD-related cognitive deficits in unaf-
fected siblings of ADHD probands in the search for cognitive endophenotypes of ADHD. 
Endophenotypes are defined as heritable vulnerability traits that heighten the risk for 
developing a disorder (Gottesman and Gould, 2003). Endophenotypes offer a simplified 
approach to dissect complex traits by reducing heterogeneity and as such may boost the 
power for genetic analyses, as well as shed light on the functional outcomes of genes 
(Gottesman and Gould, 2003). Cognitive deficits that are present in unaffected siblings 
and thus shared between affected and unaffected relatives are assumed to provide an 
index of the multifactorial liability to ADHD (Waldman, 2005). Conversely, cognitive 
deficits that are not shared between affected and unaffected siblings may have a unique 
effect on the development of the disorder. This affected-unaffected siblings design 
has been frequently applied in ADHD research and has led to many studies document-
ing an increased incidence of behavioral symptoms, comorbid symptomatology, and 
ADHD-related cognitive deficits in unaffected family members of ADHD probands (for 
an extensive review see Rommelse et al., 2011).
We may improve our understanding of the role of common versus unique genetic 
risk factors in ADHD by examining ADHD related cognitive deficits in single-, and multi-
incidence ADHD families. We hypothesized that ADHD-related cognitive deficits are only 
present in unaffected family members from multi-incidence (here referred to as multi-
plex; MPX), but not single-incidence (here referred to as simplex: SPX) ADHD families. 
SPX families are defined as nuclear families with only one affected individual and at 
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least one unaffected male sibling. MPX families consist of at least two (or more) affected 
individuals in the family (Sullivan et al., 2012). The assumption is that individuals from 
SPX families are more likely than individuals from MPX families to develop ADHD as a 
result of sporadic genetic and/or non-genetic causes strictly unique to the patient. Then 
unaffected relatives in SPX families would show less or even no behavioral or cogni-
tive deficits compared controls and would deviate more from the cognitive profile of 
their affected brother or sister. In contrast, unaffected relatives in MPX families would 
show cognitive deficits, compared to controls, and about as similar as the probands. 
In other words, the within-family contrast between probands and unaffected siblings 
regarding cognitive or behavioral aspects of the disorder is larger in SPX compared to 
MPX families. Unaffected siblings can be viewed as an ideal reference group, indexing 
the ‘full potential’ of children with ADHD had they not developed the disorder (while 
correcting for shared environmental influences). Higher within-family contrasts might 
thus be indicative of more severely impaired cognitive abilities in the affected children 
from those families. This model of different etiologies in SPX and MPX families has been 
developed and confirmed in research in Autism Spectrum Disorders (ASD) (Gerdts et al., 
2013, Sebat et al., 2007). For example, a more than threefold rate of de novo mutations 
were identified in ASD SPX families (~7-10%), compared to ASD MPX families (~2-3%) 
or control families (~1%) (Sebat et al., 2007). In contrast, members of MPX families more 
often exhibit ASD traits compared to members of SPX families, indicative of a more 
pronounced role of shared genetic predispositions (Gerdts et al., 2013). The association 
between de novo mutations and ADHD has received little research attention, unlike ASD 
(D’Onofrio et al., 2014). Recent studies that point towards a role for rare genetic variants 
such as de novo mutations in ADHD highlight the need for future studies exploring this 
issue (Ben Amor et al., 2005, D’Onofrio et al., 2014, Williams et al., 2010).
The present study extends the findings by Rommelse et al. (Rommelse et al., 2008a, 
Rommelse et al., 2007a, Rommelse et al., 2008b, Rommelse et al., 2007b, Rommelse et al., 
2008c, Rommelse et al., 2007c, Rommelse et al., 2008d) by testing whether ADHD-related 
cognitive deficits are only present in unaffected siblings from MPX ADHD families. If 
correct, then the use of cognitive endophenotypes in the search for ADHD risk genes 
might be of particular use for MPX, but not SPX ADHD. Further, we aimed to examine 
whether cognitive impairments may be different in SPX and MPX ADHD as indicated 
by dissimilar cognitive profiles in SPX and MPX ADHD patients. So far, no studies have 
been undertaken that differentiate between single- and multi-incidence ADHD, but it 
is plausible that different heritable forms of ADHD might result in dissimilar cognitive 
disabilities.
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metHods
participants
ADHD families were recruited as part of the Dutch part of the International Multicenter 
ADHD Genetics (IMAGE) study (as previously described in Rommelse et al., 2008a). Inclu-
sion criteria for all participants were at least two biological siblings (in case families: at 
least one child with a clinical diagnosis of ADHD) and one biological parent willing to 
participate, offspring age between 4 and 20 years, European Caucasian descent, an IQ 
≥ 70, and no diagnosis of autism, epilepsy, brain disorders or known genetic disorders, 
such as Down-syndrome or Fragile-X-syndrome. All children and parents were carefully 
phenotyped for ADHD using validated and standardized questionnaires and diagnostic 
interviews. Families were stratified into SPX and MPX based on the number of affected 
individuals. SPX families were required to have a single-affected proband, a minimum 
of one male sibling and all siblings and parents of the proband unaffected by ADHD; 
MPX families were required to have two or more affected individuals. A total of 31 ADHD 
SPX nuclear families (including 31 probands and 47 unaffected siblings), 171 ADHD MPX 
nuclear families (including 264 probands and 123 unaffected siblings), and 142 control 
nuclear families (263 children) were included in the current study, see Table 1 for sample 
characteristics and Oerlemans et al., 2014 (chapter 4) for a full description of phenotyp-
ing and family classification.
measures
Cognitive functioning was examined across a range of domains. Full scale IQ was 
prorated by four subtests of the Wechsler Intelligence Scale for Children or Wechsler 
Adult Intelligence Scale: Similarities, Vocabulary, Block Design and Picture Completion 
table 1. Sample characteristics
Controls (c) ADHD probands Unaffected siblings Group contrasts
ADHD vs. controls1. SPX 2. MPX 3. SPX 4. MPX
M sd M sd M sd M sd M sd
Number of kids N = 263 N = 31 N = 264 N = 47 N = 123
Age 11.7 3.2 11.8 2.5 11.5 2.6 10.9 3.4 11.6 3.5 ns
Sex (% males) 41.1 87.1 73.6 74.5 38.2 1=2=3>4=c
CPRS DSM-IV Combined Scale 46.5 4.5 76.1 8.0 74.8 10.3 48.1 7.3 50.6 9.5 1=2>3=c, 3=4, 4>c
CTRS DSM-IV Combined scale 46.4 4.5 69.7 8.0 67.7 10.8 48.3 6.3 50.1 7.9 1=2>3=c, 3=4, 4>c
Note. ADHD = attention-deficit/hyperactivity disorder; SPX = simplex; MPX = multiplex, CPRS = Conners 
Parent Rating Scale; CTRS = Conners teacher rating scale; c = controls; 1 = SPX probands; 2 = MPX probands; 
3 = SPX unaffected siblings; 4 = MPX unaffected siblings; ns = non significant
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(Wechsler, 2000, 2002). The forward condition of Digit Span was used to obtain an 
indication of verbal attention. Four executive function tasks were included: response 
inhibition, visual and verbal working memory, and set shifting. Response inhibition 
was measured with the commonly used Go-NoGo paradigm where participants were 
instructed to withhold a response when the NoGo target was depicted. Visual and 
verbal working were measured by instructing the participants to correctly reproduce 
sequences of figures (visual) or digits (verbal) that increased in difficulty after each suc-
ceeded trial. Set shifting was measured by administering a task that required a mixture 
of compatible and incompatible responses, hypothesized to require a higher level of 
cognitive flexibility. Motor functioning was measured using a simple reaction time task 
and a motor control task. Last, a timing measure was included to measure the variability 
of motor timing. Table 2 provides an overview of the neurocognitive tasks used. For full 
task descriptions, see Appendix 1 or elsewhere (Rommelse et al., 2008a).
procedure
Neurocognitive assessment of the children with ADHD and their siblings took place at 
the VU University Amsterdam or at the Radboud university medical center in Nijmegen, 
the Netherlands and is described in more detail elsewhere (Rommelse et al., 2008c). 
table 2. Description of the neurocognitive tasks
Task Measurement potential Dependent variables
Intelligence
Vocabulary, Similarities, Block 
Design, Picture Completiona
intelligence Total IQ (TIQ)
Attention
Digit Spana Verbal attention maximum span forward
Executive functions
Stop Task inhibition stop signal reaction time (SSRT)
Digit Spana verbal working memory maximum span backwards
Visuospatial Sequencing visuospatial working 
memory
percentage correct identified targets 
in correct order (part forward)
Shifting Attentional Set Visual set shifting percentage errors
Motor functions
Baseline Speed baseline variability variability of reaction time (SD in ms).
Tracking motor control without 
continuous adaptation
stability (SD of distances in mm). (non-
preferred hand)
Timing
Motor Timing timing estimation variability in reaction time (SD)
Note. For task details, see Appendix 1 or elsewhere (Rommelse et al., 2008a).
a based on Wechsler Intelligence Scale for Children or Wechsler Adult Intelligence Scale
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To avoid possible inter-rater or location effects, cognitive performance was measured 
using standardized computerized tasks with fixed settings and computer-calculated 
outcome measures (e.g. error percentages or mean reaction times) across the two sites. 
In addition, all examiners were thoroughly trained using a standardized training proto-
col and were regularly supervised and observed during task administration to monitor 
standardized assessment across sites and examiners. Stimulants were discontinued for 
at least 24 hours before testing and non-stimulants according to their plasma half life to 
allow for sufficient wash-out. Children were motivated with small breaks and received a 
gift at the end of the session. Additional data collected included blood or saliva samples 
and behavioral data of all family members. The study was approved by the local medical 
ethics board. After the study procedures had been fully explained, parents and children 
(12 years and older) signed for informed consent. Children younger than 12 years of age 
were asked to give their assent for participation.
data-analyses
The percentage of missing data was <5% for all dependent measures, except for stop sig-
nal reaction time (SSRT). Here, 8.4% of the data were missing. Missings were imputed by 
means of Expectation Maximization (Tabachnick and Fidell, 2001). Analyses were carried 
out with and without expectation maximization, which revealed similar results and led 
to the same conclusions. Results were therefore reported with missing data replaced. To 
account for the influence of age and sex on neurocognitive performance, we regressed 
scores for each measure on age and sex and used the unstandardized residuals as de-
pendent variables. Most of the unstandardized residuals were not normally distributed, 
therefore, a van der Waerden transformation was applied to normalize the dependent 
measures (Norusis, 1992). This also facilitated the comparison between variables since 
variables were all depicted on the same scale. A number of dependent variables were 
mirrored so that the z-scores of all measures had the same meaning: lower z-scores 
indicated poorer performance (e.g. more errors or more variable responses).
Linear mixed models (LMM) were used to account for the dependency in the data due 
to inclusion of siblings and probands by estimating a random intercept. Dependent vari-
ables were the neurocognitive measures and group was the independent variable. We 
contrasted specific groups of interest to answer our research questions. LMM analyses 
were run with group defined as (a) probands versus unaffected siblings versus controls, 
separately for SPX and MPX families, to examine whether cognitive deficits were present 
in (SPX and MPX) probands and MPX, but not SPX, unaffected siblings, (b) SPX versus 
MPX unaffected siblings to examine whether cognitive performance of first-degree 
relatives was poorer in MPX compared to SPX families, and (c) MPX versus SPX probands 
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to examine whether potentially different heritable forms of ADHD would result in (dis)
similar cognitive profiles in ADHD patients. Furthermore, within family discrepancy 
scores (estimated mean of proband minus mean of unaffected sibling) in SPX versus 
MPX families were compared to examine whether within family contrast was higher in 
SPX than MPX families. A False Discovery Rate (FDR) correction with a q-value setting 
of 0.05 was applied to control for multiple testing (Benjamini, 2010). Given the unequal 
sample size for MPX and SPX families, emphasis was given to effect sizes next to the p-
values. Effect sizes (Cohen’s d) were calculated to define small (d = .20), medium (d = .50), 
and large effects (d = .80) (Cohen, 1988). All analyses were carried out in SPSS version 20.
results
cognitive measures sensitive for spX-mpX stratification
Endophenotypes in MPX but not SPX ADHD families
Testing our first hypothesis, we found indeed that SPX unaffected siblings were unim-
paired compared to controls on all cognitive domains (all p-values >.17, effect sizes in 
terms of Cohen’s d ranging from .00-.22) except for verbal working memory (p=.029, 
d=.32), whereas MPX unaffected siblings performed poorer than controls on all cogni-
tive domains (p-values <.033, d-values =.21-.49), except for stability of motor control 
(p=.151, d=.15). Moreover, comparisons between SPX and MPX unaffected siblings 
revealed a significantly better performance of SPX unaffected siblings in three domains, 
namely visual working memory (p=.024, d=.40), inhibition (p=.005, d=.51), and time esti-
mation: p=.005, d=.49). Within-family discrepancy (proband-unaffected sibling contrast) 
was larger for SPX probands than for MPX probands for visual working memory (t=2.65, 
p=.012). SPX probands differed significantly from their unaffected siblings on TIQ, visual 
working memory, and variability of time estimation (p-values <.009, d-values =.53-.74), 
whereas MPX probands differed from their unaffected siblings only on TIQ (p<.001, 
d=.29), see Figure 1 and Table 3.
Cognitive deficits in MPX versus SPX ADHD probands
Testing our second hypothesis, we found that the cognitive profiles of SPX and MPX pro-
bands were highly similar. Both probands from SPX and from MPX families performed 
significantly worse than controls on estimated TIQ, verbal and visual working memory, 
and variability of time estimation (SPX; p-values <.006, d-values =.52-.71; MPX: p-values 
<.001, d-values =.43-.64) and could not be dissociated from each other (p-values >.20, 
d-values <.22).
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Impairments in verbal attention, response inhibition, set shifting, and stability of mo-
tor control appeared to be most pronounced in MPX ADHD probands. Relative to normal 
controls, MPX probands showed significant impairments (p-values <.029, d-values 
=.21-.45), whereas SPX probands showed no problems on inhibition (p=.341, d=.18), 
set shifting (p=.218, d=.25), or motor control problems (p=.445, d=.13). The significant 
difference between SPX probands and controls on verbal attention (p=.043, d=.38) did 
not survive FDR correction (q-value =.132). However, SPX and MPX probands could not 
 
 
 
 
 
p < .001 p < .001 p = .001 
p = .009 
 
 
 
 
 
p < .001 p < .001 p = .001 
p = .009 
figure 1 Cognitive deficits in MPX, but not SPX unaffected siblings from ADHD families.
Note. The interpolation lines represent the mean z-score and the 95% CI of normal controls. The error bars 
represent the 95% confidence interval (CI). Lower z-scores indicate worse performance. Significant group 
differences that survived FDR correction between case groups and controls, are depicted using asterisks 
(*** p < .001, ** p < .01).  SPX and MPX ADHD probands performed significantly worse than controls and 
could not be dissociated from each other on TIQ, visual memory and variability of time estimation. MPX, but 
not SPX unaffected siblings showed similar cognitive impairments on these domains.
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Chapter 5 : Different cognitive impairments in single-, and multi-incidence ADHD families
be dissociated from each other (p-values >.15, d-values <.28) nor from their unaffected 
siblings (p-values >.27, d-values <.22) on these domains and within-family discrepancy 
did not differ between SPX and MPX families (t-values <.85, p-values >.30), see Figure 2.
measures not sensitive to spX-mpX stratification
A few domains were insensitive to SPX-MPX stratification. First, for verbal working mem-
ory, a performance intermediate between cases and controls was found in MPX and SPX 
unaffected siblings. Both SPX and MPX unaffected siblings performed significantly worse 
than controls (p=.029, d=.32 and p=.006, d=.27, respectively), but similar to their affected 
brothers/sisters (p-values >.13, d-values <.25). However, the difference between SPX 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*** **
    * 
     * 
    *** 
  *** 
   ***   ** 
figure 2 Cognitive domains most pronounced in MPX ADHD families
Note. The interpolation lines represent the mean z-score and the 95% CI of normal controls. The error bars 
represent the 95% confidence interval (CI). Lower z-scores indicate worse performance. Significant group 
differences that survived FDR correction between case groups and controls, are depicted using asterisks 
(*** p < .001, ** p < .01, *p < .05).  Probands and unaffected sibling from MPX, but not SPX ADHD families 
were impaired on verbal attention, inhibition, set shifting and motor control.
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unaffected siblings and controls became non-significant after FDR correction (q-value 
=.077). Second, probands and unaffected siblings from both SPX and MPX families were 
equally unimpaired on baseline variability (p-values >.10, d-values <.16), see Table 3.
discussion
In the current study, we aimed to examine whether the cognitive architecture under-
lying SPX and MPX ADHD families is different and useful for parsing the etiological 
heterogeneity of ADHD. Based on the assumption that individuals from SPX families are 
more likely than individuals from MPX families to develop ADHD as a result of sporadic 
genetic and/or non-genetic causes strictly personal to the patient, we hypothesized that 
shared cognitive deficits between affected and unaffected siblings are present in MPX, 
but not SPX families. Further, we hypothesized that potentially different heritable forms 
of ADHD might result in dissimilar cognitive profiles in SPX and MPX ADHD probands. 
Consistent with our hypothesis, SPX unaffected siblings were unimpaired compared 
to controls, except for verbal working memory, whereas MPX unaffected siblings 
showed an intermediate performance between cases and controls on most domains. 
Furthermore, the cognitive profiles of SPX and MPX probands were highly similar, except 
that (a) impairments in response inhibition and stability of motor control were more 
pronounced in MPX probands than in SPX probands, and (b) when compared to their 
unaffected siblings, impairments in TIQ, visual working memory and timing abilities 
were more pronounced in SPX cases compared to MPX cases.
Results largely confirmed the hypothesized dissociation between SPX and MPX fami-
lies based on cognitive performance of probands and their unaffected siblings. Indeed, 
unaffected siblings from MPX families demonstrated a similar (but milder) cognitive 
vulnerability profile as probands from those families, whereas unaffected siblings from 
SPX families were indistinguishable from controls on all measures but verbal working 
memory. The former finding replicates previous analyses in this sample (Rommelse 
et al., 2008a, Rommelse et al., 2007a, Rommelse et al., 2008b, Rommelse et al., 2007b, 
Rommelse et al., 2008c, Rommelse et al., 2007c, Rommelse et al., 2008d) as well as many 
previous studies without stratification according to family history. The latter finding is 
novel and indeed suggests that in a percentage of ADHD cases (15.3% in our sample) 
different modes of inheritance may underlie the disorder in the proband that are mostly 
not shared with the unaffected family members. These SPX probands further seem to 
be relatively more strongly impaired in TIQ, visual working memory and timing abilities. 
When using unaffected siblings as an ideal reference group (viewed as indexing the ‘full 
potential’ of children with ADHD had they not developed the disorder), an ‘SPX subtype’ 
of ADHD may relate to factors that particularly decrease overall intelligence, visual work-
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ing memory and time estimation. (Rare) genetic variations in genes associated with IQ/
intellectual (dis)ability and working memory (e.g. COMT) (Boonstra et al., 2008, Green et 
al., 2013), or environmental factors that have a detrimental effect on the development 
of the brain (e.g. prematurity, low birth weight and fetal distress) (Bilder et al., 2013), 
might thus play particularly important roles in the development of SPX ADHD. This sug-
gests that sporadic ADHD might be more prevalent among children with lowered (but 
still normal) intelligence levels. In contrast, the classical response inhibition difficulties 
as well as verbal attention and motor coordination problems were less outspoken in 
SPX versus MPX ADHD. This may suggest that factors related to these traits (e.g. ge-
netic polymorphisms in DAT1 are associated with response inhibition (Boonstra et al., 
2008)) are less involved in SPX forms of ADHD. The dopamine-modulated basal ganglia 
neurocircuits are proposed to underpin inhibitory control and also play an important 
role in motor control (Fliers et al., 2009, Sonuga-Barke, 2005). Moreover, dopamine plays 
an important role in attention and auditory processing (Bailey, 2012). Abnormalities in 
structure and function of these circuits caused by genetic variation might thus be hy-
pothesized to be less often observed in SPX ADHD. It is challenging to explain why SPX 
unaffected siblings were impaired in verbal working memory and not other cognitive 
domains. A possible explanation might be that auditory (or verbal) tasks are generally 
more difficult than visual tasks, because auditory measures are more closely related to 
the attentiveness required for daily life than visual measures (Park et al., 2011). Given 
that (a) SPX unaffected siblings displayed somewhat elevated levels of ADHD traits com-
pared to controls (see sample characteristics) and (b) inattention is a core characteristic 
of ADHD, this might explain why SPX unaffected siblings did show some problems in 
this particular area. However, since SPX unaffected siblings were unimpaired on verbal 
attention, this suggests that the verbal working memory deficit is not fully explained 
by attention problems. Working memory problems in SPX unaffected siblings did not 
extent to the visuo-spatial domain. Possibly, verbal working memory is most sensitive 
to (mild) susceptibility for ADHD. Additional research is however needed to further 
investigate this issue. In any case, these preliminary findings suggest that the rarer SPX 
forms of ADHD may have partially different cognitive underpinnings compared to MPX 
forms of ADHD and a different pattern of familial-determined cognitive vulnerabilities, 
with minimal cognitive vulnerabilities in unaffected siblings.
In contrast to the situation in SPX families, when selectively analyzing cognitive traits in 
family members from MPX families, virtually for all cognitive domains a strong endopheno-
typic group pattern was found: non-affected siblings originating from families in which at 
least two members had ADHD, showed substantial cognitive vulnerabilities, similar to their 
affected sibling. These findings suggest that in families with shared risk factors for ADHD, 
using cognitive traits to detect these underlying causal factors may be a powerful ap-
proach. Particularly impairments in inhibition, motor control, visual working memory and 
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time estimation seem sensitive to such effects and promising areas for further research in 
this context. These neurocognitive functions may be useful in creating more homogeneous 
subgroups of patients with (MPX) ADHD. This reduces heterogeneity and may facilitate our 
understanding of the involved biological processes, boost power for genetic analyses, as 
well as shed light on the functional outcomes of genes (Gottesman and Gould, 2003).
The direct comparison between SPX and MPX probands revealed very similar cog-
nitive problems. These findings suggest a phenomenon referred to in developmental 
psychopathology as equifinality (Cicchetti and Rogosch, 1996), that is, even though 
partly different developmental pathways might underlie SPX and MPX ADHD, these 
result in quite similar cognitive deficits and also in similar severity of ADHD symptoms. 
By examining cognitive functions or behavioral symptoms alone, these different under-
lying etiological factors cannot be identified. Instead, causal effects might be muted by 
the presence of multiple distinct subgroups of ADHD patients with different etiologies 
(Nigg et al., 2005). Although the reality of equifinality is well-recognized, few solutions 
have been provided to tease etiological heterogeneity apart. Stratification into SPX and 
MPX seems therefore highly relevant in defining relevant subgroups in order to facilitate 
research that aims to unravel these multiple pathways leading to the same cognitive 
impairments and ADHD symptomatology
Our findings further highlight the fact that there is clearly no 1:1 relationship between 
cognitive problems and behavioral problems (de Zeeuw et al., 2008): unaffected siblings 
from SPX and MPX families did not differ from each other regarding (the absence of ) ADHD 
symptoms, yet substantial cognitive vulnerabilities were only present in MPX unaffected 
siblings. This corroborates with the conclusions from a systematic review on cognitive 
(dis)similarities in ADHD persisters and remitters; both were equally impaired at follow-
up on almost all domains assessed (van Lieshout et al., 2013). It suggests that cognitive 
vulnerabilities and behavioral problems are to some extent disentangled during the 
course of development. It has been hypothesized that neurocognitive deficits in ADHD 
are epiphenomena instead of core causal factors, that are related to the same etiological 
factors but do not mediate between genes and behavior (Kebir and Joober, 2011, Kendler 
and Neale, 2010, Rommelse et al., 2011). This could explain the highly similar cognitive 
profiles of MPX affected and unaffected siblings (who are likely to share etiological risk 
factors for ADHD), and the highly deviant cognitive profiles of SPX affected and unaf-
fected siblings (where causal risk factors for ADHD appear strictly personal to the patient). 
More longitudinal studies are definitely needed in this fascinating area of research.
A number of limitations of this study need to be considered. First, only a small proportion 
of families could be classified SPX (13.5% in our sample). Therefore, we calculated effect 
sizes to accompany statistical testing. We nonetheless restricted interpretation to significant 
findings; it follows that our study need replication in larger samples. Further, boys were 
overrepresented in both proband groups and in SPX unaffected siblings, but were under-
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represented in MPX unaffected siblings and controls. This was due to the fact that a) in child-
hood, ADHD is more frequently diagnosed in males and b) the presence of male unaffected 
siblings was only required for SPX, but not MPX families. However, we do not believe that 
this has affected the results, since the effect of sex was controlled for in this study.
In all, our results support the hypothesis that a partly different cognitive architecture 
may underlie SPX and MPX forms of ADHD, which becomes evident when contrasting 
cognitive performances within families. When using performance of unaffected siblings 
as a reference, TIQ, visual working memory and time estimation are particularly impaired 
in SPX ADHD, suggesting sporadic (non-)genetic causes acting predominantly on these 
domains. Response inhibition and motor control seem relatively unimpaired in SPX 
forms of ADHD. In contrast, familial (MPX) ADHD is related to a wide range of cogni-
tive vulnerabilities, translated to comparable (but milder) impairments in non-affected 
siblings. These findings suggest that different causal pathways may lead up to –on the 
surface- comparable cognitive deficits and ADHD symptoms in children with ADHD, and 
that SPX-MPX stratification may be a step forward in unravelling these various causal 
pathways. Clinically, subgroups of ADHD patients may have distinct prognoses and 
benefit most from different treatment strategies (Nigg et al., 2005), which indicates that 
awareness of the impact of family history on the presence of ADHD traits and cognitive 
impairments in probands and their unaffected siblings is relevant for the development 
of treatment plans and for genetic counseling.
Key bullet points
•	 The etiology of ADHD is heterogeneous; small disease-increasing effects 
of multiple common genetic variants likely play a role in multi-incidence 
(MPX) families, while rare genetic variants (e.g. de novo mutations) likely 
play a role in single-incidence (SPX) families.
•	 We may improve our understanding of etiological heterogeneity of ADHD 
by studying cognitive deficits in SPX versus MPX ADHD.
•	 A partly different cognitive architecture appears to underlie SPX and MPX 
ADHD. MPX ADHD is related to a wide range of cognitive vulnerabilities, 
translated to comparable (but milder) impairments in unaffected siblings. 
SPX ADHD is related to TIQ, visual working memory and time estimation 
impaired in probands but not in siblings.
•	 Clinically, SPX and MPX ADHD patients may have distinct prognoses and 
benefit from different treatment strategies.
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appendiX 1. full description of neuropsycHoloGical measures
measures
Four of the tasks described below were selected from the Amsterdam Neuropsychologi-
cal Tasks (ANT) program (De Sonneville, 1999b). The ANT is a computer-aided assessment 
battery that allows for the systematic evaluation of information processing capacities. 
Test-retest reliability and validity of the ANT-tasks are satisfactory (De Sonneville, 2005). 
Each computer task contained an instruction trial where the examiner provided a typical 
item of the task, and a separate practice session. If necessary, the instruction was re-
peated. All subjects were able to perform the training items before testing. Furthermore, 
several subtests from the Wechsler Intelligences Scales for Children (WISC-III) or the 
Wechsler Adult Intelligence Scale (WAIS-III) were selected (Wechsler, 2000, 2002). These 
subtests were administered following manual guidelines.
Intelligence
Full scale IQ was prorated by four subtests of the WICS-III or WAIS-III: Similarities, Vocabu-
lary, Block Design and Picture Completion (Wechsler, 2000, 2002). Verbal IQ (VIQ) and 
Performal IQ (PIQ) were each prorated by two subtests (i.e. Similarities and Vocabulary 
for VIQ and Block Design and Picture Completion for PIQ). These selected WISC-III sub-
tests are known to correlate between .90-.95 with the Full-scale IQ (Groth-Marnat, 1997).
Executive function
Executive function (EF) was measured using tests that tap into three major aspects of 
EF, namely inhibition, cognitive flexibility and working memory. All measures were stan-
dardized and some scores were mirrored so that low z-scores indicated poorer perfor-
mance). Inhibition was measured using the Stop task (Logan, 1994, Logan et al., 1984). 
Children were presented with two types of trials: go-trails and stop-trails. Children were 
asked to press a mouse key as quickly and accurately as possible when the go-stimulus 
was presented, but withhold their response to the stop-trial. Dependent variable was 
the Stop signal reaction time (SSRT). Cognitive flexibility was measured using the Shift-
ing Attentional Set (De Sonneville, 1999a). A horizontal bar with ten grey squares was 
presented permanently at the centre of the screen. The stimulus was a colored square 
that moved across the bar in a random direction (either one square to the left or to 
the right).  Three parts were administrated: in part 1, the stimulus was colored green 
and compatible responses were required (i.e. children were instructed to click the mouse 
key that corresponded to the direction in which the stimulus moved). In part 2, the 
stimulus was colored red and incompatible responses were required (i.e. children were 
instructed to click the response mouse button opposite to the direction of the mov-
ing stimulus). In part 3, the color of the stimulus shifted randomly between green and 
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red and both compatible and incompatible responses were required. Cognitive flexibility 
was operationalized as the difference in percentage of errors (accuracy) between part 1 
and the compatible trials of part 3 (Oerlemans et al., 2013). Working memory (WM) was 
measured using two tasks: one spatial and one verbal task. Spatial WM was tested using 
the Visuo-Spatial Sequencing (VSS) task. Stimuli consisted of nine figures presented 
symmetrically in a 3 by 3 square. On each trail, a sequence of figures was pointed at by 
a computer-driven hand. Children were then instructed to reproduce the sequence in 
forward order. The difficulty level increased after each succeeded trial. Dependent mea-
sure was the total percentage of correctly identified targets in the correct order. Verbal 
WM was measured using the maximum span of the backward condition of the Digit 
Span subtest of the WISC-III/WAIS-III. Children were instructed to repeat a sequence of 
digits in backward order. One digit was added to the sequence if the child reproduced 
the sequence successfully (Wechsler, 2002).
Motor functioning
Motor functioning was measured using a simple reaction time task and a motor control 
task. The Baseline Speed (BS) task was used to measure the variability of motor output 
(De Sonneville, 1999a). When a fixation cross in the center of a computer screen changed 
into a white square, children were asked to press a mouse key as quickly as possible. To 
prevent anticipation strategies, the time interval between a response and the next emer-
gence of the square varied randomly. Dependent measure was the standard deviation of 
reaction time in ms. Tracking (TR) was used to test motor control (De Sonneville, 1999a). 
The task was completed with the non-preferred hand; hand preference was ascertained 
by asking children with which hand he/she preferred to draw or write. Children were 
instructed to trace an invisible midline (radius 8 cm) between an outer (radius 8.5 cm) 
and inner (radius 7.5cm) circle with a mouse cursor, clockwise with the right hand and 
counter clockwise with the left hand. Dependent variable was the standard deviation of 
the distances in mm (stability).
Timing
The Motor Timing task was designed to measure the variability of motor timing (Le 
Couteur et al., 2003). Children were asked to press a mouse button when they thought 
a 1-second time interval had elapsed. The start of the interval was announced by a 
tone. After the response, visual feedback concerning the accuracy of the response was 
presented on the screen. A response was corrected if it fell between the lower and up-
per boundary set by a dynamic tracking algorithm. The dependent measure was the 
standard deviation of reaction times in ms.
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Does the cognitive architecture of simplex 
and multiplex ASD families differ?
Based on:
Oerlemans, A.M., Hartman, C.A., Franke, B., Buitelaar, J.K. & Rommelse, N.N.J. Does 
the cognitive architecture of simplex and multiplex ASD families differ? (submitted 
for publication)
132
abstract
background: The heterogeneity of autism spectrum disorders (ASD) hinders research 
into etiology and effective treatment. An approach to parse etiologic heterogeneity is 
to form more homogeneous subgroups of patients based on their familial occurrence of 
the disorder (stratification into so-called multiplex [MPX] versus simplex [SPX] families). 
The aim of this study was to test the hypothesis that SPX and MPX ASD families differ in 
their cognitive architecture.
Methods: Tasks measuring intelligence, social cognition, and executive functioning 
were administered to 54 SPX and 91 MPX ASD probands, 77 SPX and 46 MPX unaffected 
siblings, and 124 controls aged 6-20 years.
results: SPX and MPX ASD cases did not differ in cognitive performance; both showed 
similar impairments in verbal and performal IQ, face and affective prosody recognition, 
and verbal working memory. Unaffected siblings (regardless SPX or MPX) performed 
normal on most cognitive tasks, except for impaired affective prosody recognition in 
SPX and MPX siblings and lower IQ scores in MPX (but not SPX) siblings. Significant 
within-family contrasts were found in SPX (but not MPX) ASD families.
Conclusions: These results suggest quantitative rather than qualitative differences be-
tween SPX and MPX forms of ASD: SPX affected children were more dissimilar from their 
non-affected sibling compared to MPX affected children from their non-affected sibling. 
Further, cognitive deficits associated with ASD may have a stronger determining effect 
on the disorder compared to related disorders such as attention-deficit/hyperactivity 
disorder (ADHD). Recognition of affective prosody may be particularly sensitive towards 
familial risk factors for ASD.
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introduction
Autism spectrum disorder (ASD) is a group of highly heritable and severely impairing 
neurodevelopmental disorders, characterized by impairments in interaction, commu-
nication and restricted, stereotyped and repetitive behaviour (APA, 2013). ASD is the 
most heritable of all complex neuropsychiatric conditions, with heritability estimates 
ranging up to 90% (Lichtenstein et al., 2010). ASD is marked by substantial heterogene-
ity in symptom presentation, developmental course and etiologic mechanisms (Jones 
and Klin, 2009). The genetics of ASD is complex with involvement of both rare and com-
mon genetic variants. Rare genetic variants predisposing to ASD are currently thought 
to account for 10-20% of all ASD cases (Betancur, 2011). They include rare mutations in 
genes which lead to monogenic disorders that are frequently associated with ASD, such 
as fragile X syndrome and tuberous sclerosis, as well as mutations and copy number 
variations (CNVs, these constitute deletions or duplications of larger fragments of DNA 
often involving several genes) that may contribute to (mono- and) oligogenic forms of 
ASD (Berg and Geschwind, 2012, Betancur, 2011, Devlin and Scherer, 2012, Persico and 
Napolioni, 2013). Common variants, e.g. single nucleotide polymorphism (SNPs), impli-
cated in the etiology of ASD, on the other hand, are assumed to each contribute a (very) 
small increase in disease risk (Wang et al., 2009). As ASD strongly reduces reproductive 
fitness, it has been argued that part of the genetic contribution to ASD is due to de novo 
mutations (D’Onofrio et al., 2014, Neale et al., 2012). In addition to the strong genetic 
background, environmental influences, gene x environment interaction, epigenetic 
factors, and pre-/perinatal complications also play an important role in susceptibility 
to ASD (Dietert et al., 2011, Gardener et al., 2009, 2011, Kinney et al., 2010, Wong et al., 
2014). Multiple causal pathways may thus underlie the same clinical profiles, and, at the 
same time, the complex etiology may result in highly heterogeneous clinical profiles.
The heterogeneous character of ASD strongly hinders research into etiology and 
effective treatment. An approach to parse etiologic heterogeneity is to form more 
homogeneous subgroups of patients based on the familial occurrence of the disorder. 
Several studies have reported on the genetic differences between families with only one 
individual with ASD (the so-called single-incidence or simplex [SPX] families) compared 
to families with two or more affected individuals (multiple-incidence or multiplex [MPX] 
families). These studies reported a more than threefold rate of de novo mutations in SPX 
families (~7-10%), compared to MPX families (~2-3%) or control families (~1%) (Marshall 
et al., 2008, Sebat et al., 2007). In MPX families, shared genetic predispositions based on a 
multifactorial etiology of common genes appear to play a more important role (Freitag, 
2007), with members of MPX families more often exhibiting ASD traits compared to 
members of SPX families (Gerdts et al., 2013, Virkud et al., 2009). We recently replicated 
the latter finding in the sample described in the current study (Oerlemans et al., 2014a). 
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These findings suggest that individuals from SPX families are more likely than individu-
als from MPX families to develop ASD as a result of sporadic genetic and/or non-genetic 
causes strictly personal to the patient.
Assuming that SPX-MPX stratification identifies forms of ASD with a different genetic 
architecture, we aimed to study whether cognitive deficits differ between SPX and MPX 
families, in probands and/or in unaffected siblings. Cognitive studies in individuals with 
ASD have found deficits in intelligence (typically strengths in performal IQ  over verbal 
IQ ), social cognition (SC), executive functions (EF) and central coherence (CC) (Black et 
al., 2009, Happe and Ronald, 2008, Joseph et al., 2002). Direct comparisons of cognitive 
deficits between individuals with SPX and MPX ASD are mostly lacking thus far, and 
the vast majority of cognitive studies have failed to clearly specify or adjust for simplex 
or multiplex ascertainment process. So far, studies in SPX ASD-only samples report a 
higher frequency of performal > verbal IQ discrepancy in cases compared to controls 
(Ankenman et al., 2014), and an altered cortical shape in brain regions that have been 
implicated in communication, higher order social processes (e.g. empathy and theory 
of mind), spatial attention, visual processing and face recognition (Dierker et al., 2013). 
Studies in MPX ASD-only samples report deficits in EF components such as planning and 
set-shifting, theory of mind, and fluid and crystallized intelligence (Nydén et al., 2011). To 
our knowledge, only one study has examined the association of SPX versus MPX status 
with cognitive functioning. Verbal and non-verbal IQ and head circumference [HC; as-
sociated with impaired brain connectivity and higher order abilities (Courchesne and 
Pierce, 2005)] were compared between children and adolescents with autism from SPX 
and MPX families. The authors reported that enlarged HC was related to social deficits in 
SPX, but not MPX individuals, and that individuals with the lowest nonverbal IQ scores 
were mostly classified SPX, whereas individuals with a higher than average nonverbal 
IQ were mostly MPX (Davis et al., 2013). These findings suggest that both SPX and MPX 
forms of ASD are associated with a wide range of similar disabilities in higher order 
cognitive processes, but that some cognitive factors may be uniquely related to either 
SPX or MPX ASD (e.g. lower IQ scores were reported for SPX ASD), and more research is 
needed to clarify this issue.
Studies reporting on the presence of ASD-related cognitive deficits in first-degree rela-
tives are sparse and report inconsistent findings (Gokcen et al., 2009, Hilton et al., 2012, 
Oerlemans et al., 2014b, Wong et al., 2006). A possible explanation for these discrepant 
findings might be that these studies did not differentiate between etiologically different 
(inherited versus non-inherited) forms of ASD and thus might have investigated rela-
tives with and without familial loading as a mixed group. A recent study using SPX-MPX 
stratification to examine executive function of the parents of patients with familial versus 
non-familial (sporadic) schizophrenia confirmed this idea and reported that executive 
functions were only impaired in parents with a family history of schizophrenia (Erol et 
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al., 2012). Of interest to us is whether similar patterns can also be found in familial (MPX) 
versus sporadic (SPX) ASD.
To test whether the cognitive architecture underlying SPX and MPX autism families 
is different and useful for parsing the etiological heterogeneity of ASD, the cognitive 
performance of ASD probands and unaffected siblings from SPX and MPX families was 
compared with each other and with healthy controls. We selected cognitive tasks that 
assess various cognitive domains previously implicated in ASD (Eapen et al., 2013, Gok-
cen et al., 2009), or have been described as promising cognitive endophenotypes for 
ASD in previous literature (Oerlemans et al., 2013, Oerlemans et al., 2014b, Rommelse et 
al., 2011). We hypothesized that potentially different forms of ASD might result in dis-
similar cognitive profiles in SPX and MPX ASD probands, a finding with implications for 
treatment. Further, we hypothesized that the within family contrast between probands 
and unaffected siblings regarding cognitive aspects of the disorder was larger in SPX 
compared to MPX families as indicated by (mild) cognitive deficits (similar to their af-
fected brother/sister) compared to controls in unaffected siblings from MPX, but not 
SPX families, a finding highly relevant to the identification of cognitive endophenotypes 
for genetic research.
metHod
participants
ASD families were recruited as part of the large family-genetic Biological Origins of 
Autism (BOA) study, (as described previously in Van Steijn et al., 2012). Inclusion criteria 
for all participants were at least two biological siblings (in case families: at least one 
child with a clinical diagnosis of ASD) and one biological parent willing to participate, 
offspring age between 4 and 20 years, European Caucasian descent, an IQ ≥ 70, and 
no diagnosis of epilepsy, brain disorders or known genetic disorders, such as Down-
syndrome or Fragile-X-syndrome. All children and parents were carefully phenotyped 
for ASD using validated and standardized questionnaires and a diagnostic interview. 
Families were then stratified into SPX and MPX based on the number of affected indi-
viduals. SPX families were required to have a single-affected proband, a minimum of one 
male sibling and all siblings and parents of the proband unaffected by ASD; MPX families 
were required to have two or more affected individuals. A total of 54 ASD SPX families 
(including 54 probands and 77 unaffected siblings), 59 ASD MPX families (including 91 
probands and 46 unaffected siblings) and 124 control children were included in the cur-
rent sample, see Table 1 for sample characteristics and Oerlemans et al., 2014a (chapter 
4) for a full description of phenotyping and family classification.
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measures
Table 2 provides an overview of the cognitive tasks used. For full task descriptions, see 
Appendix 1 or elsewhere (Oerlemans et al., 2013).
table 1. Sample characteristics
Controls (c) ASD probands Unaffected siblings Group 
contrasts
ASD vs. 
controls
1. SPX 2. MPX 3. SPX 4. MPX
M (sd) M (sd) M (sd) M (sd) M (sd)
Number of childrena 124 54 91 77 46
Mean number of children 
per family
2.3 2.7 2.8
SPX = MPX > 
controls
Age 10.9 (3.6) 12.3 (3.5) 11.6 (3.4) 12.4 (3.6) 12.0 (3.7) 1=2=3=c, 4>c
Sex (% males) 41.9 85.2 71.4 72.7 41.3 1=2=3>4=c
SCQ Total Score 3.0 (2.6) 17.9 (6.6) 19.6 (6.5) 3.2 (3.3) 6.2 (6.3) 1=2>4>3=c
CSBQ ASD coreb 2.6 (3.8) 26.2 (11.4) 27.5 (8.6) 5.4 (6.2) 11.5 (10.1) 1=2>4>3=c
Note. ASD = Autism spectrum disorders; SPX = simplex; MPX = multiplex; SCQ = social communication 
questionnaire; CSBQ = child social behavior questionnaire; c = controls; 1 = SPX probands; 2 = MPX pro-
bands; 3 = SPX unaffected siblings; 4 = MPX unaffected siblings
aaffective prosody was not administered to children younger than 9 years of age and therefore based on 42 
SPX probands, 70 MPX probands, 62 SPX unaffected siblings, 34 MPX unaffected siblings and 79 controls.
bASD core is an aggregate score of the CSBQ subscales reduced contact and social interests, difficulties in 
understanding social information, stereotyped behaviour and fear of and resistance to changes.
table 2. Description of the neuropsychological tasks.
Taska Measurement potential Dependent variables
Intelligence
Vocabulary, Similarities, Block 
Design, Picture Completion
estimated IQ VIQ and PIQ
Social cognition
Face Recognition face recognition mean reaction time (ms)
Identification of Facial Emotions identification of facial 
emotional expressions
mean reaction time (ms)
Prosody affective prosody mean reaction time (ms)
Executive function
GoNoGo inhibition percentage false alarms – percentage misses
Digit Span verbal working memory max span backwards
Spatial Temporal Span visuospatial working 
memory
percentage correct identified targets in 
correct order (part  backward)
Response Organization Objects cognitive flexibility percentage errors
Note. WISC/WAIS-III = Wechsler Intelligence Scale for Children or Wechsler Adult Intelligence Scale-III
a Details on each of the paradigms are provided elsewhere (Oerlemans et al., 2013a)
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procedure
Cognitive assessment of participants took place at Karakter Child and Adolescent Psy-
chiatry University Centre Nijmegen and is described in more detail elsewhere (Oerlemans 
et al., 2013). If possible, stimulants were discontinued for at least 24 h before testing and 
non-stimulants according to guidelines to allow for sufficient wash-out. Children were 
motivated with small breaks and received a gift at the end of the session. Additional data 
collected included blood or saliva samples and behavioral data of all family members. 
The study was approved by the local medical ethics board and parents and children (12 
years and older) signed for informed consent. Children younger than 12 years of age 
were asked to give their assent for participation.
data analyses
Unlike the other tasks, the affective prosody recognition task was not administered to 
children younger than 9 years of age. The affective prosody recognition data was based 
on 42 SPX probands, 70 MPX probands, 62 SPX unaffected siblings, 34 MPX unaffected 
siblings and 79 controls. The percentage of missing data was < 5% for the majority of 
dependent measures. Exceptions were missing values of 9.4% for inhibition and 9.9% 
for variability of time estimation. Missings were replaced by means of Expectation 
Maximization(Tabachnick and Fidell, 2001). Analyses were carried out with and without 
expectation maximization, which revealed similar results and conclusions. Results were 
therefore reported with missing data replaced. To account for the influence of age and 
sex on neuropsychological performance, we regressed scores for each measure on age 
and sex and used the unstandardized residuals as dependent variables. Most of the 
unstandardized residuals were not normally distributed, therefore a van der Waerden 
transformation was used to normalize the dependent measures (Norusis, 1992). This 
facilitated the comparison between variables since variables were all depicted on the 
same scale. Several of the dependent variables were mirrored so that the z-scores of 
all measures had the same meaning: lower z-scores indicated poorer performance (e.g. 
more errors, slower and more variable responses).
Linear mixed models (LMM) were used to account for the dependency in the data 
due to inclusion of siblings and probands by estimating a random intercept. Dependent 
variables were the cognitive measures and group was the independent variable. We 
contrasted specific groups of interest to answer our research questions. LMM analyses 
were run with group defined as (a) probands versus unaffected siblings versus controls, 
separately for SPX and MPX families, to examine whether cognitive deficits were pres-
ent in (SPX and MPX) probands and MPX, but not SPX, unaffected siblings, (b) MPX 
versus SPX probands to examine whether potentially different heritable forms of ASD 
would result in (dis)similar cognitive profiles in ASD patients, and (c) SPX versus MPX 
unaffected siblings to examine whether cognitive performance of first-degree relatives 
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was poorer in MPX compared to SPX families. Furthermore, within family discrepancy 
scores (estimated mean of proband minus mean of unaffected sibling) in SPX versus 
MPX families were compared to examine whether within family contrast was higher in 
SPX than MPX families. A False Discovery Rate (FDR) correction with a q-value setting of 
0.05 was applied to control for multiple testing (Benjamini, 2010). Effect sizes (Cohen’s 
d) were calculated to define small (d = .20), medium (d = .50), and large effects (d = .80) 
(Cohen, 1988). All analyses were carried out in SPSS version 20.
results
cognitive measures sensitive to spX-mpX stratification
Cognitive deficits are more pronounced in SPX than MPX ASD probands
Testing our first hypothesis, we found that the cognitive profiles of SPX and MPX pro-
bands were very similar. Both SPX and MPX probands had significantly lower VIQ (SPX: 
p < .001, effect size in terms of Cohen’s d = .69; MPX: p < .001, d = .68) and PIQ (SPX: p = 
.008, d = .42; MPX: p = .045, d = .28), and poorer face recognition (SPX: p < .001, d = .65; 
MPX: p = .004, d = .40), affective prosody recognition (SPX: p < .001, d = .92; MPX: p < 
.001, d = .70), and verbal working memory (SPX: p = .003, d = .46; MPX: p = .031, d = .31) 
than controls. However, the effects on PIQ and verbal working memory in MPX (but not 
SPX) probands became non-significant after FDR correction (q-values > .10). Further, SPX 
(but not MPX) probands differed significantly from controls in the identification of facial 
emotions (SPX: p = .010, d = .40; MPX: p = .097, d = .19), suggesting that SPX forms of 
ASD makes patients more prone to deficits in these domains, see Figure 1 and Table 3.
Comparing siblings within families revealed that affected and unaffected siblings 
from MPX families resembled each other more closely in cognitive functioning than 
affected-unaffected siblings from SPX families. In SPX families, within-family discrepancy 
(proband-unaffected sibling contrast) was larger for SPX than for MPX families for VIQ (t 
= 2.56, p = .012) and identification of facial emotions (t = 2.38, p = .019). SPX probands 
differed significantly from their unaffected siblings on both measures (VIQ: p < .001, d = 
.59; facial emotions: p = .002, d = .50), whereas MPX affected and unaffected siblings did 
not differ significantly from each other (p-values > .12, all d values = .03-.29). This might 
suggest that impairments in these cognitive domains are more pronounced in SPX than 
MPX cases. Significant differences between SPX affected and unaffected siblings were 
also found for PIQ (p = .003, d = .42), face recognition (p = .004, d = .52) and verbal 
working memory (p = .039, d = .36), although the latter effect became non-significant 
after FDR correction (corrected p = .07). For visual working memory, significant affected-
unaffected sibling contrasts were found for both SPX (p = .020, d = .39) and MPX (p = 
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figure 1 Comparing unaffected siblings from, and within-family contrasts in SPX and MPX ASD families
Note. ASD = autism spectrum disorder; n.s. = non significant. The interpolation lines represent the mean z-
score and the 95% CI of normal controls. The error bars represent the 95% confidence interval (CI). Lower 
z-scores indicate worse performance. Significant group differences (case groups versus controls) that survived 
FDR correction are depicted using asterisks (*** p < .001, ** p < .01). Within-family contrasts are depicted us-
ing squiggly brackets. Within-family contrasts were higher in SPX compared to MPX families for IQ, emotion 
recognition and visual working memory, suggesting that affected and unaffected siblings from MPX families 
resembled each other more closely in cognitive functioning than affected-unaffected siblings from SPX fami-
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.043, d = .33) families, but, the effect in MPX families did not survive FDR correction 
(corrected p = .15). These findings support the hypothesis that MPX, but not so much 
SPX, unaffected siblings share some of the ASD-related cognitive deficits.
Comparing unaffected siblings from SPX and MPX ASD families
In agreement with our second hypothesis, we found that unaffected siblings from MPX 
families had a significantly lower VIQ (similar to their affected brother/sister) compared 
to controls (siblings vs. controls: p < .001, d = .57; siblings vs. probands: p = .409, d = 
.12), whereas SPX unaffected siblings were unimpaired in this domain (p = .392, d = 
.13). SPX and MPX unaffected siblings also differed significantly from each other on this 
measure (p = .011, d = .47). Opposing our hypothesis, both SPX and MPX unaffected 
siblings scored significantly worse than controls, but similar to their affected brother or 
sister on affective prosody (SPX: p < .001, d = .65; MPX: p = .002, d = .65), see Figure 1. The 
unaffected siblings from both SPX and MPX families displayed a normal performance on 
all other cognitive measures (SPX: all p-values > .27, all d-values < .16; MPX: all p-values 
> .25, all d-values < .20).
measures not sensitive to spX-mpX stratification
As describe above, both MPX and SPX unaffected siblings differed significantly from 
controls (but not from their affected brother/sister) on affective prosody. Further, SPX 
and MPX probands and unaffected siblings were unimpaired on visual working memory 
(p-values > .17, all d values < .21), inhibition (p-values > .07, all d values < .31), and set 
shifting (p-values > .09, all d values < .20), see Table 3.
discussion
The main goal of the current study was to examine whether the cognitive architecture 
underlying SPX and MPX autism families is different and useful for parsing etiological 
heterogeneity of ASD. This model of different etiologies in SPX and MPX families is based 
on evidence from behaviorally-based and genetic research (Freitag, 2007, Gerdts et al., 
2013, Marshall et al., 2008, Sebat et al., 2007, Virkud et al., 2009). We hypothesized that (a) 
the different forms of ASD might result in dissimilar cognitive profiles in SPX and MPX 
lies. Unaffected siblings from both SPX and MPX families were unimpaired on these cognitive domains (a-e). 
In line with our expectations, we found that MPX unaffected siblings had a significantly lower VIQ (similar to 
their affected brother/sister) compared to controls, whereas SPX unaffected siblings were unimpaired in this 
domain. In addition, within-family contrast was highest in SPX ASD families, but non-significant in MPX ASD 
families for VIQ (e). An unexpected finding was that SPX (like MPX) unaffected siblings differed significantly 
from controls (but not from their affected brother/sister) on affective prosody (f ).
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ASD probands, and (b) unaffected siblings from MPX but not SPX would display (mild) 
cognitive deficits compared to controls. Our results showed that directly comparing SPX 
and MPX ASD cases, no cognitive differences were detected and both were associated 
with impairments in VIQ, PIQ, face recognition, affective prosody recognition, and verbal 
working memory compared to healthy controls. However, when compared to their 
unaffected siblings, impairments in identification of facial emotions, VIQ, PIQ, and verbal 
working memory were more pronounced in SPX cases compared to MPX cases. Unaf-
fected siblings from MPX families had a significantly lower VIQ (similar to their affected 
brother/sister) compared to controls, whereas SPX unaffected siblings were unimpaired 
in this domain. Both MPX and SPX unaffected siblings differed significantly from controls 
on affective prosody and were unimpaired on the other cognitive domains. ASD pro-
bands and unaffected siblings from MPX families resembled each other more closely in 
cognitive functioning than affected-unaffected siblings from SPX families.
Results support the hypothesis that a partly different cognitive architecture may 
underlie SPX and MPX forms of ASD, which only becomes evident when contrasting 
cognitive performances within families. That is, the direct comparison between autistic 
children from SPX and MPX families revealed very similar cognitive problems, but when 
using unaffected siblings as an ideal reference group (viewed as indexing the ‘full poten-
tial’ of children with ASD had they not developed the disorder and correcting for shared 
environmental factors), SPX probands seem to be relatively more strongly impaired in 
intelligence, verbal working memory and emotion recognition than MPX probands, 
which is not explained by a more severe ASD phenotype in SPX probands (i.e., in our 
sample, SPX and MPX ASD probands demonstrate equally severe ASD traits, see sample 
characteristics).  This could indicate that partly different developmental pathways may 
result in a similar phenotype and similar cognitive deficits, a phenomenon that has been 
referred to in developmental psychopathology as equifinality (Cicchetti and Rogosch, 
1996). ASD has often been associated with lower full scale IQ or intellectual disability 
(ID) (Charman et al., 2011). One model that has been proposed for the overlap between 
ID and ASD suggests that rare, highly penetrant mutations set the stage for abnormal 
developmental trajectories including ASD, developmental delay and mental retardation 
(Eapen, 2011). Assuming that SPX ASD is more likely than MPX ASD to develop as a result 
of such rare (sporadic) genetic causes, our finding and the finding of Davis et al. that ASD 
children with low(ered) intelligence levels more often had SPX than MPX forms of ASD 
corroborate this theory (Davis et al., 2013).
SPX unaffected siblings were largely unimpaired on cognitive measures compared to 
controls, except for affective prosody, whereas MPX unaffected siblings were impaired 
on both affective prosody and VIQ. Several implications may result from this finding. 
First of all, it suggests that affective prosody is the most sensitive cognitive marker for 
detecting familial risk for ASD. This finding is in line with previous analyses using the 
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same cognitive task in a younger subsample of this cohort (Oerlemans et al., 2014b). 
The perception of emotional expressions via affective prosody is highly relevant for the 
development of Theory of Mind (ToM), which refers to the ability to understand other 
people’s thoughts, beliefs, and other internal states (Korkmaz, 2011, Korpilahti et al., 
2007). Many believe that social cognition deficits are central to explaining the difficulties 
experienced by people with ASD (Baron-Cohen, 1995, Korkmaz, 2011). Our finding that 
unaffected siblings (regardless SPX/MPX status) were impaired on affective prosody, but 
not on other cognitive domains, might suggest that impaired social cognition is the 
primary cognitive deficit in ASD, resulting from shared (genetic and/or environmental) 
risk factors that disrupt the ability to process emotional cues in individuals with autism 
and (to some extent) their unaffected first-degree relatives. Subsequently, impaired 
social cognition might lead to other cognitive problems (such as poor EF or verbal work-
ing memory), most pronounced or uniquely present in affected individuals. Second, it 
suggests that the unaffected siblings from SPX families are not completely clean from 
cognitive deficits. The finding is consistent with findings that although de novo genetic 
variations most likely play a role in the development of simplex ASD, they do not fully 
explain genetic etiology (Krumm et al., 2013). In other words, also in SPX ASD families 
some risks may be shared between family members (Klei et al., 2012), and the distinction 
between MPX and SPX ASD may rather be quantitative and not qualitative. Third, only 
a few comparisons between MPX unaffected siblings and controls reached significance. 
This finding clearly contrasts with studies in ADHD that firmly demonstrate significant 
impairments on cognitive functions and brain morphology in first-degree unaffected 
relatives who are at risk of the disorder (Allen et al., 2009, Rommelse et al., 2011). This 
does not seem to be due to a simple lack of power: visual inspection of the data indicate 
no or only very minor cognitive impairments on several domains that are impaired in the 
MPX probands (face recognition, PIQ, verbal working memory). This suggests that –in 
contrast to ADHD - cognitive factors in ASD may have a stronger determining effect 
on the development of the final phenotype. Or, alternatively, the reversed effect from 
phenotype to aberrant cognition is stronger in ASD than it is in ADHD: the presence of 
the core social problems characteristic of ASD might seriously hinder cognitive develop-
ment in other domains (e.g. poorer EF skills might be a consequence of early atypical 
input from another cognitive system such as theory of mind, as discussed by (Pellicano, 
2012)), which is less true for the core (often intermittent and receptive towards treat-
ment) symptoms of ADHD. In any case, our findings suggest that cognitive deficits as-
sociated with ASD may have a stronger determining effect on the disorder compared to 
related disorders such as ADHD. An important exception is affective prosody, suggesting 
this domain may be sensitive towards familial risk factors for ASD.
Some limitations to this study need to be acknowledged when interpreting the results. 
First, sample sizes were moderate; it follows that our study needs replication in larger 
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samples to fully uncover effects. Second, boys were overrepresented in both proband 
groups and in SPX unaffected siblings, but were underrepresented in MPX unaffected 
siblings and controls. This was likely due to the fact that a) ASD is more frequently 
diagnosed in males and b) because the presence of male unaffected siblings was only 
required for SPX, but not MPX families. However, we do not believe that this has affected 
the results, since the effect of sex was controlled for in this study. Third, although effort 
was made to include several tasks tapping the domains of SC and EF, we were not able to 
assess all aspects of these cognitive domains. For example, fluency, planning and theory 
of mind were not assessed here. We cannot rule out the possibility that the cognitive 
functions not studied here are sensitive to familial effects. All in all, results suggest 
quantitative differences between SPX and MPX forms of ASD, which becomes evident 
when contrasting cognitive performances within families. These findings may help parse 
etiological heterogeneity of ASD by stratifying ASD families into families with stronger 
versus weaker familial aggregation of ASD-related neurocognitive deficits.
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appendiX 1. full description of neuropsycHoloGical measures
measures
Six of the tasks described below were selected from the Amsterdam Neuropsychological 
Tasks (ANT) program (De Sonneville, 1999). The ANT is a computer-aided assessment 
battery that allows for the systematic evaluation of information processing capacities. 
Test-retest reliability and validity of the ANT-tasks are satisfactory (De Sonneville, 2005). 
Each computer task contained an instruction trial where the examiner provided a typical 
item of the task, and a separate practice session. If necessary, the instruction was re-
peated. All subjects were able to perform the training items before testing. Furthermore, 
several subtests from the Wechsler Intelligences Scales for Children (WISC-III) or the 
Wechsler Adult Intelligence Scale (WAIS-III) were selected (Wechsler, 2000, 2002). These 
subtests were administered following manual guidelines.
Intelligence
Verbal and Performal IQ were prorated by four subtests of the Wechsler Intelligences 
Scales for Children (WISC-III) or the Wechsler Adult Intelligence Scale (WAIS-III): Similari-
ties and Vocabulary for VIQ and Block Design and Picture Completion for PIQ (Wechsler, 
2000, 2002). These selected WISC-III subtests are known to correlate between .90-.95 
with the Full-scale IQ (Groth-Marnat, 1997).
Social cognition
Social cognition (SC) was measured using three tasks from the ANT. The Face Recog-
nition (FR) task was used to measure the capacity to process social (facial) stimuli (De 
Sonneville, 1999). Stimuli consisted of color photographs of a human face with a neutral 
expression, were presented on a computer screen. Children were then asked to identify 
a target face in a display set that consisted of four faces. If the target face was present 
in the display set, the subject was asked to click the ‘yes-button’ (right computer mouse 
button for right-handed subjects, and left computer mouse button for left-handed 
subjects), if the display set did not contain the target face the subject was asked to 
press the ‘no-button’ (left computer mouse button for right-handed subjects, right 
computer mouse button for left-handed subjects). The Identification of Facial Emotions 
(IFE) task was used to measure the capacity to understand facial emotional expressions 
(De Sonneville, 1999). Stimuli consisted of photographs of a human face, presented 
on a computer screen, with each photograph presenting a face with either a neutral 
or emotional (happy, sad, angry, fear, disgust, surprise, shame, contempt) expression. 
Children were asked to judge whether the presented photograph showed the target 
emotion or not by clicking a mouse button (responses were to be given as described 
above). The Prosody (PR) task was administered to test the ability to recognize ‘emotions 
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in voices’ (De Sonneville, 1999). Stimuli consisted of spoken sentences with a neutral 
content, presented through a headphone. Sentences were spoken in a happy, sad, angry 
or frightened manner, with each emotion represented by twelve sentences, in random 
order. The children were asked to verbally identify the emotion in the voice. Response 
time was recorded using a headphone that acted like a voice-key response. Dependent 
variable in all three tasks was mean reaction time (in ms).
Executive function
Executive function (EF) was measured using tests that tap into three major aspects 
of EF, namely inhibition, cognitive flexibility and working memory. All measures were 
standardized and some scores were mirrored so that low z-scores indicated poorer 
performance). Inhibition was measured using the GoNoGo (GNG) task (De Sonneville, 
1999). Children were presented with two types of trials: go-trails and no-go-trails. Chil-
dren were asked to press a mouse key as quickly and accurately as possible when the 
go-stimulus was presented, but withhold their response to the stop-trial. Dependent 
variable was accuracy (% false alarms - % misses) (Oerlemans et al., 2013). Cognitive 
flexibility was measured using the Response Organization Objects (ROO) (De Sonnev-
ille, 1999). The stimulus was a colored circle that was presented to the left or right of a 
fixation cross. Three parts were administrated: in part 1, the stimulus was colored green 
and compatible responses were required (i.e. children were instructed to click the mouse 
key that corresponded to the direction in which the stimulus moved). In part 2, the 
stimulus was colored red and incompatible responses were required (i.e. children were 
instructed to click the response mouse button opposite to the direction of the moving 
stimulus). In part 3, the color of the stimulus shifted randomly between green and red 
and both compatible and incompatible responses were required. Cognitive flexibility was 
operationalized as the differences in mean number of errors (accuracy) between part 
1 and the compatible trials of part 3 (Oerlemans et al., 2013). Working memory (WM) 
was measured using two tasks: one spatial and one verbal task. Spatial WM was tested 
using the Spatial Temporal Span (STS) task. Stimuli consisted of nine figures presented 
symmetrically in a 3 by 3 square. On each trail, a sequence of figures was pointed at 
by a computer-driven hand. Children were then instructed to reproduce the sequence 
in backward order. The difficulty level increased after each succeeded trial. Dependent 
measure was the total percentage of correctly identified targets in the correct order. 
Verbal WM was measured using the maximum span of the backward condition of the 
Digit Span subtest of the WISC-III/WAIS-III (Wechsler, 2002).
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abstract
background: Autism spectrum disorder (ASD) and attention-deficit/hyperactivity 
disorder (ADHD) frequently co-occur. Besides shared genetic factors, pre- and perinatal 
risk factors (PPFs) may determine if ASD, ADHD, or the combination of both disorders 
becomes manifest. This study aimed to test shared and unique involvement of PPFs for 
ASD and ADHD, using an approach that stratifies the sample into affected/unaffected 
offspring and single-incidence (SPX) versus multi-incidence (MPX) families.
Methods: Pre- perinatal data based on retrospective parent-report were collected in 
288 children from 31 SPX and 59 MPX ASD families, 476 children from 31 SPX and 171 
MPX ADHD families, and 408 control children.
results: Except for large family size and more firstborns amongst affected offspring, 
no shared PFFs were identified for ASD and ADHD. PPFs specifically related to ASD 
(maternal infections and suboptimal condition at birth) were more often reported in af-
fected than unaffected siblings. PPFs associated with ADHD (low parental age, maternal 
diseases, smoking and stress) were shared between affected and unaffected siblings. 
Firstborn-ship was more frequent in SPX than MPX ASD probands.
Conclusions: Our results suggest that the co-morbidity of ASD and ADHD is not likely 
explained by shared PPFs. Instead, PPFs might play a crucial role in the developmental 
pathways leading up to either disorder. PPFs in ADHD appear to index an increased 
shared risk, whereas in ASD PPFs possibly have a more determining role in the disorder. 
SPX-MPX stratification detected possible etiological differences in ASD families, but 
provided no deeper insight in the role of PPFs in ADHD.
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introduction
Autism spectrum disorder (ASD) and attention deficit/hyperactivity disorder (ADHD) are 
both highly heritable, impairing neurodevelopmental disorders that manifest early in 
development and frequently co-occur (Lichtenstein et al., 2010). ASD is characterized by 
impairments in social interaction, deficits in verbal and non-verbal communication and 
by restricted or repetitive patterns of behavior and interests. ADHD is characterized by 
symptoms of hyperactivity, impulsivity and/or inattention (American Psychiatric APA, 
2013). High co-morbidity might be explained by shared genetic factors, as indicated by 
twin studies (Lichtenstein et al., 2010, Ronald et al., 2008). However, genetic effects do 
not account for all phenotypic covariation (Ronald et al., 2008), implying that the high 
co-morbidity rates of ASD and ADHD might also be explained by other factors, such as 
shared pre- and perinatal risk factors (PPFs) (Rutter and Silberg, 2002).
PPFs have proven important in the etiology of both ASD and ADHD. However, since 
ASD or ADHD have been studied mostly in isolation, we have little knowledge about 
whether PPFs are shared between the disorders. In meta-analyses of ASD, advanced 
parental age at birth, maternal prenatal medication use, gestational bleeding, diabetes, 
being firstborn, fetal distress, birth injury or trauma, low 5-minute APGAR score and low 
birth weight (< 5.5 pounds or 2,500 gram) were more frequently observed in ASD than 
in controls (Gardener et al., 2009, 2011). Maternal infections, maternal stress, suboptimal 
condition of the child at birth, prematurity, and smoking during pregnancy were also 
found related to ASD (Visser et al., 2013). Additionally, a recent study reported that a 
birth weight more than two standard deviations above average for gestational age also 
increases the risk of developing ASD (Abel et al., 2013). Research on ADHD indicates that 
prenatal exposure to nicotine, alcohol, drugs or toxins, and maternal stress, low birth 
weight, low maternal age and poor maternal diet are associated with an increased likeli-
hood of developing ADHD (Langley et al., 2005, Mick et al., 2002, Mill and Petronis, 2008, 
Thapar et al., 2013, Throckmorton-Belzer et al., 2009). Furthermore, an association has 
been reported between neonatal complications and the severity of ADHD symptoms 
(Ben Amor et al., 2005). Only two studies so far investigated which early childhood indi-
cators (amongst which, PPFs) might be shared between ASD and ADHD, by examining 
these risk factors in the general population (Jaspers et al., 2013, St Pourcain et al., 2011). 
St Pourcain et al. found that maternal smoking might be common to ASD- and ADHD-
like symptoms (St Pourcain et al., 2011). Jaspers and colleagues reported that male 
gender and low educational level of the mother were overlapping indicators, yet PPFs 
such as maternal smoking and low birth weight were specific for ADHD and ASD traits, 
respectively (Jaspers et al., 2013). All considered, these findings on population-based 
samples suggest limited overlap of PPFs in ASD and ADHD, except perhaps for low birth 
weight and maternal smoking. The role of shared PPFs might, however, be different in 
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clinical samples, given greater severity of clinical symptoms among referred cases. In the 
current study that combines two clinical ASD and ADHD cohorts, we aimed to explore 
this issue further.
Which role PPFs play in a disorder can be understood by looking at the prevalence 
of these risk factors in unaffected siblings of patients. The advantage of an affected-
unaffected sibling design is that it controls for familial (genetic background and shared 
environmental) risk factors (Ben Amor et al., 2005). When certain PPFs are present in 
both affected and unaffected siblings, these factors are probably related to an overall 
increased risk of developing the disorder (trait factors), without a unique, determining 
contribution to the disorder. Vice versa, PPFs (predominantly) found in affected offspring 
but not in unaffected offspring may have a more penetrant, possibly uniquely determin-
ing effect on the development of the disorder (state factors). Research that compared 
affected and unaffected ASD siblings showed that medication use during pregnancy, 
being firstborn, higher non-optimality scores, low birth weight and low APGAR scores 
are all relatively more prevalent in autistic children compared to their unaffected sib-
lings (Deykin and MacMahon, 1980), suggesting that these factors may explain why the 
probands did develop ASD, yet their siblings did not. In ADHD families, affected children 
appear to have significantly higher rates of perinatal complications such as low birth 
weight and medical conditions when compared to unaffected siblings, but intriguingly, 
smoking and alcohol consumption during pregnancy does not appear to differ among 
siblings (Ben Amor et al., 2005). Recent studies using genetically informative designs 
suggest the latter factors to be a proxy of ADHD risk genes passed from mother to 
offspring, rather than predominantly environmental toxic factors (D’Onofrio et al., 2013, 
Thapar et al., 2013). The above described research indicates that there might indeed be 
specific PPFs that are present in affected individuals, but also PPFs that are shared by 
affected and non-affected (ADHD) siblings. This is the first study to examine which PPFs 
are related to ASD and/or ADHD and to what extend these factors are uniquely present 
in affected offspring or shared between affected and unaffected siblings.
A second and more in depth approach that can improve our understanding of the 
role of PPFs in ASD and ADHD is to stratify families into simplex (SPX) or multiplex (MPX) 
affected ones. Families with only one affected individual are referred to as SPX and 
families in which two or more individuals are affected, are defined as MPX. This stratifica-
tion allows us to differentiate between common risk factors present in multiple family 
members (which will be more frequent in MPX families) versus non-shared, unique risk 
factors, only present in affected persons (more frequent in SPX families). This approach 
has been proven to be helpful in research on genetic factors in ASD. Individuals with ASD 
from MPX families generally carry more common, shared genetic factors for the disorder 
(Freitag, 2007), while the symptoms of ASD-affected individuals from SPX families are 
more likely to have a unique cause for their disorder, such as de novo mutations or rare 
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copy number variations that are unshared with other family members (Marshall et al., 
2008, Sebat et al., 2007). Consistent with this, individuals from MPX families show higher 
levels of ASD traits than individuals from SPX families (Constantino et al., 2010, Virkud et 
al., 2009). With regard to the PPFs, MPX and SPX stratification may add to insights which 
PPFs reflect mostly genetically driven rather than incidental environmental risk factors.
In sum, this is the first study that tests sharing and uniqueness of the involvement 
of PPFs for ASD and ADHD using an approach that stratifies the sample into affected 
versus unaffected offspring and SPX versus MPX-affected families. We tested whether (1) 
PPFs only present in affected –but not unaffected- offspring may have a unique, highly 
penetrant contribution to the disorder instead of increasing the overall liability for the 
disorder only slightly, and (2) offspring from MPX families shares a larger proportion of 
PPFs than that of SPX families indicating that PPFs in MPX families most likely reflect 
genetically driven risk factors, whereas PPFs in SPX families might reflect (purely envi-
ronmental) risk factors.
metHod
participants
ASD and ADHD families were recruited as part of two large family-genetic studies: the Bio-
logical Origins of Autism (BOA) study and the Dutch part of the International Multicenter 
ADHD Genetics (IMAGE) study (as described previously in van Steijn et al., 2012). Inclusion 
criteria for all participants were at least two biological siblings (in case families: at least 
one child with a clinical diagnosis of ASD or ADHD) and one biological parent willing to 
participate, offspring age between 4 and 20 years, European Caucasian descent, and an 
IQ ≥ 70. Children with a diagnosis of epilepsy, brain disorders or known genetic disorders, 
such as Down-syndrome or Fragile-X-syndrome were excluded from participation in order 
to reduce etiological heterogeneity and providing ASD and ADHD samples with consider-
able clinical homogeneity. All children and parents were carefully phenotyped for ASD 
and ADHD using validated and standardized questionnaires and diagnostic interviews. 
Families were stratified into SPX and MPX based on the number of affected individuals. SPX 
families were required to have a single-affected proband, a minimum of one male sibling 
and all siblings and parents of the proband unaffected by ASD or ADHD; MPX families were 
required to have two or more affected individuals. A total of 288 children from ASD families 
(including: 56 SPX probands, 96 MPX probands, 81 SPX unaffected siblings, and 55 MPX un-
affected siblings), 476 children from ADHD families (including: 31 SPX probands, 270 MPX 
probands, 47 SPX unaffected siblings, and 128 MPX unaffected siblings), and 408 control 
children were included in this study, see Table 1 for sample characteristics and Oerlemans 
et al., 2014 (chapter 4) for a full description of phenotyping and family classification.
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measure
Pre- and perinatal information was retrospectively collected from the parents using 
standardized questionnaires, derived from the Prechtl optimality scales (Gillberg and 
Gillberg, 1983). The items were grouped into PPFs based on related content following 
the division successfully used in other studies (Schrieken et al., 2013, Visser et al., 2013), 
see Table 2. For each factor, a dichotomous variable was created, coding ‘1’ if the risk fac-
tor was present and ‘0’ indicating absence of the risk factor. Some additions were made. 
First, the factor ‘pregnancy after fertility treatment’ was added, because children born 
following assisted reproductive technologies (ARTs) have been found to be at higher 
risk of autism than the general population (Zhan et al., 2013). Second, given that both 
low and high birth weight and parental age were found to be associated with adverse 
outcomes, it was decided to examine the effect of these categories separately (Abel et 
al., 2013).
table 2. Pre-and perinatal risk factors
Prenatal Perinatal
1. Parental age at conception
    - low (mothers < 25 years, fathers < 30 years)
    - high (mothers  ≥ 35 years, father ≥ 40 years)
2. Miscarriages / bleeding
miscarriages in history, gestational bleeding
3.  Maternal diseases
diabetes, (pre-) eclampsia, high blood pressure, severe 
nausea
4. Maternal infections
virus, severe infections
5. Maternal intoxications
   - alcohol use during pregnancy
   - tobacco use during pregnancy
6. Stress during pregnancy
severe tensions, concerns about the child
7. Labor/parturition
prolonged parturition (≥24 hours), caesarian section, 
forceps extraction, vacuum extraction, breech 
presentation
8. Prematurity (< 37 weeks)
9. Birth weight
   - low birth weight (< 2,500 grams)
   - high birth weight (> 4,500 grams)
10. Suboptimal condition of child at birth
low APGAR score at 5 min (<8), respiratory distress, 
faeces in amniotic fluid, umbilical cord around neck, 
physical injury
11. Family size/Firstborn#
12. Pregnancy after fertility treatment
Note. the items underlying the factors are presented in italic. For each item, a dichotomous variable was 
created, coding ‘1’ if the complication was present and ‘0’ if the complication was not present. Then, items 
were grouped into the pre/perinatal factors based on related content. If at least one complication was 
present during pregnancy or delivery, ‘1’ was coded on the overlapping factor.
# Because siblings were included in this study, we compared mean family size between disorders and 
examined firstborn-ship in the post hoc analyses only.
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Questionnaires were filled in separately for each child at home, mostly by the mother of 
the child. Additional data collection included demographic information, blood samples 
of all family members and neuropsychological data of the children. The study was ap-
proved by the local medical ethics board, and parents and children (12 years and older) 
signed for informed consent.
data analyses
In the BOA (ASD) study, the pre-/perinatal risk factor questionnaire was part of the 
standard test protocol and administered to all participating families. The percentage 
of missing data within the ASD cohort was random and < 5% for all risk factors. The full 
pre-/and perinatal risk factor questionnaire was only administered to about 50% of the 
participating ADHD families (IMAGE study), since it was added to the protocol at a later 
stage. A shorter version of the questionnaire (which did not include all pre-/perinatal 
exposures) was later sent to the remaining families. This resulted in missing data > 
50% for the PFFs miscarriages/bleeding, maternal diseases, maternal infections, labor/
parturition, stress during pregnancy, suboptimal condition at birth, and pregnancy after 
fertility treatment, because these PFFs were not assessed in about half of the sample 
(note that families entered the study randomly and that therefore missingness is ran-
dom, including an equal proportion of case and control families). Missing data for the 
other PFFs was 17.1% for prematurity, 16.2% for high and low birth weight, 15.9% for 
alcohol use and 15.6% for smoking during pregnancy. Missing data was not imputed to 
prevent spurious associations.
First, to examine which PPFs were associated with ASD and/or ADHD, Wald chi-square 
values were calculated using generalized estimated equations (GEE) with a binary 
logistic model, robust estimators, and exchangeable structure for working correlation 
matrices. To correct for familial dependency within the data set, family number was used 
a repeated measure. Independent variables were type of disorder (ASD vs. ADHD vs. 
control) and sex and the two-way interaction type of disorder*sex. The two-way interac-
tion was dropped from the model when non-significant. Sex was added to the model 
because previous studies reported that pre-/perinatal complications are more prevalent 
in boys (Lukkari et al., 2012) and because groups differed in percentage males (see Table 
1). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Dependent 
variables were the PPFs described above and separate analyses were run for each of the 
dependent variables. Because siblings were included in this study and only one child 
per family can be firstborn, the factor firstborn could not be compared between ASD 
vs. ADHD vs. controls. Instead, family size was examined between disorders. The factor 
firstborn was examined in post hoc analyses described below.
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Second, for all PPFs significantly associated with either ASD or ADHD or both post 
hoc analyses were conducted to test a) whether the effect was specific to affected 
children or shared between affected and unaffected siblings and b) whether the effect 
was selectively found in either SPX or MPX families. Similar GEE analyses were run with 
independent variables a) diagnosis (affected vs. unaffected siblings) and sex or b) type 
of family (SPX vs. MPX families) and sex. For the factor firstborn, mean family size was 
included as covariate to account for the number of children per family. The post hoc 
analyses were run separately for ASD and ADHD cohorts. A False Discovery Rate (FDR) 
correction with a q-value setting of 0.05 was applied to control for multiple testing 
(Benjamini, 2010). However, because of the small numbers of individuals available for 
some of the exposures and the hypothesis-generating nature of our study, a distinction 
was made between significance (i.e. findings that remained significant after multiple 
testing), nominal significance (i.e. findings that did not remain significant after multiple 
testing), and trend-level significance (p <.10), in order to not miss out on possible rel-
evant findings  that can be tested in future studies. Note, therefore, that trend-level and 
nominal significant findings should be interpreted with caution, while associations that 
survived correction for multiple testing have the highest chance of being replicated in 
future studies. All analyses were carried out in SPSS version 20.
results
Table 3 presents the χ² tests for the PPFs for ASD and ADHD families. Significant main 
effects of type of disorder (ASD families vs. ADHD families vs. controls) were found for 
low parental age (χ² (2, N=1166) = 35.30, p<.001), tobacco use during pregnancy (χ² (2, 
N=1050) = 11.61, p=.003), stress during pregnancy (χ² (2, N=783) = 15.45, p<.001), and 
family size (χ² (2, N=1172) = 38.81, p<.001). Trend-level effects were found for maternal 
diseases (χ² (2, N=783) = 5.73, p=.057) and maternal infections (χ² (2, N=779) = 4.64, 
p=.098). Comparisons between ASD and ADHD families revealed that only one of these 
PPFs was significantly associated with both disorders, namely the factor family size (ASD 
families vs. controls: χ² (1, N=696) = 28.54, p<.001, OR=1.64 [95% CI: 1.37-1.97]; ADHD 
families vs. controls χ² (1, N=884) = 27.98, p<.001, OR=1.41 [95% CI: 1.24-1.61]; ASD 
vs. ADHD families: p=.084). Case parents had significantly more children than control 
families and this did not differ between ASD and ADHD. The other identified PPFs were 
associated with either ASD or ADHD. Nominally significant associations between ASD 
and the factors maternal infections and suboptimal condition at birth (χ² (1, N=539) = 
3.83, p=.050, OR=3.97 [95% CI: 1.00-15.82]) and χ² (1, N=540) = 3.88, p=.049, OR=1.52 
[95% CI: 1.00-2.31], respectively) were found. Children from ASD families were almost 4 
times more likely to have suffered from a severe infection during pregnancy and were 
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1.5 times more likely to have experienced at least one suboptimal condition at birth 
than controls. These factors were not significantly associated with ADHD. Further, a trend 
level effect of high birth weight was found in ASD (χ² (1, N=668) =2.74 p=.098; OR=2.38 
[95% CI: .85-6.63]). Specifically associated with ADHD were the PPFs low parental age (χ² 
(1, N=878) = 21.20, p<.001, OR=2.26 [95% CI: 1.60-3.21]), tobacco use during pregnancy 
(χ² (1, N=768) = 7.87, p=.005, OR=2.12 [95% CI:1.52-4.48]), and stress during pregnancy 
(χ² (1, N=497) = 12.17, p<.001; OR=2.61 [95% CI: 1.52-4.48]). A nominally significant as-
sociation was found between ADHD and maternal diseases (χ² (1, N=497) = 5.67, p=.017, 
OR=1.84 [95% CI: 1.11-3.04]). Children from ADHD families were over 2 times more likely 
to have young parents than control children. Furthermore, case mothers were almost 
twice as likely to have suffered from at least one disease and were over twice as likely 
to have smoked or experienced stress during pregnancy as control mothers, see Table 
3 and Figure 1. Moreover, the proportion of children from ADHD families exposed to 
these four risk factors was significantly higher than that of individuals from ASD families 
figure 1 Identified risk factors for individuals from ASD or ADHD families.
Note. ASD = autism spectrum disorders; ADHD = attention-deficit/hyperactivity disorder. OR = odds ratio. 
Represented are the odds that a risk factor was present in children from ASD/ADHD families compared to 
control children (reference line). Significant odd ratios are indicated with an asterisk (*** p < .001, * p < .05)
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(p-values <.006). A reverse effect was found for high parental age (χ² (2, N=1168) = 11.51, 
p=.003), with parents of ADHD cases being less likely to have an advanced parental age 
than control parents (χ² (1, N=878) =10.85 p=.001; OR=.45 [95% CI; .28-.72]).
As a next step, we compared affected vs. unaffected siblings for their exposure to PPFs. 
We found that after controlling for family size, ASD affected children were more likely to 
be firstborn than their unaffected siblings (χ² (1, N=288) = 8.77, p=.003, OR=6.48 [95% CI: 
1.88-22.33]). A trend-level effect of being firstborn was found for ADHD as well (ADHD: 
χ² (1, N=476) = 3.23, p=.072, OR=1.16 [95% CI: .99-1.35]). A suboptimal condition at birth 
was nominally significantly more frequently reported in ASD-affected compared to ASD-
unaffected siblings (χ² (1, N=287) = 4.47, p=.034, OR=1.70 [95% CI: 1.04-2.79]), whereas 
ASD-affected and unaffected offspring did not differ from each other with regard to the 
prevalence of maternal infections (p = .114) or high birth weight (p=.460). Within ADHD  
p =.003 p = .072 
p = .064 
p = .034 p = .015 p = .036 
 
p =.003 p = .072 
p = .064 
p = .034 p = .015 p = .036 
figure 2 Comparisons between ASD and ADHD probands and their unaffected siblings, stratified for SPX 
and MPX families
Note. ASD = autism spectrum disorders; ADHD = attention-deficit/hyperactivity disorder; SPX = simplex; 
MPX = multiplex. The interpolation lines represent the percentage of control children with the risk factor 
present. Dotted lines indicate trend-level significant findings
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families, no differences were found between ADHD-affected and unaffected siblings 
for any of the identified PPFs (p-values >.10). However, despite suboptimal condition 
at birth not being significantly associated with ADHD, this perinatal complication was 
nominally significantly more often reported in ADHD-affected compared to ADHD-
unaffected offspring (χ² (1, N=244) = 4.39, p=.036, OR=2.13 [95% CI: 1.05-4.33]). Similarly, 
stress during pregnancy was more frequent in ASD-affected vs. ASD-unaffected children 
(χ² (1, N=286) = 5.91, p=.015, OR=2.19 [95% CI: 1.16-4.13]), see Figure 2.
A final step in the data analyses was the stratification into SPX vs. MPX families. This 
revealed a trend-level significant difference between SPX and MPX ASD families in the 
factor being firstborn (χ² (1, N=288) = 3.44, p=.064, OR=.51 [95% CI: .24-1.04], with SPX 
ASD families having proportionally more firstborns than MPX ASD families. Trend-level 
effects were found for SPX versus MPX ASD unaffected siblings on suboptimal condition 
(χ² (1, N=135) = 5.91, p=.052, OR=.44 [95% CI: .19-1.01]) and for SPX versus MPX ADHD 
siblings on being firstborn (χ² (1, N=175) = 3.35, p=.067, OR=.51 [95% CI: .24-1.05]). Sib-
lings from MPX families were more likely to be firstborn (ADHD) or to have experienced 
a suboptimal condition at birth (ASD) than unaffected siblings from SPX families, see 
Figure 2.
discussion
This is the first study to test sharing and uniqueness of the involvement of PPFs for ASD 
and ADHD, using an approach that stratifies the sample into affected versus unaffected 
offspring and SPX versus MPX affected families. Our results revealed that except for large 
family size and more firstborns amongst affected offspring, no shared PFFs were identi-
fied for ASD and ADHD. PPFs specifically related to ASD (maternal infections and subop-
timal condition at birth) were more often reported in affected offspring. PPFs associated 
with ADHD (low parental age, maternal diseases, maternal smoking and maternal stress) 
were shared between affected and unaffected siblings. Stratification into SPX and MPX 
revealed that SPX ASD probands were more often firstborn, but were less likely to have 
experienced a suboptimal condition at birth than MPX ASD probands. Firstborn-ship 
was also highest amongst MPX compared to SPX ADHD unaffected siblings.
Except for large family size and more firstborns amongst affected offspring, no shared 
PFFs were identified for ASD and ADHD. This is surprising given that cross-disorder traits 
were present in both ASD and ADHD affected and unaffected siblings, mainly in MPX 
families (see sample characteristics). This may suggest that the comorbid presence 
of ASD and ADHD symptoms is not likely explained by shared pre-and perinatal risk 
factors. The finding that affected siblings were more often firstborns than unaffected 
siblings concurs with previous literature (Gardener et al., 2009, Marin et al., 2014). This 
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suggests that being firstborn may increase the risk for ASD and ADHD alike, and pos-
sibly increase the risk for psychopathology in general (Feehan et al., 1994, Happe, 1999). 
Other alternative (or additional) explanations for the increased risk of developing ASD 
or ADHD as a firstborn have also been suggested. For instance, becoming a parent for 
the first time is life-changing and puts high demands on parents. Parents are often more 
anxious and restrictive with the first child than with later children (Eisenman, 1992) and 
firstborn children (particularly boys) experience significantly higher ineffective parent-
ing behaviors as compared to children without siblings or those with older siblings 
(Arim et al., 2012). Interestingly, family size was larger in families including children with 
ASD or ADHD. Large family size has been previously associated with ADHD (Biederman 
et al., 1995) and has been linked to negative child outcomes such as lower average 
educational levels (Booth and Hiau, 2009). Parents who choose to have more children 
might be (inherently) different from parents with fewer children, suggesting that family 
size may be considered a proxy for developmental risk.
Several PPFs were either associated with ASD (maternal infections and suboptimal 
condition at birth) or ADHD (low parental age, maternal diseases, smoking during 
pregnancy, and stress during pregnancy). Higher frequencies of maternal infections 
and suboptimal conditions at birth in ASD cases are consistent with previous findings 
(Gardener et al., 2011, Visser et al., 2013). These factors are likely to reflect immune 
dysfunction and hypoxia, impacting on neurodevelopment (Kolevzon et al., 2007, 
Onore et al., 2012). Young maternal age is a known risk factor for behavioral problems 
and has been previously linked to ADHD (Gustafsson and Kallen, 2011). The finding 
that maternal smoking and stress during pregnancy were significantly associated with 
ADHD also corroborates with previous findings (Thapar et al., 2013). Some studies have 
reported GxE interactions between some key ADHD risk genes (DAT1, DRD4), maternal 
smoking (Neuman et al., 2007), and maternal stress (Grizenko et al., 2012), others did not 
(Altink et al., 2009). Whether maternal smoking and stress are causal agents or proxy 
variables for the genetic risk to develop ADHD remains unclear (D’Onofrio et al., 2013). 
The link between maternal tobacco use or maternal stress and offspring ADHD might be 
attributable to transmission of ADHD risk genes, in addition to any true environmentally 
mediated effect (Thapar et al., 2013). Proposed mechanism linking stress during preg-
nancy and ADHD include a disruption in stress-response systems and prefrontal cortex 
development (Class et al., 2014). Last, maternal diseases such as gestational diabetes 
mellitus (GDM) and preeclampsia have been previously associated with ADHD (Cannon 
and Keller, 2006, Nomura et al., 2012). Maternal diseases might impact fetal brain growth, 
possibly resulting in greater inattention and hyperactivity (Ornoy, 2005). Our study adds 
importantly to the existing literature by showing that PPFs are relatively specific for ASD 
and ADHD. These findings might suggest that the strong overlap between the disorders 
is unlikely to be caused by many overlapping pre- or perinatal risk factors.
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More differentiation in the role of PPFs contributing to ASD and ADHD was found 
when stratifying the sample into affected versus unaffected children. In ADHD, all PPFs 
were shared between affected and unaffected siblings. This corroborates previous find-
ings that some PPFs in ADHD (i.e., maternal smoking and alcohol use during pregnancy) 
did not differ among affected and unaffected siblings (Ben Amor et al., 2005). This was 
not the case in ASD. Here, PPFs were more prevalent in autistic children compared to 
their unaffected siblings (Deykin and MacMahon, 1980). This suggests that PPFs in ASD 
may have a unique, highly penetrant contribution to the disorder and are more likely 
to be true determinants, whereas in the case of ADHD, PPFs are weak risk factors that 
only slightly increase the overall liability for the disorder in a family. Further stratification 
into SPX and MPX families had some additional value in understanding the role of PPFs, 
especially for ASD. SPX and MPX ASD families differed with respect to birth order and 
suboptimal conditions at birth, pointing to potential pre-/perinatal etiological differ-
ences between SPX and MPX forms of ASD. Differences in birth rank effects between 
SPX and MPX ASD families were previously examined, but the results were opposite to 
ours (Turner et al., 2011), with middle children (particularly those born second) having a 
higher risk of developing autism than other children in MPX families and increasing risk 
with each additional birth in SPX families. It was argued that the latter finding might be 
explained by a higher number of (possibly causative) de novo mutations due to increas-
ing parental age. It is a challenge to explain our finding that SPX affected offspring was 
more often firstborn than unaffected offspring. Possibly, gene x environment interac-
tions and purely environmental mechanisms for the development of ASD are different 
for the two types of ASD families. SPX and MPX ADHD could not be dissociated from 
each other regarding PPFs. These results suggest that SPX-MPX stratification is more 
suitable to differentiate effects of PPF in ASD families, but in its current form it does not 
provide further insight in the role of PPFs in ADHD. However, the limited sample sizes 
of SPX ADHD families in combination with the low exposure rates for some of the PPFs 
might have resulted in a lack of power. Based on our results, some risk factors appear 
to be more frequently shared by affected and unaffected siblings from MPX than SPX 
ADHD (e.g. maternal diseases and stress during pregnancy). Surely, more research is 
needed to confirm this hypothesis.
Of note, no evidence was found for the association of low birth weight with ASD or 
ADHD, which was the most promising common risk factor based on previous reports 
(Ben Amor et al., 2005, Gardener et al., 2011). A possible explanation might be that low 
birth weight is often associated with advanced maternal and paternal age (Shah et al., 
2010), and the proportion of mothers older than 35 years at conception was significantly 
smaller in case mothers than in control mothers in our study. We could not replicate the 
consistently reported finding of advanced parental age being associated with ASD in our 
sample (Gardener et al., 2009). Also, no support was found for maternal smoking being a 
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shared PPF for ASD and ADHD. Previous studies reported that maternal smoking might 
be specifically related to PDD-NOS, but not (childhood) autistic disorder or Asperger’s 
syndrome (Visser et al., 2013). In our sample, we did not examine subgroups within ASD, 
which might have diluted the effect. Alternatively, among the ASDs, PDD-NOS is the 
most difficult subtype to distinguish from ADHD, and maternal smoking may actually be 
a unique (genetically driven) PPF for ADHD (Jaspers et al., 2013).
A number of limitations of this study should be considered when weighing the results. 
First, this study should be viewed as a first step towards a better understanding of the 
unique and shared contribution of PPFs to the development of sporadic or common ASD 
and/or ADHD. However, the combination of limited sample sizes of SPX ADHD families 
in combination with the low exposure rates and interdependence for some of the PPFs 
might have resulted in decreased power to detect some true group differences. There-
fore, our results should be interpreted with caution. A large majority of ADHD cases stem 
from MPX families, SPX ADHD families seem to be a relatively rare phenomenon in itself 
(15.3% in our sample). Strategic oversampling of SPX ADHD families might be necessary 
to increase the power of studies using the SPX-MPX stratification. A second important 
limitation is that our study design was not suited to test causal inference, thus caution 
is required in assuming that PPFs have causal effects on ASD and ADHD. As Thapar and 
Rutter (2009) pointed out previously, significant associations between pre-/perinatal 
risk factors and psychiatric disorders may arise because of postnatal risks (e.g. parent 
mental health problems, social adversity) or through unmeasured confounders includ-
ing maternally transmitted inherited factors (Thapar and Rutter, 2009). For example, in a 
novel natural experimental design examining children who are genetically unrelated to 
their mother as a result of in vitro fertilization (IVF), Thapar and colleagues showed that 
the association between maternal smoking and ADHD may be genetically transmitted 
from mother to child rather than being a direct effect of smoking on the fetus (Rice et 
al., 2009, Thapar et al., 2009). Therefore, additional studies (indeed using natural experi-
ments as in Rice et al., 2009, Thapar et al., 2009), even though highly difficult to undertake, 
are needed to further test whether the identified PFFs are true causal factors for ASD 
and ADHD. We feel that our study nonetheless adds to the current literature because 
to our knowledge, this is the first study that examined (a) overlapping pre-/perinatal 
risk factors for ASD and ADHD, and (b) whether risk factors are shared or non-shared 
between affected and unaffected siblings which may lead to important conclusions 
about the role of a risk factor in the development of a disorder. In addition, our results 
may potentially explain why some individuals develop ASD and others ADHD, because 
(a) different PPFs were associated with either disorders, and (b) in ADHD, the significant 
associations between disorder and PPFs might reflect inherited factors, whereas in ASD 
they are likely to reflect direct pre-/perinatal effects. Third, the pre- and perinatal data 
was collected retrospectively which could have resulted in a recall bias when comparing 
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cases to controls. However, previous research shows a reasonable agreement between 
parent report and medical records for most birth-related data (Buka et al., 2004), and it 
is unlikely to explain our main finding of PPFs being rather specific for ASD and ADHD. 
Nevertheless, a more optimal design to map out the role of pre-/perinatal risk factors in 
ASD and ADHD would be to study these factors prospectively during different stages 
of pregnancy (e.g. in a longitudinal follow-up study of high-risk infant siblings). Fourth, 
because a shorter form of the questionnaire was administered in about half of the ADHD 
families, some PPFs had a substantial amount of missing values. However, we believe 
that insofar this has affected our results, it would likely lead to underestimation of the 
effect of pre- and perinatal complications on ADHD since we identified significant as-
sociations between ADHD and maternal disease, stress during pregnancy despite the 
high percentage of missings on these factors. Last, boys were overrepresented in the 
clinical samples compared to the control cohort and previous studies report that pre-/
perinatal complications are more prevalent in boys (Lukkari et al., 2012). Therefore we 
controlled for sex in our analyses.
To conclude, the findings reported here indicate that pre- and perinatal complications 
are more frequent in children with ASD and ADHD compared to control children. Most of 
the pre-and perinatal factors were uniquely related to either ASD or ADHD, suggesting 
that the high co-morbidity is not likely to be explained by shared pre-and perinatal risk 
factors. Instead, PPFs might play a crucial role in the developmental pathways discrimi-
nating the disorders on a background of shared genetic factors. Further stratification 
into SPX vs. MPX families appeared to detect some differences, particularly in ASD 
families, pinpointing to potential pre-/perinatal etiological differences between SPX and 
MPX forms of the disorder. These results can stimulate further research on the complex 
etiologies of ASD and ADHD and the role of PPFs herein.
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Chapter 2 focused on the three core cognitive domains that are proposed to underlie 
ASD (i.e. social cognition [SC], executive function [EF] and central coherence) and ex-
amined whether these domains co-segregated within ASD and whether they showed 
signs of familiality and thus might be viable endophenotype candidates for ASD. The 
performance of 140 children with ASD, 172 siblings and 127 controls on tasks measuring 
SC (face recognition, emotional prosody, and facial emotion recognition), EF (inhibi-
tion, cognitive flexibility, and verbal working memory) and local processing style was 
assessed. Compelling evidence was found for co-segregation of SC and EF, but not 
local processing style within ASD, indicating that particularly SC and EF may be fruit-
ful domains in future family studies of the genetic contribution to ASD. Given that SC 
and EF are both strongly related to ASD, using the underlying shared variance of both 
constructs in genetic research may increase the power for detecting susceptibility genes 
for ASD. Furthermore, our results have shown that performances on SC and EF tasks are 
highly correlated within probands, suggesting that probands who perform worse on one 
domain are likely to display deficits in the other domain. Moreover, siblings of autistic 
individuals (regardless of their affected status) tend to display a similar cognitive profile 
as their affected brother or sister and are therefore at risk for impairments in SC and EF 
as well. This latter finding highlights the importance of assessing cognitive functioning 
in sibling risk groups, early in development to determine if SC and EF problems develop, 
and further on if these lead to other functional impairments (e.g., in school performance 
or peer relations).
In chapter 3, we examined whether emotion recognition is a viable endophenotypic 
candidate for ASD and to assess the impact of comorbid ADHD in this context. The per-
formance of 90 children with ASD (43 with and 47 without ADHD), 79 ASD unaffected 
siblings and 139 controls aged 6-13 years on facial emotion and affective prosody rec-
ognition was assessed. Results revealed that the recognition of both facial emotion and 
affective prosody was impaired in children with ASD and aggravated by the presence of 
ADHD. The latter finding could only be partly explained by typical ADHD cognitive defi-
cits, such as inhibitory and attentional problems. The performance of unaffected siblings 
could overall be considered at an intermediate level, performing somewhat worse than 
the controls and better than the ASD probands. Our findings suggest that particularly 
speed measures of emotion recognition might be a viable endophenotype for ASD and 
a fruitful target in future family studies of the genetic contribution to ASD and comorbid 
ADHD. Furthermore, our results suggest that children with comorbid ASD and ADHD 
are at highest risk for emotion recognition problems and clinicians should therefore pay 
special attention to these children suffering from symptoms of both spectra.
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In chapter 4 we examined whether stratification into simplex (families with only one 
affected individual; SPX) and multiplex (families with two or more affected individuals; 
MPX) families might be a promising approach for creating (etiologically) more homo-
geneous subgroups of patients. Second, we examined whether SPX-MPX stratification 
is a useful tool to detect shared etiological underpinnings for ASD and ADHD. This 
approach builds on the idea that polygenic and multifactorial causes of disease will 
increase symptom levels in most or all members of the family (mostly present in MPX 
families), whereas sporadic genetic and non-genetic causes will be strictly personal to 
the patient (mostly present in SPX families). The approach has been successful in ge-
netic ASD research, but has rarely been used in ADHD research. This is the first study to 
divide ADHD families into SPX and MPX and look across ADHD and ASD SPX and MPX 
families at traits of both conditions, in siblings as well as parents. ASD and ADHD traits 
were measured in 56 ASD and 31 ADHD SPX nuclear families, 59 ASD and 171 ADHD 
MPX nuclear families and 203 control nuclear families using parent-, teacher-, spouse-, 
and self-report questionnaires. The results revealed that SPX-MPX stratification indeed 
detected quantitative differences in ASD families, with SPX families being less densely 
affected with ASD than MPX families, suggesting that stratification based on family oc-
currence may help parse ASD heterogeneity and that future studies examining causal 
factors/pathways for ASD should consider family history. In contrast, stratification did 
not distinguish ADHD families; SPX and MPX unaffected relatives (siblings and parents) 
both showed equally elevated levels of ADHD traits compared to controls. Furthermore, 
heightened symptom levels of both disorders, particularly in MPX unaffected relatives, 
indicate shared (multifactorial) underpinnings underlying ASD and ADHD. The observed 
higher levels of cross-disorder traits in ASD than ADHD MPX unaffected siblings might 
even suggest that risk factors underlying ASD overlap to a larger degree with risk factors 
underlying ADHD than vice versa. These findings could inform (genetic) counseling ap-
proaches and therapeutic interventions.
In chapter 5 we examined whether the cognitive architecture underlying SPX and MPX 
ADHD families is different and useful for parsing the etiological heterogeneity of ADHD. 
It was hypothesized that cognitive impairments may be different in SPX and MPX forms 
of ADHD as indicated by (a) the presence of disorder-related cognitive deficits in MPX, 
but not SPX unaffected siblings and (b) dissimilar cognitive profiles in SPX and MPX 
patients. This is the first study to suggest that different causal pathways may underlie 
simplex (SPX) and multiplex (MPX) forms of ADHD. Tasks measuring total IQ, executive 
functioning, motor functioning, and time estimation were administered to 31 SPX and 
264 MPX ADHD probands, 47 SPX and 123 MPX unaffected siblings, and 263 controls, 
aged 6-19 years. Our results showed that several cognitive domains (IQ, visual working 
memory and time estimation) were most impaired in SPX ADHD probands, whereas 
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the formerly proposed ‘key’ cognitive problems related to ADHD (inhibition and mo-
tor control) were not impaired in these SPX probands. Importantly, unaffected siblings 
of SPX families were cognitive unimpaired. This was in sharp contrast to the cognitive 
underpinnings in MPX families: MPX probands and their unaffected siblings showed 
a wide range of cognitive problems, more in line with previous studies on cognitive 
endophenotypes in ADHD. These findings suggest that different causal pathways may 
lead up to –on the surface- comparable cognitive deficits and behavioural symptoms in 
children with ADHD, and that SPX-MPX stratification may be a step forward in unravel-
ling these various causal pathways. Clinically, SPX and MPX ADHD patients may have 
distinct prognoses and benefit from different treatment strategies.
In chapter 6 we examined whether the cognitive architecture underlying SPX and 
MPX ASD families is different and useful for parsing the etiological heterogeneity of 
ASD. It was hypothesized that cognitive impairments may be different in SPX and MPX 
forms of ASD as indicated by (a) dissimilar cognitive profiles in SPX and MPX patients, a 
finding with implications for treatment and (b) the presence of disorder-related cogni-
tive deficits in MPX, but not SPX unaffected siblings, a finding highly relevant to the 
identification of cognitive endophenotypes for genetic research. Tasks measuring intel-
ligence, social cognition, and executive functioning were administered to 54 SPX and 
91 MPX ASD probands, 77 SPX and 46 MPX unaffected siblings, and 124 controls aged 
6-20 years. Our results suggest quantitative differences between SPX and MPX forms of 
ASD, which becomes evident when contrasting cognitive performances within families. 
Children with ASD and their unaffected siblings (regardless SPX or MPX) all had poorer 
social cognition skills. Lower IQ scores were present in MPX and SPX affected children 
and MPX (but not SPX) unaffected siblings. Executive functions were relatively spared 
in both types of families. In all, SPX affected children were more dissimilar from their 
non-affected sibling compared to MPX affected children from their non-affected sibling. 
The finding that unaffected siblings (regardless SPX or MPX) performed normal on most 
cognitive tasks contrasts findings in related disorders such as ADHD. These findings 
suggest that cognitive deficits associated with ASD may have a stronger determining 
effect on the disorder compared to related disorders. An important exception is affective 
prosody, suggesting this domain may be sensitive towards familial risk factors for ASD. 
These findings may help parse the etiological heterogeneity of ASD by stratifying ASD 
families into families with stronger versus weaker familial aggregation of ASD-related 
neurocognitive deficits.
Chapter 7 set out to (a) identify the pre-/perinatal antecedents associated with ASD, 
ADHD, or both disorders and (b) examine whether these are unique (only found in 
affected offspring) or common (also present in non-affected offspring siblings), using 
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the MPX-SPX stratification approach. Pre-/perinatal data based on retrospective parent-
report were collected in 288 children from 31 SPX and 59 MPX ASD families, 476 children 
from 31 SPX and 171 MPX ADHD families, and 408 control children. Except for large 
family size and more firstborns amongst affected offspring, no shared pre-/perinatal 
risk factors were identified for ASD and ADHD, indicating that the co-morbidity of ASD 
and ADHD is not likely explained by shared pre-/perinatal risk factors. Instead, pre-/
perinatal antecedents might play a crucial role in the developmental pathways leading 
up to the specific disorder. Pre-/perinatal factors specifically related to ASD (maternal 
infections and suboptimal condition at birth) were more often reported in affected 
than unaffected siblings. In contrast, pre-/perinatal factors associated with ADHD (low 
parental age, maternal diseases, smoking and stress) were shared between affected and 
unaffected siblings. This suggests that pre-/perinatal factors in ADHD index an increased 
shared risk, whereas in ASD these factors possibly have a more determining role in the 
disorder. SPX-MPX stratification detected some differences, particularly in ASD families, 
pinpointing to potential pre-/perinatal etiological differences between SPX and MPX 
forms of the disorder. SPX-MPX stratification provided no deeper insight in the role of 
such antecedents in ADHD, but the combination of limited sample sizes of SPX ADHD 
families with the low exposure rates and interdependence for some of the pre-/perinatal 
factors might have resulted in decreased power to detect some true group differences. 
All in all, pre- and perinatal complications were more frequent in children with ASD 
and ADHD compared to control children. Counseling of pregnant women should focus 
on decreasing maternal stress during pregnancy by helping mothers to cope with or 
decrease the exposure to stress, or advising pregnant women to stop smoking to reduce 
the risk of ADHD.
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General aims of tHis tHesis
The main aim of this thesis is to examine shared and unique mechanisms underlying 
ASD and ADHD by comparing pre-/perinatal antecedents and associated cognitive 
deficits in both disorders. An attempt was made to parse etiological heterogeneity 
by forming subgroups based on familial re-occurrence of the disorders, which might 
facilitate research into disease etiology and eventually aid in developing effective, indi-
vidualized treatment for ASD and ADHD. We sought to identify viable cognitive endo-
phenotypes for ASD (chapters 2 and 3), following ADHD research in which this method 
has been frequently and successfully applied. Additionally, we examined whether these 
potential endophenotype candidates are influenced by similar familial factors (chapter 
2) and whether comorbid symptoms of ADHD impacts on the manifestation of ASD 
endophenotype candidates (chapter 3). In chapters 4-7, we stratified the sample into 
single-incidence or sporadic (SPX) and multi-incidence or familial (MPX) families and 
compared behavioral phenotypes, cognitive functioning, and pre-/perinatal risk factors 
between disorders and between family types. Here, the three specific aims described in 
the introduction will be discussed in light of the present results, along with other issues 
that emerged from this research, critical reflections on study design and methods, and 
suggestions for clinical practice and future research.
WHicH coGnitive endopHenotypes for asd can be identified?
social cognition endophenotypes are most promising for asd
Results from several studies suggested that affective prosody might be a promising en-
dophenotype candidate for ASD (chapters 2, 3 and 6) given that it meets several of the 
proposed criteria for endophenotypes (Bearden and Freimer, 2006, Cannon and Keller, 
2006, Gottesman and Gould, 2003). Here, it was shown that affective prosody recogni-
tion was poorer in ASD-affected individuals compared to controls and thus associated 
with the disorder. This corroborates previous findings (Charbonneau et al., 2013, Golan 
et al., 2007, Korpilahti et al., 2007, Lindner and Rosen, 2006, Philip et al., 2010). Particu-
larly effects in speed stood out: children with ASD were slower to recognize emotions in 
facial and vocal expressions (chapter 3). Clinically unaffected siblings displayed similar 
deficits as their affected brothers and sisters, fulfilling the criterion that deficits should 
be present in unaffected first-degree relatives (chapters 3 and 6). Moreover, affective 
prosody recognition deficits appeared to be familial as indicated by significant sibling 
correlations (chapter 2). The convergence of these results speaks to the promise of af-
fective prosody as an endophenotype for ASD. Interestingly, impairments in affective 
prosody did not differ between affected and unaffected siblings from SPX and MPX ASD 
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families. Thus, SPX unaffected siblings also displayed poorer affective prosody recogni-
tion, despite the proposed lower genetic loading for the disorder. This might suggest 
that affective prosody is a primary deficit underlying multiple causal pathways leading 
to ASD and thus a key target in understanding etiological pathways towards ASD.
Less convincing were results regarding facial emotion recognition. Impaired facial 
emotion recognition is reported in a broad range of child and adolescent psychiatric 
disorders and is likely to contribute to enduring difficulties in social relationships that 
characterize all of these disorders (Collin et al., 2013). This implies that factors underlying 
facial emotion recognition processes play a role in the development of multiple psychi-
atric disorders (including ASD and ADHD) and thus an important area for future research 
into shared and unique risk factors for these disorders. Although facial emotion recogni-
tion deficits were familial and co-segregated with prosodic impairments (chapter 2), 
results were inconclusive as to whether or not unaffected siblings differed significantly 
from controls on this measure. In chapter 3 we observed that unaffected siblings were 
significantly slower that controls in recognizing facial emotional expressions, whereas in 
chapter 6, we did not find a difference between siblings and controls. A possible expla-
nation for this discrepancy is the difference in age range between the two studies (i.e. 
ages 6-13 years in chapter 3 and ages 6-20 years in chapter 6). Deficits in facial emotion 
recognition might be more pronounced in younger age than in older age and siblings 
might have a delayed (but not necessarily impaired) development of facial emotion 
recognition compared to controls. The impact of age and development on the relation-
ship between ASD and cognitive functioning in affected and unaffected siblings is an 
under-investigated area, but we know from studies in ADHD that the endophenotype 
characteristics of cognitive control functioning in unaffected siblings diminishes over 
time (Thissen et al., 2014). This suggests that we should consider a developmental ap-
proach in future studies exploring endophenotypes for ASD (and ADHD). An alternative 
explanation, however, might be found in the fact that stratification into SPX and MPX 
families decreased the power to the extent that we were not able to detect differences, 
with the implication that differences in facial emotion recognition between unaffected 
siblings and controls are subtle. Previous literature has also been inconclusive regard-
ing the endophenotypic properties of facial emotion recognition. Some studies have 
reported similar deficits in unaffected first-degree relatives (Adolphs et al., 2008, Kadak 
et al., 2014, Losh et al., 2009, Losh and Piven, 2007, Neves et al., 2011), others did not 
(Buitelaar et al., 1999, Castelli, 2005). Most of the studies reporting impaired functioning 
in unaffected relatives tested parents -instead of siblings- of autistic children, which 
might also partly explain different findings. This explanation however counter-argues 
an involvement of delayed development.
Taken together, our findings suggest that impairments in different aspects of social 
cognition might be qualitatively different from each other, with impaired recognition 
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of facial expressions only present in those with the disorder (state-dependent) or a 
developmental consequence of the disorder, whereas impaired recognition of affective 
prosody runs in ASD families regardless of the presence of a disorder and may provide 
an index of the multifactorial liability to ASD. Possibly, however, not a qualitative dif-
ference but a differential developmental trajectory explains the findings: children may 
more easily overcome their facial expression than their affective prosody recognition 
impairments. Clearly, more research is needed to explore the viability of facial emotion 
recognition as an endophenotype for ASD.
are impairments in executive functions not primary to asd?
Importantly, we found little support for executive functions (EF) as endophenotypes 
for ASD. This is remarkable given that EF deficits were found to be highly familial (as 
indicated by moderate to strong sibling correlations) and highly correlated with social 
cognition functioning. This led us to consider using the shared variance in future endo-
phenotype studies (chapter 2). In chapter 6, however, unaffected siblings were found 
to be unimpaired on various EF tasks compared to controls. This strongly contrasts with 
studies confirming the viability of several EF domains as endophenotypes for ADHD 
(Rommelse et al., 2008a, Rommelse et al., 2011, Rommelse et al., 2008b). Further, children 
with ASD showed impairments on some, but certainly not all EF domains. For example, 
ASD probands were not more inflexible than controls, which contrasts with previous 
studies (Corbett et al., 2009, Panerai et al., 2014). However, it is known from the literature 
that certain aspects of EF might be preserved in (family members of persons with) ASD 
(Losh et al., 2009, Wong et al., 2006), and the broader autism phenotype might not be pri-
marily characterized by impairments in EF (Wong et al., 2006). Also, some studies suggest 
differentiation in EF deficits within the ASD spectrum, with the EF profile of children with 
Pervasive Developmental Disorders – Not Otherwise Specified being less disturbed than 
the other groups (Verte et al., 2006). We did not differentiate between these subtypes, 
which might have blurred results. Again, reduced statistical power due to stratification 
into SPX and MPX might explain the lack of significant findings, but given that with the 
same sample sizes we were able to detect differences in the social cognition domain, we 
propose that EF deficits, more so than problems in the social cognition domain, are part 
of the defining features of ASD (state-dependent) or a developmental consequence of 
the disorder, rather than being an endophenotypic trait that is observable in unaffected 
siblings. Additional research in larger samples is needed to test this hypothesis.
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WHat Have We learned about sHared and unique underpinninGs 
for asd and adHd?
combining cognitive findings in asd and adHd: shared and unique 
cognitive deficits
Recognition of affective prosody appeared to be a promising endophenotype for ASD. 
Unfortunately, emotion recognition was not examined at the initial assessment of the 
ADHD cohort, therefore we were unable to examine the viability of emotion recognition 
as endophenotype for ADHD and compare results from the ASD and ADHD cohorts with 
each other. However in the follow-up assessment (NeuroIMAGE) the ADHD affected 
and unaffected siblings and controls completed the same facial emotion and affective 
prosody recognition tasks as the children from the ASD cohort. Tentative results from 
a recent study by our group (De Bruijn et al., in preparation) show that children with 
ADHD, but not their unaffected siblings had emotion recognition problems, suggesting 
that emotion recognition may not be a viable endophenotype for ADHD. Although the 
lack of significant group differences between unaffected siblings and controls might also 
be explained by a normalization in cognitive performance throughout adolescence in 
these unaffected siblings (Thissen et al., 2014), these findings suggest that emotion rec-
ognition is an endophenotype for ASD, but not for ADHD. In contrast,  little support was 
found for the viability of EF as endophenotype for ASD, whereas EF deficits were observ-
able in the majority of ADHD cases and in unaffected siblings from MPX ADHD families 
(chapter 5) corroborating previous studies in independent ADHD samples (Bidwell et al., 
2007, Goos et al., 2009, Jester et al., 2009, Nigg et al., 2004). This suggests that various EF 
domains could be considered viable cognitive endophenotypes for (MPX) ADHD, but 
not for ASD. Based on these findings, I propose that different cognitive constructs might 
play a pivotal role in the development of ASD and ADHD (i.e. social cognition is a core 
deficit in ASD, whereas EF in ADHD) and the presence of these specific cognitive impair-
ments might have a determining role in the development of either disorder.
Some open questions remain that I would like to address here. First, not all cognitive 
domains were assessed in both ASD and ADHD cohorts and in addition, slightly differ-
ent tasks were used to measure similar cognitive constructs in the separate cohorts. 
This prevented us from directly comparing ASD and ADHD probands with each other. 
Moreover, except for emotion recognition (chapter 3), we did not include combined ASD 
and ADHD as a separate group. Therefore, we cannot draw firm conclusion on whether 
or not combined ASD and ADHD is a different nosologic entity with separate cognitive 
processes giving rise to the comorbid presentation as suggested previously (Chantiluke 
et al., 2014, Rommelse et al., 2011). Our results so far suggest that the combined pres-
ence of both disorders aggravates cognitive deficits, but it does not allow us to draw 
firm conclusions on whether or not the deficits in this group are more than a simple 
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summary of dysfunctions found in ASD and ADHD alone. It is recommended that future 
family-behavioral genetic studies include four types of families: ASD only, ADHD only, 
ASD and ADHD, and control families, and assess multiple cognitive domains, using 
similar (and multiple) cognitive measures per domain to address this issue further.
Second, although effort was made to include several tasks tapping the domains of 
general intelligence, social cognition, executive function, and motor function, we were 
not able to assess all aspects of these domains, such as theory of mind and fluency. 
These functions have been implicated in ASD and ADHD research (Ames and White, 
2011, Buitelaar et al., 1999, Corbett et al., 2009, Dyck et al., 2001, Geurts et al., 2010, 
Miranda-Casas et al., 2013, Nyden et al., 2010): some might be more pronounced in ASD 
than ADHD (such as theory of mind (Ames and White, 2011, Geurts et al., 2010) and plan-
ning (Miranda-Casas et al., 2013)), or vice versa (Corbett et al., 2009), although research 
has been inconclusive herein. Based on the current findings we might expect to find 
impairments in ASD and ADHD probands and in ASD, but not ADHD siblings on theory 
of mind, given that it relies heavily on emotion recognition (Buitelaar and van der Wees, 
1997). In contrast, various EF tasks (planning, fluency) might be impaired in ASD and 
ADHD probands and ADHD (but not ASD) unaffected siblings.  However, this might not 
necessarily be so given that EF refers to a broad range of related, but distinct high level 
cognitive capacities.
Third, certain cognitive domains that have been proposed to be promising pleiotropic 
endophenotype candidates for ASD and ADHD were not tested in the cohorts, such as 
delay aversion, reward anticipation and sensory functioning. Delay aversion (i.e. the 
motivation to escape or avoid delay) and altered reward anticipation (i.e. processing 
the anticipation of a reward) have received a lot of research attention in the last decade 
and are considered (in addition to EF) prime cognitive deficits in ADHD (Bitsakou et al., 
2009, Furukawa et al., 2014, Plichta and Scheres, 2014). Affected-unaffected sibling stud-
ies in ADHD have consistently shown that both functions are viable endophenotype 
candidates (Rommelse et al., 2011). Very little is known about delay aversion in ASD 
(Rommelse et al., 2011), but impairments in reward anticipation have been implicated in 
ASD research (Stavropoulos and Carver, 2014), stressing the potential of this domain as 
pleiotropic endophenotype for ASD and ADHD. Sensory dysfunctioning (i.e. problems 
in processing sensations from one’s own body and the environment) is associated with 
both ASD and ADHD (Rogers and Ozonoff, 2005, Rommelse et al., 2011). In the new 
DSM-5, more attention is focused on sensory functioning with the inclusion of the sepa-
rate criterion ‘hyper-or hypo-reactivity to sensory input or unusual interest in sensory 
aspects of environment’ (APA, 2013). It is difficult to speculate whether the abovemen-
tioned domains are shared between ASD and ADHD, and if so, whether cognitive testing 
would reveal similar patterns in SPX and MPX ASD and ADHD affected and unaffected 
siblings. Future studies are needed to improve our understanding of the (pleiotropic) 
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endophenotypic properties of these cognitive domains for ASD and ADHD. The neu-
rocognitive tasks used here were thus by no means representative of the full domain 
of neurocognitive functions and tasks relevant for ASD and ADHD. Note, however, that 
compared with many studies in the literature, the studies in this thesis rank very high in 
terms of comprehensiveness of the tasks investigated.
co-occurrence of asd and adHd results in poorer emotion recognition skills
We tested the impact of the comorbid presence of ADHD on ASD-related social cognitive 
deficits (i.e. impaired recognition of facial expressions and affective prosody) (chapter 
3). Our results clearly showed that children with a combined diagnosis of ASD and ADHD 
had poorer outcomes on both visual and auditory emotion recognition than autistic 
children without ADHD. This poorer performance in the comorbid ASD and ADHD group 
was not solely a consequence of typical ADHD-related cognitive problems (such as im-
paired inhibition and attention): group differences between ASD-only and ASD+ADHD 
children on affective prosody recognition remained present after controlling for these 
measures. This corroborates other studies that suggested a more pronounced impair-
ment in children with co-diagnoses of ASD and ADHD (Tye et al., 2013a, Tye et al., 2013b). 
Whether this translates to other cognitive domains (such as EF, motor function, etcetera) 
was not tested in this thesis, but based on the findings by Tye and colleagues, this seems 
likely (Tye et al., 2013a). However, dysfunctions of children with a combined ASD and 
ADHD diagnosis might not merely be the sum of the dysfunctions seen in children with 
ASD-only and with ADHD-only (Nyden et al., 2010, Rommelse et al., 2011). These results 
demonstrate that comorbidity has a not-to-be-ignored impact on cognitive function-
ing and the presence of comorbid psychopathology should be accounted for in future 
endophenotype/cognitive research. Clinicians should pay special attention to these 
children suffering from symptoms of both spectra given that they are at highest risk for 
impaired cognitive functioning.
are pre-/perinatal antecedents specific for asd or adHd?
In chapter 7, we investigated whether shared pre-/perinatal risk factors might partly 
account for the high co-occurrence of ASD and ADHD. Since ASD or ADHD have been 
studied mostly in isolation, we have little knowledge about whether pre-/perinatal 
risk factors are shared between the disorders. Based on such previous reports, it was 
expected that certain pre-/perinatal risk factors (such as advanced parental age, low 
birth weight, stress and smoking during pregnancy) might be shared between ASD 
and ADHD, given that these risk factors were found to be significantly associated with 
both disorders. Other pre-/perinatal risk factors might be specifically related to ASD 
(e.g. maternal infections, and birth injury or trauma) or ADHD (e.g. exposure to alcohol 
or toxins, low maternal age), given that these factors were only implicated in ASD or 
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ADHD research (Gardener et al., 2009, 2011, Langley et al., 2005, Mick et al., 2002, Mill 
and Petronis, 2008, Thapar et al., 2013, Throckmorton-Belzer et al., 2009, Visser et al., 
2013). Our study was designed to test the sharing and uniqueness of the involvement 
of pre-/perinatal risk factors for ASD and ADHD by directly comparing ASD and ADHD 
cases and their unaffected siblings from sporadic and familial case families. Much to our 
surprise, no pre-/perinatal risk factors were found to be significantly associated with 
both disorders. Instead, risk factors were relatively specific for ASD and ADHD, although 
this finding should be interpreted with caution given the limited sample sizes of SPX 
ADHD families combined with the low exposure rates and interdependence for some 
of the pre-/perinatal risk factors. Another important finding was that the risk factors 
associated with ADHD (amongst others smoking during pregnancy) appear to index an 
increased shared risk corroborating previous studies suggesting that the association 
between ADHD and maternal smoking might be an inherited or gene x environmental 
effect (Thapar et al., 2013). In contrast, in ASD, pre-/perinatal risk factors were only pres-
ent in affected offspring and thus possibly have a more determining role in the disorder.
To our knowledge, no previous studies were published that report on the specificity 
of pre-/perinatal risk factors for ASD and ADHD. Recently, a study was published that 
hypothesized that ASD and ADHD, as well as cerebral palsy (CP), are all the result of an 
exaggerated fetal central nervous system inflammatory response to a pre-/perinatal re-
sponse (such as hypoxia, maternal infection a fetal infection, or a maternal inflammatory 
disease), with a suggested timing effect of the insult 32-40 weeks post-conception for 
ADHD and 36-48 weeks post-conception for ASD (Strickland, 2014). Strickland suggests 
inflammatory insults might impact on glutaminergic and GABAergic tracts (both devel-
op during the last trimester of the pregnancy) potentially resulting in the development 
of one of these disorders. In addition, thalamic white matter tracts might be involved 
in ADHD development (Strickland, 2014). This might suggest that it is not the specific 
insult, but the timing of the insult that might be relevant for ASD or ADHD development. 
We did not investigate timing effects of the identified pre-/perinatal risk factors, but this 
would be an interesting addition to our current design. Notwithstanding the limitations 
of our study, our findings provide a novel perspective on pre-/perinatal antecedents in 
ASD and ADHD. They suggest that pre-/perinatal risk factors play a crucial role in the 
developmental pathways discriminating the disorders, potentially on a background 
of shared genetic factors. These results can stimulate further research on the complex 
etiologies of ASD and ADHD and the role of pre-/perinatal antecedents herein. A more 
optimal design to map out the role of pre-/perinatal risk factors in ASD and ADHD would 
be to study these factors (including inflammatory insults and maternal infections) pro-
spectively during different stages of pregnancy (e.g. in a longitudinal follow-up study of 
high-risk infant siblings) while considering the role of gene x environmental interactions 
between these pre-/perinatal insults and genetic susceptibility to the disorders.
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eXplorinG tHe validity of spX-mpX stratification
does spX-mpX stratification help in identifying shared and unique 
underpinnings of asd and adHd?
All considered, one could answer affirmatively. Comparing ASD traits in SPX and MPX 
ADHD family members (and vice versa, ADHD traits in SPX and MPX ASD families) al-
lowed us to test whether the overlap between ASD and ADHD in affected children and 
their first-degree family members depends on shared or non-shared causal mechanisms 
underlying the primary disorder in the family. If the shared additive genetic factors 
proposed to explain the large portion of covariance in ASD and ADHD (Ronald et al., 
2008) are polygenic in nature, then we would expect to find a heightened prevalence 
of comorbid ASD symptoms in ADHD MPX, but not SPX families (and vice versa higher 
prevalence of ADHD in ASD MPX but not SPX families). This was indeed what we found. 
Highest levels of cross-disorder traits were found in first-degree relatives from MPX 
families, suggesting that these relatives were at highest risk for developing ASD and 
ADHD traits (compared to relatives from SPX families and normal controls). Based on 
our findings it might thus be hypothesized that in most cases, the genetic risk factors 
underlying comorbid ASD and ADHD are common polymorphisms with small effects 
given the higher prevalence of comorbidity in MPX families. Tentative findings suggest 
that these common polymorphisms may modulate ASD and ADHD severity (Gadow 
et al., 2013). This does not preclude the possibility that strong genetic effects can also 
lead to comorbidity in a subset of families, as the literature on CNVs for ADHD suggests 
that the same rare variants (with potentially large(r) effect sizes) overlap with those for 
ASD (Williams et al., 2012, Williams et al., 2010) and in several ASD CNV studies, family 
members of the ASD patients also carrying the CNV had diagnoses of ADHD (Marshall et 
al., 2008, Rommelse et al., 2010, Weiss et al., 2008). However, it is known that ASD greatly 
reduces reproductive fitness (meaning that affected individuals do not transmit the 
genetic defects) (Ploeger and Galis, 2011). Rare, deleterious variants underlying ASD are 
thus likely subjected to natural selection and therefore removed (or maintained at a low 
frequency) in the population (Jouan et al., 2012). This also decreases the likelihood that 
rare genetic variants with large effect account for many comorbid ASD and ADHD cases.
Moreover, the type of diagnosis (ASD or ADHD) of the proband appeared informative 
for behavioral comorbidity outcomes in these children and their unaffected relatives. 
Unaffected siblings from families with multiple siblings with ASD were at highest risk 
for ASD and ADHD symptoms. The reversed pattern was not found (MPX ADHD unaf-
fected siblings having highest levels of ASD traits), suggesting that ADHD might be 
seen as a milder, less severe subtype within the ASD spectrum as has been stated in the 
gradient overarching disorder hypothesis (Van der Meer et al., 2012) or that risk factors 
underlying ASD may overlap to a larger degree with risk factors underlying ADHD than 
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vice versa (Rommelse et al., 2010, van Steijn et al., 2012). All in all, our findings indicate 
that family members of MPX families are at highest risk of displaying subthreshold ASD 
and/or ADHD symptoms, making these families of particular interest for future studies 
targeting the overlap between ASD and ADHD.
is spX-mpX stratification based on familial re-occurrence a promising 
approach to parse etiological heterogeneity in asd and adHd?
Overall, our findings suggest that differences exist between SPX and MPX forms of ASD 
and ADHD hinting at potentially different underlying causal pathways. When comparing 
affected children from SPX and MPX families with each other, it was found that familial 
(MPX) ADHD was related to a wide range of cognitive vulnerabilities, including deficits 
in response inhibition and motor control. In contrast, these domains were relatively 
spared in SPX ADHD, yet lower TIQ and impairments in visual working memory and time 
estimation were more pronounced in these SPX ADHD probands (chapter 5). Similarly, 
SPX ASD probands also displayed lowest IQ compared to MPX cases, in addition to more 
pronounced emotion recognition problems (chapter 6). These findings suggest that 
different causal pathways may lead up to –on the surface- comparable cognitive deficits 
in affected children, a phenomenon referred to in developmental psychopathology as 
equifinality (Cicchetti and Rogosch, 1996). Although the reality of equifinality is well-
recognized (Nigg et al., 2004, Sonuga-Barke, 2002), few solutions have been provided 
to tease etiological heterogeneity apart. SPX-MPX stratification may be a step forward 
in unravelling these various causal pathways and may thus help reduce etiological 
heterogeneity.
Further support for the usefulness of SPX-MPX stratification in parsing etiological 
heterogeneity was found when looking at the cognitive manifestations of unaffected 
siblings. What is often overlooked in the literature is the heterogeneous character of the 
unaffected sibling group. In schizophrenia, another complex, highly heritable disorder, 
different cognitive subtypes (normal, mixed, impaired) within the unaffected siblings 
group were found (Quee et al., 2014) and this is expected for ASD and ADHD siblings 
as well given the high etiological heterogeneity of both disorders. We proposed that 
different modes of inheritance (i.e. sporadic vs. familial) likely explained why some 
unaffected siblings perform cognitively normal (siblings from SPX families), whereas 
others are impaired (siblings from MPX families). Our findings strongly support this 
hypothesis for ADHD, but less so for ASD. In ADHD, unaffected siblings from SPX ADHD 
families were generally unimpaired compared to controls (except for verbal working 
memory), whereas MPX ADHD unaffected siblings showed impairments on most cog-
nitive domains. Thus, siblings stemming from families with non-shared (de novo) risk 
factors underlying the disorder in the proband performed normal on cognitive tasks 
(‘the normal group’), whereas siblings stemming from families with shared (inherited) 
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risk factors underlying the disorder in the proband showed similar (yet milder) cogni-
tive impairments as their affected brother or sister (‘the mixed or impaired groups’). In 
contrast –and rather unexpectedly-, unaffected siblings from both SPX and MPX ASD 
families performed significantly poorer than controls on affective prosody recognition. 
Here, the difference between SPX and MPX unaffected siblings was less obvious given 
that the unaffected siblings from SPX ASD families were not completely clean from 
cognitive deficits. The finding that unaffected siblings from SPX ASD and ADHD families 
displayed some cognitive problems (i.e. poorer affective prosody recognition in ASD and 
poorer verbal working memory in ADHD), suggests that also in SPX families some risks 
may be shared between family members, and the distinction between MPX and SPX 
may be quantitative rather than qualitative. Etiological heterogeneity of ASD and ADHD 
may be parsed by stratifying families into families with stronger (MPX) versus weaker 
(SPX) familial aggregation of disorder-related neurocognitive deficits.
do we need to subgroup children based on familiality?
These results cater to the ongoing debate on the need of subgrouping in ASD and ADHD 
(Grzadzinski et al., 2013). The high within-disorder heterogeneity of both ASD and ADHD 
presents significant challenges to the search for genes and for effective treatments. 
Genetic and intervention studies might be more effective if ‘true’ etiological subgroups 
within ASD or ADHD could be identified for study, rather than the heterogeneous whole. 
Recent attempts have mostly focused on defining subgroups (beyond current DSM-5 
defined subtypes) at the phenotypic or cognitive level (Charman et al., 2011, Georgia-
des et al., 2013, Nigg et al., 2002, Nigg et al., 2005, Sonuga-Barke, 2002, Willcutt et al., 
2005). For example, neuropsychological impairments characterize only a portion of the 
children with ASD and ADHD and do not contribute causally to the disorder in all cases, 
suggesting that we might need ‘neuropsychologically impaired’ subtypes (Nigg et al., 
2005). Yet, these studies do not explicitly address etiological heterogeneity. Based on 
our findings of differences between sporadic and familial forms of ASD and ADHD (nev-
ertheless resulting in fairly similar behavioral and cognitive profiles in affected children 
from these two types of families), I propose that subgrouping ASD and ADHD based on 
family re-occurrence (i.e. sporadic vs. familial) is a necessary first step in parsing etiologi-
cal heterogeneity, before behavioral or cognitive subtypes within these different modes 
of inheritance can be identified.
issues that emerge from the spX-mpX stratification method
Worthy of note is that the ratio between SPX and MPX families was different for ASD and 
ADHD. In ASD, about a third of families were SPX, a third was MPX, and a third could not 
be classified. In contrast, in ADHD the vast majority of families were MPX (72%), and only 
a small subsample (13%) could be considered SPX (another 15 % could not be classified). 
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This is an important finding in itself and may suggest that most ADHD cases are caused 
by multifactorial common genetic and non-genetic risk factors with low penetrance, 
whereas in ASD, a substantial proportion of causes is likely caused by non-transmitted 
(de novo) genetic or incidental environmental risk factors. This might partly explain why 
rare, genetic variants have received relatively little attention in ADHD research, although 
recently several studies were published on rare variants and de novo mutations in ADHD 
(Ben Amor et al., 2005, Elia et al., 2012, Lionel et al., 2011, Williams et al., 2012, Williams 
et al., 2010). In any case, a small proportion of ADHD families exist in which only one 
individual has developed ADHD whilst the other family members are also at heightened 
risk (given elevated levels of ADHD traits in unaffected relatives). These families might 
be particularly valuable for detecting protective mechanisms decreasing the risk for 
developing ADHD and of particular interest for (whole-) exome sequencing studies 
exploring the genome for rare ADHD-related de novo mutations. That is, whole-exome 
sequencing has begun to shed light on the role of rare and de novo coding sequence 
variation, particularly in simplex ASD samples (Iossifov et al., 2012, O’Roak et al., 2011, 
O’Roak et al., 2012, Sanders et al., 2012). Applying these analyses in simplex ADHD fami-
lies may lead to the discovery of new ADHD risk variants.
Some limitations emerged from this model that need to be addressed. First, SPX-
MPX stratification is not a straightforward one. Correct classification requires valid 
knowledge of family history and fecundity is a major confounder (Sullivan et al., 2012). 
Moreover, classification was based on the number of affected individuals per nuclear 
family, which indicates that in order to accurately classify the family, no subsequent 
pregnancies should follow the birth of the (then) youngest child and all individuals 
should carefully be phenotyped. This limits the ability of the SPX-MPX stratification in 
providing current generation parents with reliable risk estimates of having another 
child with the disorder. Including extended family data (grandparents, cousins, aunts, 
and uncles) might improve classification, but this requires substantial extra work, and 
runs into several ethical and practical issues (such as privacy regulations, deaths, lack 
of reliable clinical diagnosis especially for older generations). Notwithstanding the 
difficulties with correct classification, current clinical genetics practice uses family his-
tory to predict recurrence-risk of ASD. From the literature, it is known that recurrence 
rate is significantly higher in multiplex than simplex families (32.2% versus 13.5-20.1%) 
(Ozonoff et al., 2011). Our results suggest that family history might also be informative 
in ADHD genetic counseling and research. Second, it should be noted that no formal 
diagnosis was made in parents. Instead, we based the affected status of parents on self- 
and spouse report questionnaires (particularly for parents of ASD families), which may 
have overstepped the clinical boundaries of these instruments. Future studies should 
consider including observational measures and (semi-)structured diagnostic interviews 
to improve classification. Third, a number of families could not be classified based on 
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current criteria, particularly for ASD. Including extended family data might help with this 
issue as well, but alternatively, adapting criteria (e.g. an unaffected father also counts as 
unaffected male relative) might be worthwhile to consider. Preventing bias, we excluded 
these families in our analyses, but this resulted in a loss of (a) statistical power, and (b) 
potentially meaningful information these families could provide about risk factors or 
protective factors for ASD and ADHD. Future studies should therefore improve classifica-
tion.
It is important to keep in mind that SPX-MPX stratification is an overly simplified 
model to distinguish between different (non-)heritable forms of the disorder based 
on diagnostic status of the family members. Although SPX-MPX stratify is a first step 
forward, genetic hypotheses should ideally be directly tested by conducting genetic 
analyses in parent-child triads to confirm whether de novo mutations might underlie 
SPX families, and common risk factors might underlie MPX families. Still, it is unlikely that 
there is a simple dichotomy between SPX and MPX ASD/ADHD. Our findings that differ-
ences between SPX and MPX ASD/ADHD families are quantitative rather than qualitative 
(chapters 4-6), suggest that whilst factors uniquely present in the affected child (such as 
de novo mutations) might underlie ASD or ADHD in some of the SPX cases, multifactorial 
risk factors might still underlie the disorder in others (Krumm et al., 2013, Sullivan et al., 
2012). Vice versa, rare transmitted mutations may play a role in familial forms of ASD and 
ADHD. Recently, exome sequencing in extended pedigrees with multiple ASD affected 
individuals was used to identify new ASD loci (Cukier et al., 2014). The authors stated 
that since multi-incidence extended families are likely to carry ASD susceptibility loci 
of moderate to high effect, identity by descent (IBD) filtering in these pedigrees would 
permit them to isolate genes contributing to ASD pathogenesis. Using this method, the 
authors identified several new genes that likely play a role in ASD, some of them related 
to other neuropsychiatric and neurodevelopmental disorders such as intellectual dis-
ability and epilepsy (Cukier et al., 2014). Although we are still far from understanding 
the genetic background of ADHD and ASD, stratification based on family re-occurrence 
in both ASD and ADHD samples might further advance genetic research and provide 
deeper insights in genetic risks for both disorder.
do tHe results of tHis tHesis lead to a better understandinG of 
tHe overlap betWeen asd and adHd?
Together, the studies presented in this thesis provided us with a deeper insight into 
the shared and unique underpinnings of ASD and ADHD. Both disorders are character-
ized by impairments in cognitive functions, but different cognitive constructs (social 
cognition in ASD and EF in ADHD) might play a pivotal role in the development of ASD 
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and ADHD, respectively. Further, the comorbid presence of both disorders aggravated 
the cognitive impairments, indicating that comorbidity should not be ignored in future 
studies exploring the role of cognition in ASD and ADHD. Our findings also suggest 
that high co-occurrence is likely caused by shared (pleiotropic) common genetic vari-
ants with low penetrance given that levels of comorbid pathology were highest in 
MPX families, particularly in ASD, which corroborates previous findings (Ronald et al., 
2008). MPX families thus might be of primary interest when exploring shared genetic 
risk factors for ASD and ADHD. These findings also suggest that risk factors of ASD may 
overlap to a greater extent with risk factors for ADHD than vice versa (Rommelse et al., 
2010, van Steijn et al., 2012). Lastly, the lack of shared pre-/perinatal risk factors for ASD 
and ADHD indicates that the high comorbidity is not likely explained by overlapping 
pre- and perinatal antecedents. Instead, pre-/perinatal risk factors may play a crucial role 
in the developmental pathways discriminating the disorders on a background of shared 
genetic factors.
key findinGs
Ø Both affected and unaffected siblings from ASD families exhibit emotion recognition 
problems.
Ø Children with comorbid ASD and ADHD are slower in recognizing emotions, particu-
larly in vocal emotional expressions than children with ASD only.
Ø In ASD families, MPX (but not SPX) unaffected siblings display notable ASD/ADHD 
symptoms compared to controls. In ADHD families, both SPX and MPX unaffected 
siblings show higher levels of ASD/ADHD symptoms than controls.
Ø In ASD families, unaffected siblings (regardless SPX or MPX) perform normal on 
most cognitive domains (IQ, face and facial emotion recognition, inhibition, work-
ing memory, and cognitive flexibility). An important exception is affective prosody 
recognition; both SPX and MPX unaffected siblings perform poorer than controls on 
this task.
Ø In ADHD families, unaffected siblings from MPX families display deficits similar to 
their affected brother/sister on IQ, inhibition, working memory, set shifting, re-
sponse variability and timing. In contrast, unaffected siblings from SPX families are 
unimpaired on these domains.
Ø Children with a sporadic form of ASD/ADHD are cognitively more severely impaired 
than children with a familial form of ASD/ADHD.
Ø Maternal infections and suboptimal condition at birth are associated with an in-
creased risk of ASD. Low parental age, maternal diseases, and smoking and stress 
during pregnancy are associated with an increased risk of ADHD. Except for large 
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family size and more firstborns amongst affected offspring, no pre-/perinatal risk 
factors are significantly associated with both disorders.
Ø In ASD families, pre-/perinatal risk factors are more often reported in affected than 
unaffected siblings, whereas in ADHD families these risk factors are shared between 
affected and unaffected siblings.
Ø There are less SPX ADHD families than SPX ASD families.
strenGtHs and limitations
The strengths of this thesis are 1) the combined use of, two large family-behavioral 
genetic cohorts of ASD families, ADHD families and control families, 2) administration 
of gold-standard, well-validated dichotomous DSM measures of ASD and ADHD to thor-
oughly screen all participating family members for ASD and ADHD, and 3) simultaneous 
study of multiple candidate endophenotypes.
Some limitations also need to be acknowledged. Discussed in more detail above 
were the limitations that arose from the SPX-MPX stratification and the selected study 
methods. Further, the small group of SPX ADHD families, and the moderate sample sizes 
for SPX and MPX ASD families might have reduced statistical power to detect group 
differences. Therefore, we calculated effect sizes to accompany statistical testing to 
qualify all effects and not only those that reached statistical significance. In addition, 
pre-/perinatal data were available for about 50% of the ADHD cohort. The combination 
of the large proportion of missing data, the small sample size of SPX ADHD families, 
and the low exposure rates and interdependence of some of the pre-and perinatal risk 
factors might have resulted in decreased power to detect some true group differences. 
This combined with the fact that we used a novel approach and were the first to directly 
compare pre-/perinatal risks for ASD and ADHD indicates that our studies need replica-
tion in independent, larger samples.
A second limitation was the wide age range (2-20 years). Age has a strong effect on 
neurocognitive performance (Paus, 2005) and is a factor in symptom presentation. 
Therefore, we controlled for age-effects by including age as a covariate in the analyses 
(chapters 2 and 3), or by regressing scores for each dependent cognitive measure on 
age and using the unstandardized residuals as dependent variables (chapters 5 and 6). 
Arguably, the study of cohorts of the same age in longitudinal designs would be the 
ideal design to address effects of age and give insight into developmental maturation. 
Inclusion of hundreds of children with a diagnosis of ADHD and ASD of the same age is, 
however, difficult to achieve.
Third, boys were overrepresented in the case groups (SPX and MPX ASD or ADHD pro-
bands, and SPX unaffected siblings from ASD and ADHD families), but underrepresented 
197
Chapter 9 : General discussion
in the control groups and MPX unaffected sibling groups. This was due to the fact that 
a) ASD and ADHD are more frequently diagnosed in males and b) the presence of male 
unaffected siblings was only required for SPX, but not MPX families. However, we do not 
believe that this has affected the results, since the effect of sex was adjusted for in each 
study. Again, achieving the same sex ratio in unaffected siblings as present in cases with 
ASD and ADHD, respectively, is very costly; it would imply to not include many available 
siblings in the study. In all likelihood, the loss of available information on “difficult to 
recruit” patients and their siblings does not outweigh the advantage that may be gained 
for matched sex samples.
A fourth limitation is that both ASD and ADHD samples consisted of average function-
ing children (IQ ≥ 70), which might limit the generalizability of our findings to the broad 
range of ASD and ADHD. It might be worthwhile to extend these results to lower-func-
tioning individuals, where the impairments on the various cognitive domains might be 
more pronounced. Results from chapters 5 and 6 suggest that children with ASD/ADHD 
and lowered intelligence levels more often had SPX than MPX forms of the disorder. The 
inclusion of lower functioning ASD or ADHD patients might reveal different SPX-MPX 
ratios. Intellectual disability is frequently caused by non-hereditary genetic mutations 
(Hamdan et al., 2011, Rauch et al., 2012). Literature has also shown that children with 
ASD with de novo mutations have significantly lower non-verbal IQs than children with 
ASD who do not carry these mutations (Ronemus et al., 2014). However, one of the dif-
ficulties that plague the literature in general is that comparable versions of tasks tapping 
relevant cognitive domains that can be used in lower functioning individuals are not 
available. This seriously hinders research in this group.
Last, only participants of European Caucasian ethnicity were included in order to 
minimize genetic variation between families. However, this may limit the generalization 
of our findings to other ethnic groups.
clinical implications
Although this thesis in general addresses a more theoretical - instead of a clinical - 
theme, results do lead to some clinical implications.
Ø Clinicians should be aware of the family history of psychopathology in diagnosis 
and counseling. First-degree family members of patients from MPX ASD and ADHD 
families are at highest risk of developing behavioral or pathology-related cognitive 
difficulties. This highlights the need to assess such problems in these relatives and to 
follow them up over time in order to track their development.
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Ø Awareness of family history might inform therapeutic interventions. Specific cog-
nitive strengths and weaknesses profiles in SPX and MPX forms of ASD and ADHD 
might help tailor treatment to best suit the needs of the affected child.
Ø Comorbidity of ADHD in ASD and vice versa should not be ignored in diagnosis, 
treatment and counseling. Children with a co-diagnosis of ASD and ADHD have 
the poorest outcomes cognitively and might benefit most from different treatment 
strategies compared to children diagnosed with ASD- and ADHD-only.
Ø Pre- and perinatal complications are more frequent in children with ASD and ADHD 
compared to control children. Counseling of pregnant women should focus on 
decreasing maternal stress during pregnancy by helping mothers to cope with or 
decrease the exposure to stress, or help pregnant women to stop smoking as this, 
among multiple positive outcomes, reduces the risk for ADHD.
recommendations for future researcH
In discussing our main findings, several recommendations for future research emerged. 
The common thread in these recommendations was that future studies should consider 
family re-occurrence and comorbidity in studying the etiology of ASD and ADHD. A 
summary of the recommendations is provided below.
Ø Comorbidity has a not-to-be-ignored impact on cognitive functioning and the pres-
ence of comorbid psychopathology should be accounted for in future endopheno-
type/cognitive research.
Ø Given that etiologies differ between single-incidence or sporadic (SPX) and multi-
incidence or familial (MPX) ASD and ADHD families, future studies should account 
for family re-occurrence of the disorder when examining the genetic and cognitive 
underpinnings, pre-/perinatal antecedents, and phenotypic manifestations of ASD 
and ADHD. Given the relatively low occurrence of sporadic ADHD, strategic overs-
ampling of SPX ADHD families might be necessary to increase the power of studies 
using the SPX-MPX stratification.
Ø As a next step, future studies should follow-up families with sporadic and familial 
ASD or ADHD to examine the behavioral and cognitive development of the affected 
and unaffected siblings over time. Longitudinal follow-up studies of extended fami-
lies (parents, siblings, and next generation offspring) would be the ideal design to 
tackle these research questions.
Ø Based on the finding that individuals with low(est) IQs were more frequently from 
SPX families, we hypothesize that risk factors that underlie sporadic cases of psycho-
pathology (such as de novo mutations or incidental environmental factors of strong 
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effect) are more frequent in lower functioning patients and result in more pro-
nounced cognitive deficits. It would be worthwhile to investigate these hypotheses 
by extending our findings to families of lower-functioning individuals. The inclusion 
of lower functioning ASD or ADHD patients might reveal different SPX-MPX ratios.
Ø Although SPX-MPX stratification is a first step forward, genetic studies should di-
rectly test parent-child triads to confirm whether de novo mutations might underlie 
SPX families, and common risk factors might underlie MPX families.
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samenvattinG in Het nederlands (summary in dutcH)
Autisme spectrum stoornissen (ASS) en aandachtstekort stoornis met hyperactiviteit 
(ADHD) zijn psychiatrische ontwikkelingsstoornissen. ASS wordt gekenmerkt door be-
perkingen in de sociale interactie en (non-)verbale communicatie en door een beperkt, 
repetitief of stereotiep gedragspatroon (APA, 2013). ADHD wordt gekenmerkt door 
concentratieproblemen en/of hyperactief (rusteloos) en impulsief gedrag (APA, 2013). 
Recente prevalentie cijfers tonen aan dat ASS bij ongeveer 1% van de populatie voor-
komt en ADHD gemiddeld bij 5% van de populatie (Erskine et al., 2013, Kim et al., 2011, 
Russell et al., 2014). Beide stoornissen komen vaker voor bij mannen dan bij vrouwen. 
Ook komen ASS en ADHD vaak samen voor: ongeveer 30-80% van de kinderen met 
ASS laten kenmerken zien passend bij de diagnose ADHD. Vice versa voldoet ongeveer 
20-50% van de kinderen met ADHD ook aan de klinische criteria voor ASS (Rommelse 
et al., 2011, Simonoff et al., 2008). Verder zijn personen met ASS en ADHD bekend met 
cognitieve functie problemen. ASS wordt onder andere gekenmerkt door problemen in 
de sociale cognitie (zoals moeite hebben met het herkennen van emoties), executieve 
functies (moeite met het wisselen van gedrag), centrale coherentie (geneigd zijn om 
te focussen op details in plaats van op het geheel) en een lagere verbale intelligentie. 
ADHD wordt onder andere gekenmerkt door executieve functie problemen (bijvoor-
beeld moeite met het remmen van gedrag), aandacht- en geheugenproblemen (zie 
voor een uitgebreid overzicht Rommelse et al., 2011).
Hoewel ASS en ADHD wereldwijd vaak voorkomen, zijn de oorzaken en mechanis-
men die ten grondslag liggen aan de ontwikkeling van één of beide stoornissen in 
een individu veelal onbekend. Het onderzoek hiernaar wordt bovendien bemoeilijkt 
door de grote verscheidenheid (ook wel heterogeniteit genoemd) in uitingsvormen, 
ontwikkelingsbeloop en onderliggende etiologische factoren, die beide stoornissen 
kenmerkt. Geen kind met ASS of ADHD is hetzelfde als een ander, en waarschijnlijk zijn 
er honderden verschillende genetische en niet-genetische risicofactoren, die doorgaans 
in combinatie met elkaar kunnen leiden tot ASS en/of ADHD. Dit belicht de complexiteit 
van beide stoornissen en de enorme uitdaging voor het huidige onderzoek, om de 
oorzaken van ASS, ADHD of beide stoornissen vast te stellen. Door het identificeren 
van etiologisch meer homogene subgroepen wordt de heterogeniteit ingeperkt. Door 
vervolgens binnen deze subgroepen te zoeken naar de biologische oorzaken van ASS 
en ADHD wordt de kans op het vinden van risicofactoren mogelijk vergroot. Daarnaast 
worden ASS en ADHD doorgaans afzonderlijk van elkaar onderzocht, hoewel ze in de 
praktijk veelvuldig samen voorkomen. Hierdoor bestaat er nog veel onduidelijkheid 
over unieke en gedeelde factoren van beide stoornissen. Door ASS en ADHD gezamen-
lijk te bestuderen, kunnen nieuwe inzichten in de pathofysiologie van beide stoornissen 
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naar voren komen. Dit kan het onderzoek naar de onderliggende etiologie en effectieve, 
individuele behandelingen voor ASS en ADHD bespoedigen.
Het verminderen van HeteroGeniteit
endofenotypen
Het vinden van (cognitieve) endofenotypen zou kunnen helpen, om meer homogene 
subgroepen van ASS en ADHD te vinden, met een vergelijkbaar etiologisch profiel (Got-
tesman and Gould, 2003, Wang et al., 2012). Endofenotypen zijn objectieve, meetbare 
kenmerken, die erfelijk bepaald zijn en in ieder geval een deel van de genetische lading 
met de stoornis delen (Bearden and Freimer, 2006, Cannon and Keller, 2006, Gottesman 
and Gould, 2003). Endofenotypen worden opgespoord door te zoeken naar vergelijk-
bare (sub)klinische uitingen in niet-aangedane familieleden. Dit type onderzoek wordt 
veelvuldig toegepast in het ADHD veld en veel publicaties beschrijven een versterkt 
voorkomen van ADHD trekken, comorbide gedragsproblematiek en ADHD-gerelateerde 
cognitieve beperkingen in niet-aangedane gezinsleden (Rommelse, 2008, Rommelse et 
al., 2011). In ASS is onderzoek naar cognitieve endofenotypen nog minder ver ontwik-
keld. Gezien de sterke invloed van erfelijke/genetische factoren op het ontstaan van de 
stoornis, lijkt deze aanpak echter zeer interessant voor ASS onderzoek.
spX-mpX indeling
Hoewel het endofenotype model veelbelovend is, kleven er aan het model ook enkele 
nadelen. Een belangrijk nadeel is dat het model geen onderscheid maakt tussen ver-
schillende erfelijke vormen van ASS en ADHD. Grofweg gaat het endofenotype model 
uit van een multifactorieel ontstaansmodel voor ASS en ADHD. Dat wil zeggen dat 
ervan uit wordt gegaan dat de stoornis ontstaat door verschillende risicogenen en 
omgevingsfactoren, die elk met een klein effect het risico op ASS of ADHD vergroten. 
Omdat eerstegraads gezinsleden van kinderen met ADHD gemiddeld 50% van de erfe-
lijke variatie gemeenschappelijk hebben, is het waarschijnlijk, dat deze gezinsleden in 
ieder geval een deel van de ASS of ADHD risicovarianten delen. Echter, het is bekend 
uit voornamelijk ASS onderzoek, dat deze veronderstelling niet altijd recht doet aan de 
werkelijkheid. In ongeveer 10% van de personen met ASS heeft de stoornis een enkele, 
aanwijsbare genetische oorzaak (zoals bij het Fragiele X syndroom), en bij nog eens 
7-10% blijken zeldzame, niet-erfelijke genetische veranderingen (de novo mutaties) een 
rol te spelen in de ontwikkeling van ASS. In genetisch ASS onderzoek wordt daarom al 
vaak onderscheid gemaakt tussen simplex ASS (één aangedaan persoon per gezin [SPX]) 
en multiplex ASS (meerdere aangedane personen per gezin [MPX]). De verwachting is 
dat in SPX ASS, vaker dan in MPX ASS, de stoornis wordt veroorzaakt door een zeldzame, 
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niet-erfelijke genetische factor (zoals een de novo mutatie), die alleen bij het aangedane 
kind aanwezig is. In MPX ASS, echter, zou de stoornis veroorzaakt worden door verschil-
lende genetische risicofactoren, die gedeeld worden door ouders en kinderen omdat 
zij genetisch aan elkaar verwant zijn. Uit onderzoek blijkt inderdaad dat de frequentie 
van de novo mutaties veel hoger ligt in SPX ASS gezinnen (~7-10%) dan in MPX ASS 
gezinnen (~2-3%) en controle gezinnen (~1%) (Sebat et al., 2007), en dat gezinsleden 
van MPX ASS gezinnen vaker en meer ASS gedragskenmerken vertonen vergeleken 
met familieleden uit SPX ASS of controle gezinnen (Gerdts et al., 2013). Hieruit volgt dat 
het zoeken naar endofenotypen voor ASS in SPX ASS gezinnen waarschijnlijk minder 
zinvol is; naar verwachting delen de niet-aangedane gezinsleden in deze gezinnen de 
risicovariant(en) niet. In ADHD onderzoek is er relatief weinig aandacht voor zeldzame 
genetische mutaties of omgevingsfactoren (zoals medische complicaties of een laag 
geboortegewicht) in het ontstaan van de stoornis, hoewel er recentelijk enkele studies 
zijn verschenen die bewijs leveren voor een rol voor deze niet-erfelijke risico varianten 
in ADHD (D’Onofrio et al., 2014, Lionel et al., 2011, Williams et al., 2012, Williams et al., 
2010). Deze bevindingen suggereren dat ook in ADHD, een mogelijk onderscheid be-
staat tussen SPX en MPX gezinnen. Eveneens waardevol is het uitzoeken of SPX-MPX 
indeling behulpzaam is in het zoeken van gedeelde en unieke grondslagen van ASS en 
ADHD. Deze vernieuwende aanpak, die besproken wordt in hoofdstukken 4 t/m 7, levert 
ons hopelijk nieuwe inzichten op over de rol van cognitie, pre-/perinatale risicofactoren, 
en gedrag in verschillende erfelijke vormen van ASS en ADHD.
doel van dit proefscHrift
Dit proefschrift heeft ten doel, om de gedeelde en unieke mechanismen, die ten grond-
slag liggen aan ASS en ADHD, te onderzoeken, door pre-/perinatale risicofactoren en 
cognitieve functies in beide stoornissen met elkaar te vergelijken. Vernieuwend aan 
dit proefschrift is, (a) dat ASS en ADHD gezamenlijk worden bestudeerd, en (b) dat er 
een onderscheid is gemaakt tussen verschillende erfelijke varianten van ASS en ADHD 
(SPX-MPX indeling) in een poging de etiologische heterogeniteit die beide stoornissen 
kenmerkt in te perken. Drie specifieke onderzoeksdoelen in dit proefschrift zijn:
a) Het identificeren van cognitieve endofenotypen voor ASS (in navolging van uitge-
breid endofenotype onderzoek in ADHD) (hoofdstukken 2 en 3).
b) Het onderzoeken van gedeelde en unieke grondslagen voor ASS en ADHD door het 
vergelijken van gedragskenmerken, cognitieve functies en pre-/perinatale risicofac-
toren in ASS en ADHD (hoofdstukken 4 – 7).
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c) Nagaan of (de mogelijke oorzaken voor) het samen voorkomen van ASS en ADHD 
afhangt van of er één gezinslid of meerdere gezinsleden per gezin zijn aangedaan. 
Voor dit doel werden aangedane en niet-aangedane gezinsleden uit SPX en MPX ASS 
en ADHD gezinnen met elkaar vergeleken op het gebied van gedrag, cognitie en de 
vroege ontwikkeling (hoofdstukken 4 - 7).
data
Om bovenstaande onderzoeksdoelen te toetsen, gebruiken we data van twee groot-
schalige familiestudies, het Biologische Oorzaken van Autisme (BOA) project en het 
Internationaal Multicenter ADHD Genetica (IMAGE) project. Aan beide projecten 
namen kinderen met een klinische diagnose ASS (BOA) of ADHD (IMAGE), hun biolo-
gische broers/zussen en hun biologische ouders deel. Alle gezinsleden zijn uitgebreid 
onderzocht op de aanwezigheid van ASS en ADHD gedragskenmerken en op cognitief 
functioneren. Onder andere intelligentie, sociale cognitie, executieve- en motorische 
functies is getoetst. Tot slot is de vroege ontwikkeling (pre- en perinataal) van elk kind 
met de ouders besproken. Voor de studies beschreven in hoofdstukken 4 t/m 7 zijn de 
deelnemende gezinnen opgedeeld in gezinnen met één individu met ASS of ADHD 
(SPX) en gezinnen met meerdere individuen met een stoornis (MPX).
de belanGrijkste bevindinGen van dit proefscHrift
Ø Kinderen met ASS en hun klinisch niet-aangedane broers en zussen laten vergelijk-
bare problemen op het gebied van emotieherkenning zien (hoofdstukken 2, 3 en 6)
Ø Het comorbide voorkomen van ASS en ADHD heeft een niet te negeren invloed op 
het cognitieve functioneren van een kind. Kinderen met zowel ASS en ADHD zijn 
langzamer in het herkennen van emoties, en vooral in het herkennen van emoties in 
de stem (affectieve prosodie), vergeleken met kinderen met enkel ASS (hoofdstuk 3)
Ø In ASS gezinnen laten MPX (maar niet SPX) niet-aangedane broers/zussen significant 
verhoogde ASS en ADHD symptomen zien vergeleken met controle kinderen. In 
tegenstelling, in ADHD gezinnen laten zowel SPX als MPX niet-aangedane broers/
zussen verhoogde niveaus van ASS en ADHD symptomen zien (hoofdstuk 4)
Ø In ADHD gezinnen laten de niet-aangedane kinderen uit MPX gezinnen vergelijkbare 
cognitieve beperkingen zien als hun aangedane broer/zus op IQ, inhibitie, werk-
geheugen, cognitieve flexibiliteit, variabiliteit in reactie en timing. Echter, de niet-
aangedane kinderen uit SPX ADHD gezinnen laten een normale cognitieve prestatie 
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zien vergeleken met controles, met een uitzondering voor verbaal werkgeheugen 
(hoofdstuk 5).
Ø In ASS gezinnen presteren de niet-aangedane kinderen normaal op de meeste 
cognitieve domeinen (IQ, gezichtsherkenning, herkenning van emotionele gezichts-
uitdrukkingen, inhibitie, werkgeheugen en cognitieve flexibiliteit), ongeacht of ze 
uit een SPX of MPX gezin komen. Een belangrijke uitzondering is affectieve prosodie; 
zowel SPX als MPX niet-aangedane kinderen laten een slechtere prestatie zien dan 
controle kinderen op deze taak, vergelijkbaar met hun aangedane broer/zus (hoofd-
stuk 6).
Ø Kinderen met een sporadische (SPX) vorm van ASS of ADHD zijn cognitief gezien 
meer beperkt dan kinderen met een familiale (MPX) vorm van ASS of ADHD (hoofd-
stukken 5 en 6).
Ø Infecties tijdens de zwangerschap en een suboptimale conditie tijdens de geboorte 
zijn geassocieerd met een verhoogd risico op ASS. Jong ouderschap en ziektes, 
roken en stress tijdens de zwangerschap zijn geassocieerd met een verhoogde 
kans op ADHD. Behalve een grotere gezinsomvang en meer eerstgeborenen onder 
aangedane kinderen, zijn er geen pre- of perinatale risicofactoren die significant 
geassocieerd zijn met beide stoornissen (hoofdstuk 7).
Ø Er zijn minder SPX ADHD gezinnen dan SPX ASS gezinnen in ons cohort. Dit betekent 
dat ADHD in de meeste gevallen veroorzaakt zal worden door een combinatie van 
vele genetische en niet-genetische risicofactoren die elk het risico op ADHD een 
klein beetje verhogen en die deels aanwezig zijn in niet-aangedane gezinsleden. 
Daarentegen lijken sporadische risicovarianten een rol te spelen in een aanzienlijk 
aantal ASS gevallen (hoofdstukken 4 t/m 7).
Welke coGnitieve endopHenotypes voor ass Hebben We 
Geïdentificeerd?
Uit de resultaten van hoofdstukken 2, 3 en 6 komt naar voren dat affectieve prosodie 
de meest veelbelovende endofenotypische kandidaat is voor ASS. Kinderen met ASS 
evenals hun klinische niet-aangedane broers en zussen zijn significant langzamer in 
het herkennen van emoties in de stem dan controle kinderen. Bovendien hangen de 
prestaties van broers/ zussen met en zonder ASS diagnose sterk met elkaar samen. 
Minder overtuigend zijn de resultaten met betrekking tot het herkennen van emoties 
in gezichtsuitdrukkingen. Hoewel gevonden is dat (a) kinderen met ASS problemen 
hebben met het herkennen van emotionele gezichtsuitdrukkingen en (b) herkenning 
van emotionele gezichtsuitdrukkingen sterk samenhangt met herkenning van emoties 
in de stem (hoofdstuk 2), zijn de resultaten met betrekking tot de aanwezigheid van 
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vergelijkbare beperkingen in niet-aangedane broers en zussen tegenstrijdig. De studie 
beschreven in hoofdstuk 3 laat zien dat niet-aangedane broers/zussen significant 
langzamer zijn dan controle kinderen, terwijl dit verschil tussen niet-aangedane broers/
zussen en controle kinderen niet meer gevonden wordt in hoofdstuk 6. Een mogelijke 
verklaring is het verschil in leeftijdsbereik tussen beide studies (6 – 13 jaar in hoofdstuk 
3 en 6 – 20 jaar in hoofdstuk 6). Een alternatieve verklaring is dat indeling in SPX en MPX 
gezinnen onze power om verschillen te detecteren vermindert.
Opvallend genoeg is er weinig bewijs gevonden voor de rol van executieve functies als 
endofenotypes voor ASS. Hoewel in hoofdstuk 2 wordt gevonden dat executieve func-
ties sterk familiaal zijn en sterk samenhangen met sociale cognitie, blijkt uit hoofdstuk 
6 dat niet-aangedane broers en zussen normaal presteren op executieve functiematen. 
Kinderen met ASS laten bovendien beperkingen zien op sommige, maar lang niet alle 
aspecten van executief functioneren. Dit sluit aan bij eerdere studies die aantonen dat 
(familieleden van) personen met ASS niet op alle executieve functies problemen heb-
ben (Losh et al., 2009, Wong et al., 2006).
Concluderend impliceren de bevindingen dat emotieherkenning (vooral affectieve 
prosodie) een veelbelovend endofenotype is voor ASS. Subgroepering gebaseerd op 
het al dan niet hebben van emotieherkenningsproblemen zou mogelijk kunnen helpen 
in het creëren van etiologisch meer homogene groepen en het identificeren van de 
verschillende etiologische paden naar ASS. Toekomstig onderzoek zou zich kunnen 
richten op het toetsen van andere cognitieve functies (zoals motorisch en sensorisch 
functioneren) als mogelijke cognitieve endofenotypes voor ASS en/of voor de combina-
tie ASS+ADHD, om daarmee meer licht te werpen op de verschillende causale paden die 
ten grondslag liggen aan de ontwikkeling van de stoornissen.
Wat Hebben We Geleerd over Gedeelde en unieke GrondslaGen 
voor ass en adHd?
De resultaten van onze zoektocht naar cognitieve endofenotypes voor ASS (overtui-
gend bewijs voor emotieherkenning, weinig bewijs voor executieve functies), lijken in 
scherp contrast te staan met studies die juist de geschiktheid van executieve functies 
als endofenotype voor ADHD onderschrijven (Rommelse et al., 2008a, Rommelse et al., 
2011, Rommelse et al., 2008b). Er is relatief weinig onderzoek gedaan naar de rol van 
sociale cognitie in ADHD en, naar ons weten, zijn er nog geen studies gepubliceerd die 
beschrijven of emotieherkenning een endofenotype is voor ADHD. Omdat emotieher-
kenning niet getoetst is in de oorspronkelijke meting van ons ADHD cohort, kunnen wij 
eveneens geen concrete uitspraken doen over de geschiktheid van emotieherkenning 
als endofenotype voor ADHD. Echter, uit de eerste voorlopige resultaten van een follow-
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up meting van het ADHD cohort komt naar voren dat emotieherkenning waarschijnlijk 
geen endofenotype voor ADHD is (De Bruijn et al., in voorbereiding). Op basis hiervan, 
concluderen wij dat verschillende cognitieve functies een centrale rol spelen in de 
ontwikkeling van ASS en ADHD (dat wil zeggen, sociale cognitie in ASS en executief 
functioneren in ADHD) en dat de aanwezigheid van deze specifieke cognitieve proble-
men mogelijk bepalen/voorspellen of een kind ASS ontwikkelt of ADHD.
Verder blijkt dat kinderen met een dubbele diagnose ASS en ADHD langzamer zijn in 
het herkennen van emoties vergeleken met kinderen met enkel ASS (hoofdstuk 3). De 
slechtere prestatie kan niet volledig verklaard worden door de mogelijke aanwezigheid 
van aan ADHD gerelateerde cognitieve problemen, zoals moeite met het vasthouden 
van de aandacht of een verminderd vermogen om eigen gedrag te remmen. Dit sluit 
aan bij andere studies die beschrijven dat kinderen met een dubbele diagnose ASS en 
ADHD meer uitgesproken cognitieve problemen laten zien (Tye et al., 2013a, Tye et al., 
2013b), hoewel het niet noodzakelijkerwijs de som betreft van problemen die kinderen 
met enkel ASS of enkel ADHD laten zien (Nyden et al., 2010). Deze resultaten benadruk-
ken dat de invloed van comorbide gedragskenmerken op cognitie niet genegeerd mag 
worden in vervolgonderzoek.
Tot slot blijkt dat het niet waarschijnlijk is, dat de overlap tussen ASS en ADHD ver-
klaard kan worden door gedeelde pre-/perinatale risicofactoren. Behalve een grotere 
gezinsomvang en meer eerstgeborenen onder aangedane kinderen zijn er geen pre- of 
perinatale risicofactoren, die significant geassocieerd zijn met beide stoornissen (hoofd-
stuk 7). Dit betekent dat pre-/perinatale risicofactoren mogelijk een cruciale rol spelen 
in de uiteindelijke ontwikkeling van ofwel ASS ofwel ADHD tegen een achtergrond van 
gedeelde genetische risicofactoren. Ons onderzoeksdesign is echter niet geschikt om 
causaliteit aan te tonen; vervolgonderzoek is nodig om deze hypothese te toetsen
Helpt de spX-mpX indelinG in de zoektocHt naar unieke en 
Gedeelde GrondslaGen voor ass en adHd?
Concluderend tonen de resultaten besproken in hoofdstukken 4 t/m 7 overtuigend 
aan, dat er etiologische verschillen zijn tussen SPX en MPX, ASS en ADHD. Niet-aange-
dane familieleden uit SPX ASS gezinnen laten nauwelijks ASS en ADHD kenmerken zien, 
terwijl MPX ASS niet-aangedane familieleden sterk verhoogde ASS en ADHD gedrags-
kenmerken laten zien vergeleken met controles (hoofdstuk 4). Op cognitief gebied is 
er weinig onderscheid tussen SPX en MPX ASS: niet-aangedane kinderen uit MPX, maar 
niet SPX ASS gezinnen, hadden een verlaagd IQ vergelijkbaar met hun aangedane 
broer/zus. Echter, kinderen met ASS en hun niet-aangedane broers/zussen –ongeacht 
SPX of MPX status- laten allemaal problemen zien bij de herkenning van emoties in 
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de stem. Executieve functies zijn relatief gespaard in alle kinderen (hoofdstuk 6). De 
bevindingen in ADHD gezinnen tonen een omgekeerd patroon. Dat wil zeggen, op ge-
dragsmatig niveau is er geen verschil tussen aangedane en niet-aangedane gezinsleden 
uit SPX en MPX ADHD gezinnen; niet-aangedane familieleden uit zowel SPX als MPX 
ADHD gezinnen laten sterk verhoogde ASS en ADHD kenmerken zien (hoofdstuk 4). 
Echter, op cognitief gebied blijken beperkingen in IQ, visueel werk geheugen en timing 
het meest prominent te zijn bij kinderen met ADHD uit SPX ADHD gezinnen, terwijl 
inhibitie en motorische controle beperkingen bij kinderen met ADHD uit MPX ADHD 
gezinnen op de voorgrond staan (hoofdstuk 5). Dit wijst op een zekere specificiteit in 
de cognitieve beperkingen geassocieerd met SPX en MPX ADHD. Bovendien laten niet-
aangedane kinderen uit SPX ADHD families normaal cognitief functioneren zien, terwijl 
niet-aangedane kinderen uit MPX ADHD families vergelijkbare cognitieve problemen 
hebben als hun broer of zus met ADHD. Tot slot wordt gevonden dat kinderen met 
ASS uit SPX gezinnen vaker eerstgeboren zijn dan kinderen met ASS uit MPX gezinnen 
(hoofdstuk 7). Dit wijst op een mogelijk verschillende rol van pre-/perinatale risicofac-
toren in de ontwikkeling van SPX en MPX vormen van ASS.
Op basis van deze bevindingen concluderen wij dat het onderscheiden van gezinnen 
waar één persoon is aangedaan en gezinnen waar meerdere personen zijn aangedaan 
een belangrijke stap is in het verminderen van heterogeniteit en het ontrafelen van 
de verschillende etiologische paden die ten grondslag liggen aan SPX en MPX vormen 
van ASS en ADHD. De implicaties van deze bevindingen voor de klinische praktijk en 
toekomstig onderzoek worden verderop besproken. Echter, het is belangrijk om in acht 
te nemen, dat de SPX-MPX indeling een sterk versimpeld model is om verschillende 
erfelijke en niet-erfelijke vormen van ASS of ADHD te onderscheiden. Verder genetisch 
onderzoek is noodzakelijk om uit te wijzen, of in SPX gezinnen inderdaad vaker niet-
erfelijke genetische of omgevingsfactoren aan de ontwikkeling van de stoornis ten 
grondslag liggen dan in MPX gezinnen. Onze bevindingen wijzen vooral op kwantita-
tieve (en niet kwalitatieve) verschillen tussen SPX en MPX ASS en ADHD. Dat suggereert, 
dat er nog steeds enige mate van heterogeniteit in de SPX en MPX groepen zal zitten. 
Ook is de SPX-MPX indeling geen statisch gegeven; een nieuwe zwangerschap zou ertoe 
kunnen leiden, dat een voorheen SPX gezin later als MPX geclassificeerd wordt. Een laat-
ste complicatie in ons onderzoek is dat een behoorlijk aantal gezinnen niet binnen de 
classificatie criteria valt, en dat slechts een klein gedeelte van de ADHD gezinnen de SPX 
status heeft, wat onze statistische power om eventuele (kwalitatieve) groepsverschillen 
te detecteren mogelijk heeft verminderd. Ondanks deze bezwaren, lijkt het stratificeren 
in SPX en MPX gezinnen een zinvolle aanpak om meer homogene groepen te creëren 
binnen de ASS en ADHD patiënten populatie. Daarmee is de indeling een waardevolle 
toevoeging aan huidig (genetisch) onderzoek.
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Welke ricHtinG Geven deze bevindinGen aan de kliniscHe 
praktijk en toekomstiG WetenscHappelijk onderzoek?
Uit dit proefschrift zijn enkele hoofdbevindingen te herleiden, die richting kunnen 
geven aan de klinische praktijk en toekomstig onderzoek.
Ø Kinderen met een dubbele diagnose ASS en ADHD hebben de slechtste uitkomsten 
op cognitief vlak. Mogelijk profiteren deze kinderen het meest van andere behan-
delstrategieën dan kinderen met een enkele diagnose ASS of ADHD. Het in kaart 
brengen van comorbide gedragskenmerken zou daarom een belangrijke rol moeten 
spelen in diagnostiek en counseling en in toekomstig onderzoek naar effectieve 
behandelmethoden voor ASS en ADHD.
Ø Uit de resultaten komt duidelijk naar voren dat er verschillen bestaan tussen SPX en 
MPX ASS en ADHD. Deze resultaten hebben implicaties voor diagnostiek, (geneti-
sche) counseling en therapeutische interventies.
§ Familieleden van MPX ASS en ADHD gezinnen lopen het hoogste risico op ge-
dragsproblematiek en/of cognitieve problemen Dit onderstreept het belang van 
het afnemen van een familieanamnese bij een kind, waarbij het vermoeden van 
ASS en/of ADHD bestaat, om de familiare belasting in kaart te brengen.
§ Het zou raadzaam zijn om de (cognitieve) ontwikkeling van niet-aangedane 
broers en zussen van (in het bijzonder) kinderen met een MPX vorm van ASS of 
ADHD in de gaten te houden, om bij eventuele problemen tijdig op te kunnen 
treden.
Ø Pre-/perinatale complicaties komen vaker voorkomen bij kinderen met ASS of ADHD 
dan bij controle kinderen. Counseling van zwangere vrouwen zou gericht kunnen 
worden op het verminderen van stress tijdens de zwangerschap of het helpen om 
te stoppen met roken tijdens de zwangerschap, omdat dit naast andere positieve 
uitkomsten, het risico op ADHD kan verkleinen.
Ø Toekomstig onderzoek naar de genetische en cognitieve grondslagen, pre-/peri-
natale risicofactoren en gedragskenmerken van ASS, ADHD of de combinatie van 
beide stoornissen, zal meer rekening moeten houden met verschillende etiologische 
vormen van ASS en ADHD. Het bestuderen van subgroepen met een verschillende 
etiologie als één totale groep leidt mogelijk tot het niet detecteren van belangrijke 
associaties tussen genen, cognitie en gedrag. Hieruit volgen enkele vervolgstappen, 
die gezet kunnen worden om tot een beter begrip te komen van de verschillen tus-
sen SPX en MPX ASS en ADHD.
§ Door middel van genetisch onderzoek zal getoetst moeten worden of sporadi-
sche risicovarianten inderdaad vaker voorkomen bij SPX ASS en ADHD, terwijl 
genetische varianten die algemeen voorkomen in de populatie, vaker aan de 
stoornis ten grondslag liggen in MPX gezinnen.
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§ Longitudinale follow-up studies, die de gedragsmatige en cognitieve ontwik-
keling van aangedane en niet-aangedane kinderen uit SPX en MPX gezinnen in 
kaart brengen, kunnen leiden tot nieuwe inzichten over het nut van de SPX-MPX 
indeling in het voorspellen van de (klinische) uitkomsten van deze kinderen over 
tijd.
§ Om de betrouwbaarheid van de SPX-MPX indeling te vergroten, kan men over-
wegen het huidige model aan te scherpen, bijvoorbeeld door data van opa’s en 
oma’s, ooms en tantes, neefjes en nichtjes toe te voegen aan de classificatie.
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dankWoord (acknoWledGements in dutcH)
Het zit erop. Na jaren van data verzamelen, analyses runnen, schrijven, nog meer analy-
ses runnen, nog meer schrijven en tot slot alle artikelen proberen te publiceren, is het 
proefschrift dan toch echt af. Er wordt vaak gezegd dat een proefschrift geen levenswerk 
is. Hoewel dat inhoudelijk wel zal kloppen (een promovendus komt doorgaans immers 
net kijken in de wondere wereld van de wetenschap), is het figuurlijk gezien een tref-
fende omschrijving van hoe ik het promotietraject heb beleefd. Het was een langdurig 
proces, met voor- en tegenslagen, successen en frustraties. Ik heb er veel van geleerd, 
over mezelf, over wetenschap beoefenen, over ASS en ADHD. Ik heb geleerd dat ik best 
aardige onderzoeksvragen kan bedenken, dat het begeleiden van stagiaires mij veel 
voldoening geeft, dat ik het werken met enorme datasets en ingewikkelde analyse-
methodes verrassend leuk vind, dat een voorliefde voor het lezen van literaire romans 
niet noodzakelijkerwijs een voorliefde voor het lezen van wetenschappelijke artikelen 
inhoudt, en dat het schrijven van artikelen – ondanks het enorme aantal computeruren- 
me toch wel ligt. Ik heb geleerd beter om te gaan met de niet aflatende stroom feed-
back, dat alles altijd langer duurt dan je denkt, dat aan voortschrijdend inzicht niet te 
tornen valt en dat pragmatisch denken noodzakelijk is (doch lastig voor iemand met een 
ietwat neurotische, perfectionistische inslag). Hoewel de werkdruk me bij tijd en wijlen 
overweldigde en ik blij ben dat het werk er nu op zit, had ik dit nooit willen missen.
Een proefschrift schrijf je niet alleen: er zijn veel mensen die direct of indirect een 
belangrijke bijdrage hebben geleverd aan de totstandkoming van dit werk. Een aantal 
daarvan wil ik graag in het bijzonder bedanken.
Allereerst, zonder deelnemers geen data. Veel dank aan alle gezinnen die deel hebben 
genomen aan het BOA project. Het was niet niets om deel te nemen; ouders werden flink 
belast met het invullen van vragenlijsten, er werden langdurige interviews afgenomen, 
de kinderen werden uitgebreid neuropsychologisch onderzocht en deelnemers lieten 
bloed prikken of stonden speeksel af. Dankzij jullie belangeloze medewerking heeft dit 
onderzoek kunnen plaatsvinden en ik ben jullie daar zeer erkentelijk voor.
Inhoudelijk gezien hebben mijn promotoren, Prof. Jan Buitelaar en Prof. Barbara Franke, 
en mijn beide copromotoren, Dr. Nanda Lambregts-Rommelse en Dr. Catharina Hart-
man, de grootste bijdrage geleverd.
Jan, stille kracht op de achtergrond. Je dacht kritisch mee en je feedback tilde de inhoud 
van mijn artikelen altijd naar een hoger niveau. Ik wil je bedanken voor de soepele sa-
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menwerking en het vertrouwen dat je in mij had de afgelopen jaren. Dank ook voor de 
kans die je me bood om als postdoc verder te werken aan ASS onderzoek.
Barbara, je bijdrage aan het gedachtegoed achter de laatste vier hoofdstukken was heel 
belangrijk. Bedankt voor je altijd opbouwende feedback. Jammer genoeg is het niet 
gelukt om het beoogde genetica artikel te schrijven. Ik hoop dat daar in de toekomst 
nog ruimte voor komt. Ik zou graag nog veel meer van je leren.
Nanda, jij begeleidde me tijdens het schrijven van mijn scriptie en vroeg me aan het 
eind van het traject of ik niet wilde blijven als promovendus. Dat liet ik mij geen twee 
keer zeggen en zo begon ik aan mijn promotietraject. Er is weinig teveel gezegd als 
ik aangeef dat je onmisbaar was tijdens dit traject. Zonder jou was dit proefschrift er 
simpelweg niet geweest. Ik heb grote bewondering voor hoe jij het begeleiden van pro-
movendi, het produceren van een veelheid aan publicaties, het binnenslepen van grote 
subsidies en het spreken op internationale congressen zo succesvol weet te combineren 
met een jong gezin en een opleiding tot GZ psycholoog. Ondanks je overvolle agenda 
maakte je altijd tijd om mijn artikelen uitgebreid te becommentariëren, mee te leven 
met acceptaties en afwijzingen, een hart onder de riem te steken als ik het even niet 
meer zag zitten. Ik heb het met je getroffen. Heel veel dank!
Catharina, jij kwam het laatste jaar van mijn traject in beeld. In eerste instantie om het 
verlof van Nanda op te vangen, maar ik ben blij dat ik je als begeleider kon behouden. Ik 
vind je een ontzettend leuke vrouw en ben bijzonder gecharmeerd van jouw no-nonsense 
aanpak. Veel dank voor de kans die je me bood om met TRAILS data te gaan werken. Je 
enthousiasme over de resultaten werkt heel aanstekelijk. Ik hoop dat we er nog een paar 
mooie publicaties uitknallen en dat we ook in de toekomst blijven samenwerken.
Aan alle leden van de leescommissie, Prof. dr. B. van Engelen (voorzitter), Dr. J.W. Muntje-
werff, Prof. dr. H. Geurts, Prof. dr. G. Zielhuis, Prof. dr. S. Durston, Prof. dr. L. Gallagher, 
en Dr. A. Scheres, ben ik veel dank verschuldigd voor de genomen moeite voor het 
bestuderen van mijn proefschrift en het voeren van de oppositie. Prof. dr. L. Gallagher, 
thank you for the time and effort spent in reading my dissertation and for coming all the 
way to the Netherlands to attend the ceremony.
Ik heb veel hulp gehad bij het verzamelen van de data waarop dit proefschrift is ge-
baseerd. Dank aan alle collega’s van Karakter die meehielpen met rekrutering, in het 
bijzonder Jos van Leeuwen die we eindeloos mochten lastigvallen voor het reserveren 
van onderzoeksruimtes. Dank aan de Nederlandse Vereniging voor Autisme en Balans 
en verschillende gemeenten in regio Nijmegen die ons hielpen bij de werving van (con-
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trole)gezinnen. Dank aan de leerkrachten die ondanks hun drukke schema tijd vrijmaak-
ten voor het invullen van de vragenlijsten. Dank aan de medewerkers van de prikpoli, 
die met veel geduld afspraken inplanden en bloed afnamen. Dank aan de medewerkers 
van de afdeling genetica die het bewerken van de bloedbuisjes op zich namen, in het 
bijzonder Johanne Groothuismink.
Veel dank ook aan alle stagiaires die hebben meegewerkt aan het neuropsychologisch 
onderzoek en het scoren van de (vele) vragenlijsten. Het was fijn om met jullie samen 
te werken. Sommige stagiaires zijn in de loop van de tijd uitgegroeid tot volwaardige 
en waardevolle collega’s. Van een aantal stagiaires heb ik de bachelor- of masterscriptie 
begeleid: Renate, Steffi, Katharina en Marlot. Katharina en Marlot, jullie wil ik in het 
bijzonder noemen omdat jullie scripties aan de basis lagen van twee hoofdstukken in 
dit proefschrift. Super gedaan meiden! Ik ben heel blij met al het werk dat jullie in de 
artikelen hebben gestoken. Ik vind het leuk om te zien dat de interesse in wetenschap-
pelijk onderzoek ook bij jullie is aangewakkerd.
Tot slot de dames die de grootste bijdrage hebben geleverd aan het BOA onderzoek: 
Daphne, Saskia en Yvette. Daphne, je bent me voorgegaan op het pad van de promotie. 
Ik ben heel trots op je dat je jouw promotietraject zo succesvol hebt afgerond en dat 
ik jouw paranimf mocht zijn. Ik ben blij dat we nog regelmatig contact hebben. Saskia, 
dank voor alle hulp bij de testdagen. Jij was een ster in het snel en goed uitvragen van 
ASS en ADHD gedrag. Yvette, je begon als onderzoeksmedewerkster, maar bent inmid-
dels ook begonnen aan een promotietraject. Heel veel succes!
Leo De Sonneville, bedankt voor alle hulp bij hoofdstuk 2. Rogier Donders, dank voor de 
altijd snelle reactie op mijn statistiekvragen. Ilse van Klei, veel dank voor het ontwerpen 
van de mooie cover.
Ik heb veel plezier beleefd aan de samenwerking met alle gezellige collega’s van de 
onderzoeksafdeling van Karakter (ook wel genaamd ‘het kippenhok’). Andrieke, Corina, 
Daphne, Evita, Iris, Kirsten, Leonie, Loes, Mireille, Mirjam, Saskia, Yvette, Yvonne, bedankt 
voor de fijne en inspirerende samenwerking. Ik denk met heel veel plezier terug aan 
de lunches in het zonnetje, de gezellige etentjes en borreltjes en de kletspraatjes op 
de werkvloer. Ik wens jullie alle goeds voor de toekomst. De collega-promovendi van 
de afdeling Psychiatrie wil ik bedanken voor de maandagmiddagmeetings, sinterkerst-
dobbelspel-avonden en sociale venten. Sanne, we hebben een geweldige tijd gehad in 
San Sebastian. Ylva, Sten, Neele en Anne, het was fijn om naast wetenschap ook bezig 
te zijn met de bestuurlijke kant van promoveren. Ik heb ons bestuursjaar bij het Promo-
vendi Overleg Nijmegen (PON) heel leuk en leerzaam gevonden.
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Jolanda, collega van het eerste uur en paranimf. We begonnen samen aan onze pro-
motietrajecten en in de eindfase hebben we menig zaterdag samen bij Karakter door-
gebracht. Met veel humor en relativeringsvermogen heb je me altijd bijgestaan, ook 
(of misschien vooral) op de momenten dat ik het even niet zag zitten. Je had altijd een 
luisterend oor en hebt enorm met mij meegeleefd, waarvoor veel dank!
Jennifer, mijn andere paranimf en sinds een half jaar kamergenootje. Jij was altijd bereid 
mee te denken of het nu om het bedenken van onderzoeksplannen, het runnen van 
analyses, het omgaan met de werkdruk, of het plannen van een promotiefeestje gaat. 
De enorme hoeveelheid intervisiemomentjes die wij het afgelopen half jaar hebben 
gehad zijn ontelbaar. Je bent zelf (bijna) aan het einde van je traject en ik weet zeker dat 
je het succesvol gaat afronden.
Minstens zo belangrijk (of misschien zelfs belangrijker) waren mijn lieve vrienden en 
familie die voor de broodnodige afleiding zorgden. Allen, heel erg bedankt voor de 
hartverwarmende belangstelling. In het bijzonder Hanneke, Josine, Karlijn, Maartje en 
Vivian. Dames van S.V. het Klootje. Ik ben zo blij met jullie! Alle leuke weekendjes weg, 
stapavondjes, festivals, kaasje-worstje-wijntjeborrelavonden, goede- en flauwekulge-
sprekken, ik zou ze voor geen goud willen missen. Het afgelopen jaar heeft veel in het 
teken gestaan van werk en ik ben blij dat er inmiddels weer meer ruimte is om samen 
leuke dingen te doen. Ik ben trots op hoe jullie alles zo goed doen in jullie eigen leven 
en ik volg het allemaal met veel belangstelling. Eeuwige vriendschap!
Mijn lieve schoonfamilie, Geert, Marian, Elles en Vincent, en Rene. Het is altijd fijn om 
jullie te zien en een zeer welkome afwisseling met werk. Giel en Loes, lieve broer en zus, 
en Arno, ontzettend dank voor jullie interesse en gezelligheid. Ik kijk altijd enorm uit 
naar onze wintersportvakanties samen. Oma, wat ben ik dankbaar dat je er 3 december 
bij bent, ik hoop dat je het een beetje leuk vindt.
Pap en mam, jullie hebben me altijd alle kansen en hulp geboden om me te ontwik-
kelen. Jullie steun, interesse en vertrouwen in mij is oneindig. Ik ben heel trots op jullie 
en ontzettend dankbaar voor het fijne thuis dat jullie mij hebben geboden.
En dan de belangrijkste persoon van allemaal, mijn lieve man Dick. Jij hebt in alles mee-
geleefd: de goede en de slechte momenten. Bedankt voor je liefde, je oneindige geduld 
en immer luisterend oor. Ik vind het heel fijn om samen met jou te mogen leven en ik 
ben er trots op dat ik jouw vrouw ben. Ik kan niet wachten tot ons volgende avontuur!
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